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 i 
ABSTRACT 
 
A major goal of synthetic biology is to recapitulate emergent properties 
of life. Despite a significant body of work, a longstanding question that 
remains to be answered is how such a complex system arose? In this 
dissertation, synthetic nucleic acid molecules with alternative sugar-phosphate 
backbones were investigated as potential ancestors of DNA and RNA. Threose 
nucleic acid (TNA) is capable of forming stable helical structures with 
complementary strands of itself and RNA. This provides a plausible 
mechanism for genetic information transfer between TNA and RNA. 
Therefore TNA has been proposed as a potential RNA progenitor. Using 
molecular evolution, functional sequences were isolated from a pool of 
random TNA molecules. This implicates a possible chemical framework 
capable of crosstalk between TNA and RNA. Further, this shows that heredity 
and evolution are not limited to the natural genetic system based on 
ribofuranosyl nucleic acids. Another alternative genetic system, glycerol 
nucleic acid (GNA) undergoes intrasystem pairing with superior 
thermalstability compared to that of DNA. Inspired by this property, I 
demonstrated a minimal nanostructure composed of both left- and 
right-handed mirro image GNA. This work suggested that GNA could be 
useful as promising orthogonal material in structural DNA nanotechnology. 
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Chapter 1 
INTRODUCTION 
The idea that DNA was the molecular structure of life began when James 
Watson and Francis Crick elucidated the DNA double helix (Figure 1.1) 
(Watson and Crick 1953). Six decades later, we have learned that DNA, in 
addition to serving as the “book of life”, has many other functions. Nucleic 
acids have provided us with useful tools for exploring and manipulating the 
activities of complex living system as well as creating potential therapeutic 
agents that can be used in the treatment of many human diseases. For example, 
the selective amplification of genomic fragments by the polymerase chain 
reaction (PCR) using designed synthetic DNA primers has become a common 
technology in genome research (Bartlett and Stirling 2003). More recently, 
inspired by naturally occurring gene regulation approach, antisense strategy 
has been developed to control the gene expression in living cells (Eguchi et al. 
1991). All these applications rely on efficient sequence-specific chemical 
(Khudyakov and Fields 2002; Muller et al. 2004) and enzymatic synthesis 
(Milligan and Uhlenbeck 1989) of RNA and DNA as well as the careful design 
of the oligonucleotide that binds the target with high affinity and specificity 
following the simple rules of Watson-Crick base pairing (Watson and Crick 
1953). 
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Figure 1.1. Structure of DNA (Watson and Crick model). A) A generic B-form 
DNA duplex. The crystal structure was obtained from Protein Data Bank 
(PDB code 436D). The figure was obtained using Pymol. B) The canonical 
Watson-Crick base pairs. 
However, it is becoming increasingly clear that as molecular recognition 
elements, nucleic acids could be far more useful than forming simple 
Watson-Crick base pairing structures. A type of special mRNA molecules 
called riboswitches effects gene expression by recognizing small molecule 
targets (Nahvi et al. 2002). Moreover, the natural components of nucleic acids 
have been altered or integrated with other functional and structural elements to 
expand the utility of nucleic acids into versatile fields such as building probes 
(Wagenknecht 2008) and material with novel functionalities (Yan 2004) and 
creating nucleic acids with enhanced or entirely new functions (Famulok 2009; 
Wilson and Szostak 1999). 
This Ph.D. thesis examines the use of synthetic nucleic acid analogs as 
building blocks for DNA nanotechnology and Darwinian evolution. The 
 3 
introductory chapter focuses on the progress of non-natural nucleic acids in 
structural DNA nanotechnology. Templated synthesis of alternative nucleic 
acid analogs is then reviewed. Last, the topic of in vitro directed evolution 
using synthetic information-carrying polymers is disscussed. The discussion 
here represents a preference and interest of the author and does not intend to 
be comprehensive. 
  1.1 Unnatural Nucleic Acids in Structural DNA nanotechnology 
In a bottom-up approach, DNA nanotechnology utilizes the specificity of 
Watson-Crick base pairing to construct well-defined structures out of DNA 
and other nucleic acids and organize material with nanometer precision (Lin et 
al 2009). Moreover, DNA nanoarchitectures have been used as probes in 
biophysical study (Sacca et al. 2008; Nangreave et al. 2011). While a 
significant effort has been made to expand the programmability of natural 
B-form DNA (Figure 1.2), very little attention has been given to the use of 
unnatural nucleic acids as building blocks for nanotechnology. By expanding 
DNA nanotechnology to include alternative polymers, it should be possible to 
create nanostructures with chemical and physical properties not found in 
natural DNA. 
The early work involving unnatural nucleic acids in DNA structural motif 
was conducted by Seeman (2004) and Yan (2006), who cleverly and carefully 
designed DNA double crossover (DX) molecules and incorporated short  
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Figure 1.2 . Models of some representative DNA tiles and their assemblies into 
periodic 2D arrays. (a) Parallelogram DNA tile formed by joining four 
Holliday junctions in parallel. (b) Double-helix (DX) tile formed through 
strand exchange between two DNA duplexes. (c) A cross-shaped tile with four 
arms (4 × 4 tile). Each arm represents a four-arm junction. (d) Six-helix 
bundle tube tile viewed from the end of the tube. For panel a−d, representative 
AFM images of the 2D arrays are shown below the corresponding cartoon 
models. (e) DNA origami: (left) principle of DNA origami, folding long 
ssDNA into shapes by multiple helper strands; (middle) star and smiley face 
DNA origami tiles self-assembled by folding a 7 kb ssDNA with more than 
200 helper strands; and (right) hairpin loops (white dots) that can be 
introduced into certain helper strands to accurately display designated 
geometries on the fully addressable origami tiles. Reprinted (adapted in part or 
whole) with permission from Biochemistry (Lin et al. 2009). Copyright 2009 
American Chemical Society. 
 
Figure 1.3. The chemical structures of peptide nucleic acid (PNA), locked 
nucleic acid (LNA), anhydrohexitol nucleic acid (HNA), and deoxyribonucleic 
acid (DNA). 
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unnatural nucleic acid strands (peptide nucleic acid (PNA) (Egholm et al. 1993) 
and locked nucleic acid (LNA) (Obika et al. 1997; Singh et al. 1998),  
respectively) (Figure 1.3). They demonstrated that this system could work as a 
general analytical tool to estimate the helicity of unnatural nucleic acids. 
As part of my Ph.D. thesis, I recently described the synthesis of a 
nanostructure composed entirely of glycerol nucleic acid (GNA, Figure 1.4)  
 
Figure 1.4. The chemical structures of flexible nucleic acid (FNA), glycerol 
nucleic acid (GNA), threose nucleic acid (TNA), and ribonucleic acid (RNA). 
(Zhang and Meggers 2005). The GNA nanostructure, a 4-helix junction (4HJ) 
motif (Zhang et al. 2008) mimics an earlier structure composed of DNA 
(Kallenbach et al. 1983). Because the GNA backbone contains only one 
stereocenter per repeating unit, it was possible to synthesize two mirror-image 
nanostructures using (S)- and (R)-GNA. A major finding was that the GNA 
4HJ was significantly more stable than the earlier 4HJ composed entirely of 
DNA (Tm 73°C for GNA versus 37°C for DNA). This feature coupled with the 
ability to construct left- and right-handed nanostructures provides new 
opportunities for building highly stable nanostructures with unique topologies 
that are not readily available to DNA.  
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Unnatural nucleic acids have expanded the repertoire of building blocks 
for DNA nanotechnology and may help introduce novel structural, chemical 
and physical properties into DNA nanostructures assembled by hierarchical 
methods. However, these potential advantages are offset somewhat by 
uncertainties in the construction of more complicated nanostructures (Lin et al. 
2009). L-DNA (Urata et al. 1991). For example, the enantiomer of the natural 
D-DNA, could have provided a possible solution to these drawbacks as L-DNA 
and D-DNA are perfect mirror-images to each other and possess the same 
duplex conformation but opposite chirality (Urata et al. 1992). Lin et al. in 
their pioneer work (Lin et al. 2009) described one-strand nanotubes and 2-D 
nanoarrays self-assembled from L-DNA by the same self-assembly designs 
and protocol as previously applied to natural D-DNA. Particularly, atomic 
force microscope (AFM) imaging confirmed that L- and D-DNA nanotubes 
exhibit opposite chirality. L-DNA nanotubes remained intact after DNA 
exonuclease digestion while D-DNA nanostructures were degraded. Taking 
this further, Seeman and co-workers (Ciengshih et al. 2011) demonstrated the 
formation of a prototype molecular weave by using a combination of D- and 
L-DNA in the same strand. In this braided nanostructure with alternating 
positive and negative nodes, L-nucleotides were used to build positive 
(left-handed) nodes instead of natural Z-DNA (Rich et al. 1984), which was 
used in the past and is not exactly a mirror image of right-handed B-DNA 
(Jovin and Soumpasis 1983), and D-nucleotides were used to build negative 
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(right-handed) nodes. This work provided a more precise way to control the 
topology of DNA nanostructures. Based on the results it is possible to build 
macroscopically woven materials on the molecular scale. 
1.2 Templated Synthesis of alternative nucleic acid analogs 
Templated synthesis of non-natural nucleic acids has been intensively 
studied, with and without the mediation of enzymes. The purposes of the study 
could be categorized into several groups. One of such studies has involved 
alternative nucleic acids of evolutionary importance, which aims to understand 
chemical routes by which information could be copied and transferred under 
primordial world. These alternative nucleic acids include flexible nucleic acid 
(FNA) (Joyce et al. 1987; Schneider and Benner 1990), glycerol nucleic acid 
(GNA) (Zhang et al. 2005), peptide nucleic acid (PNA) (Egholm et al. 1993), 
and threose nucleic acid (TNA) (Schöning et al. 2000) (Figure 1.3; Figure 
1.4). 
1.2.1 Flexible Nucleic Acid (FNA) 
One remarkable challenge facing the RNA world hypothesis (Woese 1967; 
Crick 1968; Orgel 1968; Gilbert 1986; Joyce 2002) has been the prebiotic 
ribonucleotide synthesis and its assembly into short RNA oligonucleotides 
thereafter. Considering the difficulty, several alternative information-carrying 
molecules that are more accessible under primordial conditions have been 
proposed to precede RNA and play a transitional role eventually leading to the 
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emergence of the RNA world. One of such “RNA progenitors” is FNA (Figure 
1.4). FNA monomer with a prochiral carbon becomes chiral once it is 
incorporated into oligonucleotides and adopts either a D-like or L-like 
orientation in the chain. However, the sugar backbone might be flexible 
enough to render the templated synthesis taking place in a manner less 
discriminated by the absolute configuration of the nucleotides. 
The earliest examples of template copying reactions involved the 
oligomerization of activated FNA diphosphate analogs on conventional 
polynucleotide templates (Schwartz and Orgel 1985). In these cases, 
successful oligomerization resulted in the formation of a product strand 
composed of pyrophosphate linkages rather than the more common 
phosphodiester linkages found in natural DNA and RNA. Activated FNA-G 
monomers were shown to rapidly oligomerize on poly-C templates. Control 
reactions performed in the absence of the template yielded only small amounts 
of the elongated product. Template-directed oligomerization efficiency of the 
FNA-G diphosphate analog was found to be lower than that of the dG 
diphosphate analog. Nevertheless, the observed results suggest that atactic 
products derived from prochiral FNA-G diphosphate monomers are 
successfully extended during template-directed synthesis. The latter finding is 
important because it demonstrates that this system avoids the problem of 
enantiomeric cross-inhibition seen with RNA monomers (Joyce et al. 1984).  
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In contrast to the above studies, Chaput and Switzer examined a series of 
atactic templates with FNA-C bearing a natural phosphodiester backbone to 
determine if these molecules might direct the synthesis of activated GMP 
monomers (Chaput and Switzer 2000). Analysis of the template-copying 
reactions indicated that atactic FNA-C oligonucleotides support 
template-directed synthesis, albeit with reduced efficiency when compared to 
dC templates. A key finding was that both single and multiple FNA-C residues 
in a template are capable of directing the synthesis of the complementary 
strand. RNase digestion showed that regioselective control of 
3’,5’-phosphodiester bond formation in the product strand was gradually lost 
as more FNA-C residues were introduced into the template. The main 
conclusion was that atactic FNA templates with natural phosphodiester 
linkages support template-directed synthesis, and although the template 
efficiency was less than with natural DNA, it may be presumed to be much 
higher than what would be obtained from a template bearing a mixture of all 
possible ribonucleoside isomers. 
Despite the inability of FNA to form stable duplex structures with DNA 
(Schneider and Benner 1990), Heuberger and Switzer (2008) recently 
demonstrated that both (S)- and (R)-fNTP antipodes are substrates for several 
DNA polymerases. Several polymerases accepted racemic, (R)- and (S)-fNTPs 
as substrates in primer extension reactions, leading to multiple incorporations 
of flexible nucleotides. The overall results demonstrated that, on average, 
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antipodal fNTPs are not distinguished. Mismatched fNTP-template 
combinations led to only very limited primer extension. These results show 
that functional molecular recognition properties, including Watson-Crick base 
pairing, are retained by the structurally simple FNA system even though it has 
additional degrees of freedom in its backbone relative to DNA. The above 
findings with FNA have implications for the pre-RNA world and molecular 
evolution. These polymerase studies highlight the observation that acyclic 
structures, in general, and FNA, in particular, might be a means to preserving 
the informational properties of a polymer, while avoiding enantiomeric 
cross-inhibition (Joyce et al. 1984) during replication. 
1.2.2 Threose Nucleic Acid (TNA) 
To understand the chemical etiology of nucleic acid structure, 
Eschenmoser (1999) and co-workers (Schöning et al. 2000) systematically 
investigated the structural alternatives of RNA and discovered a set of 
unnatural nucleic acids that are capable of Watson-Crick base-pairing. One of 
the intriguing analogs, (3’→2’)-α-L-threofuranosyl nucleic acid (TNA, Figure 
1.4) shows similar thermal stability to RNA and DNA in the context of duplex 
forming. TNA also forms cross-pairs with either RNA or DNA (Schöning et al. 
2000). Structural studies have shown that TNA is a better mimic of A-form 
DNA/RNA (Pallan et al. 2003; Ebert et al. 2008), although it could be readily 
accommodated into B-form DNA (Wilds et al. 2002). Non-enzymatic 
polymerization of activated rGMP against a cytosine TNA template has been 
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conducted to give short RNA products (Heuberger and Switzer 2006). All the 
evidence implicated that TNA might have served a role in the prebiotic world 
(Orgel 2000). To understand the functional potential of the TNA sequences, 
Szostak and co-workers investigated the templating properties of TNA 
(Chaput, Ichida, and Szostak 2003) and the kinetics of incorporating TNA 
triphosphates by a variety of DNA polymerases and reverse transcriptases 
(Chaput and Szostak 2003; Horhota et al. 2005; Zou et al. 2005). Preliminary 
data of a TNA-directed DNA primer-extension assay showed that most 
enzymes are capable of copying 1-3 DNA nucleotides on a TNA template. The 
primer extension efficiency was dramatically increased in the presence of 
Mn2+, which is known to relax the specificity of many DNA polymerases. In 
this particular case, Mn2+ is believed to partially compromise the progressive 
loss of contact between TNA template and the polymerase as the primer is 
extended. The error-rate of DNA synthesis was compared with TNA template 
and DNA template in order to assess the Mn2+ effect on fidelity. Sequencing 
result of the full-length DNA products from the primer-extension assay 
showed that the error-rate for TNA was 1.5-fold and 3-fold higher than for 
DNA, using Sequenase and MMLV-RT, respectively. The authors suggested 
that evolution of an improved TNA-directed DNA polymerase would enable 
the in vitro selection of TNA sequences (Chaput, Ichida, and Szostak 2003). 
In order to perform in vitro TNA selections, it is necessary to synthesize 
TNA molecules using DNA templates. Szostak and co-workers (Horhota et al. 
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2005) demonstrated that Deep Vent (exo-) DNA polymerase is capable of 
incorporating three TNA nucleotides over a DNA template. Further screening 
a number of other thermophilic DNA polymerases revealed Therminator DNA 
polymerase (Gardner and Jack 2002), an engineered exonuclease-deficient 
form of 9°N DNA polymerase containing A485L mutation as a particularly 
efficient DNA-dependent TNA polymerase. Under optimal conditions, the 
primer extension using Therminator led to sequences containing 80 
consecutive TNA residues as the transcription product (Ichida, Zou, et al. 
2005). Error rates were raised compared to the use of natural dNTPs, but low 
enough for use in in vitro selection. Based on these results, the authors 
demonstrated a conceptual system for in vitro evolution of TNA aptamers and 
enzymes (Ichida, Zou, et al. 2005; Ichida, Horhota, et al. 2005). 
1.2.3 Glycerol Nucleic Acid (GNA) 
Inspired by the discovery of TNA, Meggers and co-workers (Zhang et al. 
2005) synthesized a simple nucleic acid composed of a glycerol sugar 
connected by phosphodiester linkages (glycerol nucleic acid, GNA, Figure 
1.4). The repeating backbone unit contains one stereogenic center, which 
results in two enantiomers, namely (S)- and (R)-GNA. Both (S)- and (R)-GNA 
form antiparallel duplex structures with complementary GNA strands of the 
same stereoconfiguration. (S)-, but not (R)-GNA also forms duplex with RNA 
in an antiparallel orientation (Meggers and Zhang 2010). Szostak and 
co-workers recently examined the ability of GNA triphosphates (gNTPs) to 
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function as substrates for natural DNA polymerases (Hornota et al. 2006). 
Using a standard primer-template assay, many DNA polymerases were 
screened for the ability to extend a DNA primer with GNA. While most DNA 
polymerases readily incorporated one GNA residue, further primer extension 
beyond a single nucleotide was not observed. The difficulty in synthesizing 
longer GNA strands may be due to an incompatibility between gNTPs and 
natural polymerases. The situation was very different when the enzymatic 
synthesis of DNA was examined on GNA templates (Tsai et al. 2007). In this 
case, a variety of DNA polymerases showed GNA-dependent DNA 
polymerase activity, with Bst DNA polymerase capable of synthesizing the 
full-length DNA product on a GNA template. The authors noted that in 
addition to the presence of manganese ions in the reaction buffer, the 
substitution of adenosine for diaminopurine in the template and DNA 
monomers resulted in higher reaction efficiency. This example demonstrates 
that a stable duplex structure between the product and template strands is not 
required for enzyme-mediated polymerization, consistent with the FNA results 
noted above. 
1.2.4 Peptide nucleic acid (PNA) 
PNA constitutes a remarkably new class of synthetic analogs of nucleic 
acid. The purine and pyrimidine bases are connected by repetitive units of 
N-(2-aminoethyl) glycine (Figure 1.3) instead of the ordinary phosphodiester 
linkages. PNA backbone is not charged; therefore it undergoes hybridization 
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with RNA, DNA or itself with a high stability (Nielsen 1995). Besides, the 
constituent components of PNA have been isolated under putative prebiotic 
conditions, which suggested that PNA polymerizations might have relevance 
to primordial information storage and transfer. 
Orgel and coworkers demonstrated that activated-PNA dimer G2 could be 
condensed over a complementary DNA dC10 template (Böhler et al. 1995) 
while the same coupling on a PNA C10 template was inhibited. The sequence 
specificity of polymerization for PNA dimers (A2, C2, G2, and T2) was also 
examined on a decamer DNA template sequence 5’-CCCCXXCCCC-3’, 
where X is any of the four nucleotides. The results showed that the building 
blocks complementary to X are preferentially incorporated with considerable 
misincorporations and truncations (Schmidt et al. 1997b). 
A poly-cytosine PNA template was found to facilitate the polymerization 
of activated RNA guanosine nucleotides. The reaction is less regioselective for 
the native 3’-5’ phosphodiester bond formation than the polymerization using 
RNA templates (Böhler et al. 1995). Further studies showed that PNA 
templates could direct the polymerization of different nucleotides in a 
sequence-specific manner (Schmidt et al. 1997a).  
Inspired by the reductive amination of DNA and amido DNA (Goodwin 
and Lynn 1992), Liu and coworkers creatively developed the 
sequence-specific DNA-templated polymerization of tetrameric PNA 
aldehydes (Rosenbaum and Liu 2003). The polymerization exhibited high 
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efficiency on DNA templates containing as many as 40 nucleotides and high 
fidelity even in the presence of a mixture of different PNA building blocks 
closely related in sequence. The authors suggested that these findings are a 
key step toward the evolution of sequence-defined synthetic polymers other 
than natural biopolymers, using iterative in vitro selections. 
Another category of templated-synthesis of modified nucleic acids aims at 
identifying DNA/RNA sequences with novel functions beyond that of native 
DNA and RNA using in vitro selection (Keefe and Cload 2008; Knudsen et al. 
2002). The majority of data reported has focused on the selection using 
ribonucleotides modified at 2’-position, which increases the stability of DNA 
and RNA to chemical and nuclease-mediated degradation. To be useful in the 
selection, modified nucleotides must serve as substrates for polymerases in the 
enzymatic steps (Loakes and Holliger 2009), which include direct PCR 
amplification using a DNA polymerase and reverse transcription of the 
modified oligonucleotide library into DNA followed by transcription into the 
appropriately modified oligonucleotide library (Figure 1.5). Remarkable 
efforts have been made to discover polymerases or their variants that are 
amenable to these processes. This work led to the identification of several 
mutants of T7 RNA polymerases able to accept 2’-modifications reasonably 
well (Keefe and Cload 2008). Modifications at 5-position of T/U base are also 
tolerated by a variety of T7 RNA polymerases.  
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Figure 1.5. (a) Schematic representation of the Modified SELEX process in 
which a DNA polymerase is used to incorporate modified nucleotides into the 
oligonucleotide library. Black indicates the degenerate region of the 
unmodified oligonucleotide library, red indicates the degenerate region of the 
modified oligonucleotide library, blue indicates the fixed primer-binding 
region. (b) Schematic representation of the modified SELEX process in which 
a DNA polymerase is used to incorporate modified nucleotides into the 
oligonucleotide library. Black indicates the degenerate region of the 
unmodified oligonucleotide library, red indicates the degenerate region of the 
modified oligonucleotide library, blue indicates the fixed primer-binding 
region, and green indicates the transcription promoter sequence. Reprinted 
(adapted in part or whole) with permission from Curr. Opin. Chem. Biol. 
(Keefe and Cload 2008). Copyright 2008 Elsevier. 
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Besides increasing the stability of aptamers, modified nucleotides has been 
proved to have more advantages in the selection against challenging targets 
than native DNA/RNA in some cases. Using dUTP derivatives, Eaton and 
co-workers (Vaught et al. 2010) successfully identified aptamers to a  
protein target TNFRSF9 (Croft 2009) that had previously been found 
refractory to in vitro selection using DNA. Other chemical modifications of 
the nucleotides employed in in vitro selection include boranophosphate and 
phosphorothioate internucleotide linkages, and 4’-thio pyrimidines, all of 
which have shown enhanced nuclease-resistance (Keefe and Cload 2008). 
Chemical structures of the modified nucleotides used in in vitro selection are 
summarized in Figure 1.6. 
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Figure 1.6. Chemical structures of the modified nucleotides which have been 
reported in the process of SELEX. Reprinted (adapted in part or whole) with 
permission from Curr. Opin. Chem. Biol. (Keefe and Cload 2008). Copyright 
2008 Elsevier. 
Other alternative nucleic acids that have been used in Aptamer sequences 
include Locked nucleic acid (LNA, Figure 1.3) (Obika et al. 1997; Singh et al. 
1998) and anhydrohexitol nucleic acid (HNA, Figure 1.3) (Hendrix et al. 
1997). Short pieces of LNA/HNA strands have been incorporated into 
aptamers and/or ribozymes to enhance nuclease resistance and improve 
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activity (Kang et al. 2004; Lebars et al 2007; Kolb et al. 2005), though they 
are not directly involved in the selection process. 
1.2.5 Locked Nucleic Acid (LNA) 
LNA was first described by Imanishi (1997) and Wengel (1998). The 
methylene bridge between 2’-O and C4’ of the ribose moiety locks the sugar 
pucker into a 3’-endo conformation. LNA binds tightly to complementary 
DNA and RNA and induces A-form like duplexes (Nielsen et al. 2004; Vester 
and Wengel 2004). LNA residues could be bypassed within a DNA template 
by DNA polymerases if the LNA nucleotides are distributed along the strand. 
LNA triphosphates could be recognized by several DNA polymerases as 
substrates (Kuwahara et al. 2008). The most efficient KOD DNA polymerase 
has incorporated up to 8 consecutive LNA residues. 
1.2.6 Hexitol Nucleic Acid (HNA) 
Among a set of six-membered carbohydrate mimics of RNA developed by 
Herdewijn and co-workers (Kerremans et al. 2001), anhydrohexitol nucleic 
acid (HNA) forms the most stable cross-pair with RNA (even more stable than 
RNA self-pairing). Structural studies showed that both HNA-HNA and 
HNA-RNA duplexes adopt A-form helices (Declercq et al. 2002; Maier et al. 
2005). While several polymerases were able to incorporate a single HNA 
triphosphate, only Deep Vent (exo-) DNA polymerase could incorporate up to 
6 consecutive HNA residues at high enzyme concentration (Vastmans et al. 
2000). Under such conditions the fidelity decreased after the first two HNA 
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triphosphates were inserted. HNA oligonucleotides have been used in 
aptamers (Kolb et al. 2005) and antisense (Kang et al. 2004) with nuclease 
resistance. However, pure HNA antisense was shown ineffective possibly due 
to the lack of RNase H activity (Kang et al. 2004). 
1.3 Artificial Information-Carrying Polymers Capable of Darwinian Evolution 
Historically in vitro evolution has been limited to two types of biological 
polymers, namely nucleic acids and proteins, due to its heavy dependency on 
the use of biological machinery. Protein engineering dedicated to creating 
ribosome and polymerases tolerant to unnatural susbstrates has been proved 
useful (Wang et al. 2006). Some successful examples of modified aptamer 
selections were discussed in previous section. However, in most of the cases, 
only modest structural modifications have been proved suitable. It is hard to 
develop a general strategy for the directed evolution of a completely synthetic 
polymer system (Appella 2009; Brudno and Liu 2009). 
One approach inspired by biological evolution (Figure 1.7A) generates the 
synthetic polymers covalently linked to the encoding nucleic acid templates. 
The resulting libraries of the synthetic polymers are subjected to selection and 
the encoding template nucleic acids of the surviving molecules are amplified 
for a subsequent round of selection (Figure 1.7B). The templated synthesis of 
synthetic polymers could be either nonenzymatic or enzymatic. 
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Figure 1.7. Key Components of the Evolution of Biological or Synthetic 
Polymers. (A) Biopolymer evolution as it occurs in nature or in the laboratory. 
A polymer (such as a protein) is translated from and spatially associated with 
an information carrier (such as DNA). The resulting biopolymers undergo 
selection based on their functional properties. The information encoding 
surviving biopolymers replicates and mutates, resulting in a second generation 
of biopolymer variants related to those that survived selection. (B) Synthetic 
polymers can in principle undergo a similar evolutionary process. Translation 
could be effected by nonenzymatic or enzymatic templated synthesis in a 
manner that associates each synthetic polymer with its information carrier. 
Following selection, the information carriers encoding surviving synthetic 
polymers are amplified and mutated to generate templates for a subsequent 
round of translation. Reprinted (adapted in part or whole) with permission 
from Chem. Biol. (Brudno and Liu 2009). Copyright 2009 Elsevier. 
Liu and co-workers (Brudno et al. 2010) demonstrated a peptide nucleic 
acid (PNA) in vitro selection system, in which PNA library was generated by 
reductive amination-based polymerization. Next, the PNA sequences need to 
be liberated from the DNA templates to which they are bound so that the PNA 
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strands could fold and be subjected to selection. This is a challenging problem 
as PNA binds tightly to complementary DNA. After extensive screening, the 
Herculase II DNA polymerase was found to efficiently displace a 
40-nucleotide PNA strand from the DNA template. The resulting encoding 
template DNA could be successfully isolated and amplified using PCR even 
after a 15000-fold dilution. This strategy was employed in a mock selection to 
enrich a unique DNA sequence encoding biotinylated PNA pentamer, which 
was highly underrepresented in the starting library (1:106). After six rounds of 
selection the results showed that primary sequences identified were the unique 
encoding sequence.  
As part of my PhD. dissertation, I developed the methodology necessary to 
evolve functional TNA molecules by in vitro selection. Working in 
collaboration with another student in the lab, I identified a TNA aptamer 
binding human α-thrombin with a Kd around 200 nM after three iterative 
rounds of selection using this library, which will be discussed in Chapter 6 in 
this dissertation. Other examples of evolution-based technologies for synthetic 
polymer selection, including DNA encoded library of macrocycles (Gartner et 
al. 2004) and YoctoReactor technology (Hansen et al. 2009), are beyond the 
scope of this review and have been discussed elsewhere (Li and Liu 2004). 
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Chapter 2 
SYNTHESIS OF GLYCEROL NUCLEIC ACID (GNA) 
PHOSPHORAMIDITE MONOMERS 
AND OLIGONUCLEOTIDE POLYMERS 
2.1 Contributions 
The following chapter describes a published protocol for the synthesis of 
GNA phosphoramidite monomers and oligonucleotide polymers. All reported 
experiments were performed by Su Zhang under the guidance of Professor 
John Chaput. Su Zhang and John Chaput wrote the manuscript. The results 
from this work were published in Current Protocols in Nucleic Acid 
Chemistry. 
2.2 Abstract 
This unit describes a straightforward method for preparing glycerol nucleic 
acid (GNA) phosphoramidite monomers and oligonucleotide polymers using 
standard cyanoethyl phosphoramidite chemistry. GNA is an unnatural nucleic 
acid analogue composed of an acyclic three-carbon sugar-phosphate backbone 
that contains one stereogenic center per repeating unit. GNA has attracted 
significant attention as a nucleic acid derivative due its unique ability to form 
stable Watson-Crick antiparallel duplex structures with thermal and 
thermodynamic stabilities rivaling those of natural DNA and RNA. The 
chemical simplicity of this nucleic acid structure provides access to 
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enantiomerically pure forms of right- and left-handed helical structures that 
can be used as unnatural building blocks in DNA nanotechnology.  
2.3 Introduction 
Acyclic oliogonucleotides are experiencing a tremendous resurgence in 
basic and applied research due to their unique structural and biophysical 
properties (for review see Zhang et al., 2010). This unit contains procedures 
that describe the chemical synthesis of one type of acyclic nucleic acid 
polymer commonly referred as glycerol nucleic acid or GNA. The chemical 
synthesis and purification of glycerol nucleoside analogues bearing adenine 
(A), cytosine (C), guanine (G), and thymine (T) as the bases and of 
oligonucleotides thereof (Figure 2.1) are described in detail. Unless otherwise 
 
Figure 2.1. Chemical Structures of GNA, DNA and RNA. Reprinted with 
permission from Current Protocols in Nucleic Acid Chemistry. Copyright 2010 
John Wiley & Sons, Inc. 
stated, all of the procedures start from (R)-(+)-glycidol and yield (S)-GNA. 
The same chemistry can also be applied to (S)-(-)-glycidol to produce 
(R)-GNA. Commercially available glycidol or tritylated glycidol is used to 
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obtain the 2,3-dihydroxypropyl derivatives of each nucleobase via an epoxide 
ring opening reaction (see Basic Protocol 1). The glycerol nucleosides are then 
converted to their corresponding nucleotide phosphoramidites (see Basic 
Protocol 2 to 5), which can then be used as building blocks to synthesize GNA 
oligonucleotides (see Basic Protocol 6). 
2.4 Basic Protocol 1 
Synthesis of Enantiomerically Pure dimethoxytrityl-O-(S)-glycidol 
2,3-dihydroxypropyl derivatives of nucleobases have been synthesized by 
several different methods. The current approach is based on a modified 
version of Acevedo’s procedure (Acevedo et al., 1996), and involves a direct 
ring opening of the stable glycidol intermediate by nucleophilic attack of one 
of the four natural nucleobases. In this protocol, pure (R)-(+)-glycidol is 
tritylated using 4,4’-dimethoxytritylchloride (DMT-Cl) in dichloromethane as 
illustrated in Figure 2.2. The tritylated glycidol is used to make the A, C, and T 
 
Figure 2.2. Preparation of (S)-DMT-O-glycidol (S.2). Abbreviations: DMT-Cl, 
4,4’-dimethoxytritylchloride; Et3N, triethylamine; DCM, dichloromethane. 
Reprinted with permission from Current Protocols in Nucleic Acid Chemistry. 
Copyright 2010 John Wiley & Sons, Inc. 
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glycerol nucleoside phosphoramidites (see Basic Protocols 2, 3, and 5, 
respectively). Synthesis of the G glycerol nucleoside phosphoramidite requires 
an alternative strategy (see Basic Protocol 4). Note that (R)-(+)-glycidol 
substrates provide (S)-GNA phosphoramidite monomers that can be used to 
make GNA oligonucleotides with the natural right-handed stereoconfiguration. 
Materials 
(R)-(+)-Glycidol  
4,4’-Dimethoxytritylchloride (DMT-Cl), 95%  
Triethylamine (Et3N), 99.5%  
Dichloromethane (DCM) 
Hexanes  
Ethyl acetate (AcOEt)  
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Sodium sulfate (Na2SO4)  
100-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
2.5 x 25-cm chromatography column 
 34 
Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
200-ml separatory funnel 
Büchner funnel  
Filter paper 
UV lamp, 254 nm 
Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
1. To a 100-ml round bottom flask equipped with a magnetic stir bar, add 780 
mg (10.6 mmol) of  (R)-(+)-glycidol, 24 ml of DCM (freshly distilled 
over calcium hydride), 3.8 ml of Et3N and 4.54 g (13.4 mmol) of DMT-Cl. 
Stir the reaction at r. t. overnight under an argon atmosphere. 
2. Remove the precipitate by vacuum filtration and wash the residue with 
DCM. 
3. Wash the filtrate sequentially with sat. aq. NaHCO3, water, and brine. 
4. Dry the organic layer over Na2SO4, filter, and evaporate to dryness using a 
rotary evaporator equipped with a vacuum pump and cooling trap. 
5. Purify the oily residue by column chromatography on 20 g of silica gel in a 
5 x 25-cm column. Deactivate the column with hexanes/Et3N 97:3 and 
elute the column using a step-wise gradient of 99:1 (v/v) hexanes/Et3N to 
hexanes/AcOEt/Et3N 18:1:1. Combine the product fractions and evaporate 
to dryness. 
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The resulting product, DMT-O-(S)-glycidol (S.2) should be obtained in a 
90% yield (3.56 g, 9.47 mmol) as colorless oil. TLC (hexanes/AcOEt 10:1): Rf 
= 0.12. 1H NMR (300 MHz, CDCl3): δ=2.61 (dd, J=2.4, 5.1 Hz, 1 H), 2.76 (m, 
1 H), 3.12 (m, 2 H), 3.29 (m, 1 H), 3.79 (s, 6 H), 6.83 (m, 4 H), 7.05-7.40 (m, 
7 H), 7.45 (m, 2 H). 
2.5 Basic Protocol 2 
Synthesis of 2’-O-(2-cyanoethoxy)(diisopropylamino)phosphino-3’-O- 
(4,4’-dimethoxytriphenyl)methyl-N6-benzoyl-(S)-9-(2,3-dihydroxypropyl)- 
adenine 
This protocol describes the synthesis of N6-benzoyl-protected (S)-GNA 
adenosine nucleoside phosphoramidite S.5 from S.2 (Figure 2.3). 
 
Figure 2.3. Preparation of S.5. Abbreviations: NaH, sodium hydride; DMF, 
dimethylformamide; TMSCl, trimethylsilyl chloride; BzCl, benzoyl chloride; 
Py, pyridine; DIPEA, diisopropylethylamine; DCM, dichloromethane. 
Reprinted with permission from Current Protocols in Nucleic Acid Chemistry. 
Copyright 2010 John Wiley & Sons, Inc. 
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Materials 
DMT-O-(S)-glycidol (S.2) 
Adenine  
Sodium hydride (60% in mineral oil) (NaH)  
Dimethylformamide (DMF), anhydrous 
Pyridine, anhydrous  
Trimethylsilyl chloride (TMS-Cl)  
Benzoyl chloride (BzCl) 
Ammonium hydroxide, concentrated (conc. NH4OH)  
Dichloromethane (DCM)  
Diisopropylethylamine, redistilled (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine  
Hexanes  
Ethyl acetate (AcOEt)  
Triethylamine (Et3N)  
Methanol (MeOH)  
50- and 100-ml round bottom flasks 
Oil bath 
Magnetic stir plate and stir bar 
Gas balloon 
Graham condenser 
Rotary evaporator equipped with a vacuum pump 
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1.3 x 30-cm chromatography column 
6.4 x 45-cm chromatography column 
Silica gel (60 Å, 230-400 mesh) 
TLC plate, EMD silica gel 60 F254 
UV lamp, 254 nm 
Büchner funnel  
Filter paper 
Additional reagents and equipment for TLC and column chromatography 
Prepare S.3 
1. Add 0.71 g (5.25 mmol) of adenine and 43 mg (1.07 mmol) of NaH (60% 
in mineral oil) in 8 ml of DMF to a 50-ml round bottom flask. 
2. Allow the reaction to stir at r. t. for 2 hr under an argon atmosphere. 
3. Dissolve 1.86 g (4.95 mmol) of S.2 in 13.5 ml of DMF in a 50-ml round 
bottom flask. 
4. Add the solution from step 3 into the 50-ml round bottom flask from step 1, 
attach a condenser to the flask, and stir the reaction mixture at 105 °C for 
15 hr under an argon atmosphere. 
5. Allow the solution to cool to r. t. and remove the precipitate by vacuum 
filtration. Wash the residue with AcOEt. 
6. Evaporate the organic solvent from step 5 to dryness using a rotary 
evaporator equipped with a vacuum pump and a cooling trap. 
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7. Purify the residue by column chromatography on 50 g of silica gel in a 6.4 
x 45-cm column. Deactivate the column with DCM/Et3N 97:3 and elute 
the product using a step-wise gradient of DCM/MeOH/Et3N 35:1:0.01 to 
25:1:0.01 (v/v). Collect fractions containing the product and evaporate to 
dryness. 
The resulting product, 3’-O-(4,4’-Dimethoxytriphenyl)methyl-(S)-9-(2,3- 
dihydroxypropyl)adenine (S.3), should be obtained in a 48% yield (1.21 g, 
2.38 mmol) as a colorless foam. TLC (AcOEt/MeOH 25:1): Rf = 0.19. 1H 
NMR (300 MHz, CDCl3): δ=3.02 (dd, J=6.3, 9.6 Hz, 1H), 3.25 (dd, J=5.7, 9.3 
Hz, 1H), 3.78 (s, 6H), 4.18 (m, 1H), 4.29 (dd, J=6.6, 14.4 Hz, 1H), 4.40 (dd, 
J=2.4, 14.2 Hz, 1H), 5.75 (br s, 2H), 6.80 (m, 4H), 7.20-7.30 (m, 7H), 
7.37-7.40 (m, 2H), 7.72 (s, 1H), 8.26 (s, 1H). 
Prepare S.4 
1. Dissolve 1.69 g (3.29 mmol) of S.3 in 25 ml of anhydrous pyridine in a 
100-ml round bottom flask and add 1.7 ml (13.55 mmol) of TMS-Cl to the 
solution. 
2. Stir the reaction at r. t. for 2 hr under an argon atmosphere. 
3. Cool the mixture in a water-ice bath to 0°C and add in a drop-wise fashion 
0.59 ml (5.1 mmol) of BzCl. 
4. Continue stirring the reaction at 0°C for 0.5 hr, then at r. t. for another 2 hr. 
5. Cool the solution in a water-ice bath to 0°C and add 4 ml of water to 
quench the reaction. 
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6. Keep the reaction at 0°C and add 8 ml of conc. NH4OH by injection after 
15 min. 
7. Stir the reaction in the ice bath for an additional 50 min. 
8. Evaporate the solvent to dryness using a rotary evaporator equipped with a 
vacuum pump and a cooling trap. 
9. Re-suspend the residue in DCM and adsorb the mixture onto silica gel 
(sample/silica gel ratio 1:1.2, w/w). 
10. Purify the sample from step 9 by column chromatography (Deactivate the 
column with hexanes/Et3N 97:3 and elute using hexanes/AcOEt/Et3N 
1:2:0.01, then AcOEt/Et3N 100:1, and finally AcOEt/MeOH/Et3N 
25:1:0.01). Collect fractions containing the product and evaporate to 
dryness. 
The resulting product, 3’-O-(4,4’-Dimethoxytriphenyl)methyl-N6- 
benzoyl-(S)-9-(2,3-dihydroxypropyl)adenine (S.4), should be obtained in a 
78% yield (1.6 g, 2.57 mmol) as a colorless foam. TLC (AcOEt/MeOH 25:1): 
Rf = 0.41. 1H NMR (500 MHz, CDCl3): δ=3.14 (dd, J=6.0, 9.5 Hz, 1H), 3.21 
(dd, J=6.0, 9.5 Hz, 1H), 3.78 (s, 6H), 4.19 (m, 1H), 4.34 (dd, J=7.2, 14.2 Hz, 
1H), 4.48 (dd, J=2.8, 14.2 Hz, 1H), 6.81 (d, J=9.0 Hz, 4H), 7.21 (t, J=7.2 Hz, 
1H), 7.25-7.27 (m, 6H), 7.39 (d, J=7.0 Hz, 2H), 7.53 (t, J=7.8 Hz, 2H), 7.61 (t, 
J=7.5 Hz, 1H), 8.00 (s, 1H), 8.04 (d, J=7.5 Hz, 2H), 8.74 (s, 1H), 9.03 (br s, 
1H). 
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Prepare S.5 
1. Dry 1.20 g (1.95 mmol) of S.4 overnight under vacuum of 0.05 mmHg in a 
100-ml round bottom flask. 
2. Dissolve S.4 from step 1 and 2.1 ml (11.2 mmol) of DIPEA in 33 ml of 
DCM (freshly distilled over CaH2) under an argon atmosphere. 
3. In a drop-wise fashion, add 0.56 ml (2.53 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine to the reaction 
mixture. 
4. After 2 hr, add another 0.06 ml (0.25 mmol) of chloro(2-cyano-ethoxy)- 
(diisopropylamino)phosphine (1/10 the volume from step 3) to the reaction 
mixture. 
5. Stir the mixture at r. t. under an argon atmosphere for a total of 4 hr. 
6. Evaporate the solvent and purify the residue by column chromatography. 
Deactivate the column with hexanes/Et3N 97:3 and elute the product using 
a step-wise gradient of hexanes/AcOEt/Et3N 1:2:0.01 to 
hexanes/AcOEt/MeOH/Et3N 1:2:0.1:0.01. Combine the product fractions 
and evaporate to dryness. 
The resulting product, 2’-O-(2-cyanoethoxy)(diisopropylamino)- 
phosphino-3’-O-(4,4’-dimethoxytriphenyl)methyl-N6-benzoyl-(S)-9-(2,3-dihy
droxypropyl)adenine (S.5) should be obtained in a 82% yield (1.30 g, 1.60 
mmol) as a colorless foam. TLC (hexanes/AcOEt/MeOH 16:32:1): Rf = 0.18, 
0.34. 1H NMR (500 MHz, CDCl3): δ=1.00 (d, J=6.5 Hz, 6H), 1.06 (d, J=7.0 
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Hz, 6H), 1.10 (d, J=7.0 Hz, 12H), 2.39 (t, J=6.2 Hz, 2H), 2.47 (q, J=6.2 Hz, 
2H), 3.15 (dd, J=6.0, 10.0 Hz, 1H), 3.21-3.26 (m. 2H), 3.30 (dd, J=4.0, 12.5 
Hz, 1H), 3.45-3.69 (m, 8H), 3.78 (s, 6H), 3.79 (s, 6H), 4.37 (m, 2H), 4.47-4.58 
(m, 4H), 6.82 (m, 8H), 7.17-7.33 (m, 14H), 7.45 (m, 4H), 7.53 (m, 4H), 7.60 
(m, 2H), 8.04 (m, 4H), 8.05 (s, 1H), 8.06 (s, 1H), 8.78 (s, 1H), 8.79 (s, 1H), 
9.03 (br, 2H). 31P NMR (202 MHz, CDCl3): δ=148.98, 149.59. 
2.6 Basic Protocol 3 
Synthesis of 2’-O-(2-cyanoethoxy)(diisopropylamino)phosphino-3’-O- 
(4,4’-dimethoxytriphenyl)methyl-N4-benzoyl-(S)-1-(2,3-dihydroxypropyl)- 
cytosine 
This protocol describes the synthesis of N4-benzoyl-protected (S)-GNA 
cytidine nucleoside phosphoramidite S.7 from S.2 (Figure 2.4). 
Figure 2.4. Preparation of S.7. Abbreviations: NaH, sodium hydride; DMF, 
dimethylformamide; DIPEA, diisopropylethylamine; DCM, dichloromethane. 
Reprinted with permission from Current Protocols in Nucleic Acid Chemistry. 
Copyright 2010 John Wiley & Sons, Inc. 
Materials 
DMT-O-(S)-glycidol (S.2) 
N4-benzoylcytosine 
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Sodium hydride (60% in mineral oil) (NaH) 
Dimethylformamide (DMF), anhydrous 
Dichloromethane (DCM) 
Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Hexanes 
Acetone 
Ethyl acetate (AcOEt) 
Triethylamine (Et3N) 
50- and 100-ml round bottom flasks 
Oil bath 
Magnetic stir plate and stir bar 
Gas balloon 
Graham condenser 
Rotary evaporator equipped with a vacuum pump 
1.3 x 30-cm chromatography column 
6.4 x 45-cm chromatography column 
Silica gel (60 Å, 230-400 mesh) 
TLC plate, EMD silica gel 60 F254 
200-ml separatory funnel 
UV lamp, 254 nm 
Büchner funnel  
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Filter paper 
Additional reagents and equipment for TLC and column chromatography 
Prepare S.6 
1. Add 1.94 g (8.99 mmol) of N4-benzoyl protected cytosine and 73 mg (1.82 
mmol) of NaH (60% in mineral oil) in 18 ml of DMF in a 50-ml round 
bottom flask.  
2. Stir the reaction at r. t. for 1 hr under an argon atmosphere using a gas 
balloon. 
3. Dissolve 3.02 g (8.03 mmol) of S.2 in 19 ml of DMF in a 50-ml round 
bottom flask. 
4. Add the solution from step 3 to the 50-ml round bottom flask from step 1, 
attach a condenser to the flask, and stir the mixture at 110°C for 20 hr. 
5. Cool the reaction mixture to r. t. and remove the precipitate by vacuum 
filtration. Wash the residue with AcOEt. 
6. Evaporate the organic solvent from step 5 to dryness using a rotary 
evaporator equipped with a vacuum pump and a cooling trap. 
7. Purify the residue by column chromatography on 80 g of silica gel in a 6.4 
x 45-cm column. Deactivate the column with hexanes/Et3N 97:3 and elute 
using hexanes/acetone/Et3N 3:2:0.01. Collect the product fractions and 
evaporate to dryness. 
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The resulting product, 3’-O-(4,4’-dimethoxytriphenyl)methyl-N4- 
benzoyl- (S)-1-(2,3-dihydroxypropyl)cytosine (S.6), should be obtained in a 
46% yield (2.2 g, 3.70 mmol) as a light-yellow foam. TLC (DCM/MeOH 
25:1): Rf = 0.21. 1H NMR (300 MHz, CDCl3): δ= 3.12 (dd, J=5.7, 9,6 Hz, 1H), 
3.26 (dd, J=5.6, 9.4 Hz, 1H), 3.78 (s, 6H), 3.84 (dd, J=6.8, 13.8 Hz, 1H), 4.22 
(m, 1H), 4.36 (dd, J=2.7, 13.8 Hz, 1H), 6.84 (m, 4H), 7.20-7.64 (m, 14H), 7.89 
(s, 1H), 7.90 (s, 1H), 8.67 (s br, 1H).  
Prepare S.7 
1. Dry 1.0 g (1.7 mmol) of S.6 overnight under vacuum of 0.05 mmHg in a 
100-ml round bottom flask. 
2. Dissolve S.6 from step 1 and 1.9 ml (10.2 mmol) of DIPEA in 29 ml of 
DCM (freshly distilled over CaH2) under an argon atmosphere. 
3. Add 0.5 ml (2.2 mmol) of chloro(2-cyanoethoxy)(diisopropylamino)- 
phosphine to the reaction mixture in a drop-wise fashion. 
4. After 2 hr, add another 0.05 ml (0.22 mmol) of chloro(2-cyanoethoxy)- 
(diisopropylamino)phosphine (1/10 the volume from step 3) to the reaction 
mixture. 
5. Allow the reaction to stir at r. t. under an argon atmosphere for a total of 3 hr. 
6. Evaporate the solvent and purify the residue by column chromatography. 
Deactivate the column with hexanes/Et3N 97:3 and elute using 
hexanes/acetone/Et3N 2:1:0.01. Combine the product fractions and 
evaporate to dryness. 
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The resulting product, 2’-O-(2-cyanoethoxy)(diisopropylamino)- 
phosphino-3’-O-(4,4’-dimethoxytriphenyl)methyl-N4-benzoyl-(S)-1-(2,3-di- 
hydroxypropyl)cytosine (S.7) should be obtained in a 76% yield (1.02 g, 1.29 
mmol) as a light-yellow foam. TLC (hexanes/actone/Et3N 2:1:0.01): Rf = 0.21. 
1H NMR (500 MHz, CDCl3): δ=1.12-1.16 (m, 16H), 1.27 (t, J=7.2 Hz, 8H), 
2.43 (t, J=6.4 Hz, 2H), 2.55-2.77 (m, 3H), 3.15 (dd, J=3.0, 10.0 Hz, 1H), 3.22 
(dd, J=4.5, 10.0 Hz, 1H), 3.28 (dd, J=4.0, 10.0 Hz, 1H), 3.42-3.90 (m, 10H), 
3.78 (s, 6H), 3.79 (s, 6H), 4.31-4.45 (m, 4H), 6.82-6.85 (m, 8H), 7.19-7.36 (m, 
16 H), 7.45-7.54 (m, 8H), 7.58 (m, 4H), 7.90 (d, J=7.5 Hz, 4H), 8.60 (br, 2H). 
31P NMR (202 MHz, CDCl3): δ=149.12, 149.18. 
2.7 Basic Protocol 4 
Synthesis of 2’-O-(2-cyanoethoxy)(diisopropylamino)phosphino-3’-O- 
(4,4’-dimethoxytriphenyl)methyl-N2-isobutyryl-(S)-9-(2,3-dihydroxypropyl)- 
guanine 
This protocol describes the synthesis of N2-isobutyryl-protected (S)-GNA 
guanosine nucleoside phosphoramidite S.12 from S.1 (Figure 2.5). 
Materials  
R-(+)-glycidol (S.1) 
2-Amino-6-chloropurine 
Potassium carbonate (K2CO3) 
Dimethylformamide (DMF), anhydrous 
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Figure 2.5. Preparation of S.11. Abbreviations: K2CO3, potassium carbonate; 
DMF, dimethylformamide; HCl, hydrogen chloride; TMSCl, trimethylsilyl 
chloride; i-PrOCl, isobutyryl chloride; Py, pyridine; DMT-Cl, 
4,4’-dimethoxytritylchloride; DIPEA, diisopropylethylamine; THF, 
tetrahydrofuran. Reprinted with permission from Current Protocols in Nucleic 
Acid Chemistry. Copyright 2010 John Wiley & Sons, Inc. 
1N Hydrochloric acid solution (1N HCl) 
Pyridine, anhydrous 
Trimethylsilyl chloride (TMS-Cl) 
Isobutyryl chloride (i-PrOCl) 
Ammonium hydroxide, concentrated (conc. NH4OH) 
Tetrahydrofuran (THF) 
Pentane 
Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Hexanes 
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Ethyl acetate (AcOEt) 
Triethylamine (Et3N) 
Methanol (MeOH) 
25-, 50-, 100-, and 250-ml round bottom flasks 
Oil bath 
Magnetic stir plate and stir bar 
Gas balloon 
Graham condenser 
Rotary evaporator equipped with a vacuum pump 
1.3 x 30-cm chromatography column 
6.4 x 45-cm chromatography column 
Silica gel (60 Å, 230-400 mesh) 
TLC plate, EMD silica gel 60 F254 
UV lamp, 254 nm 
Büchner funnel  
Filter paper 
Additional reagents and equipment for TLC and column chromatography 
Prepare S.8 
1. Add 0.96 ml (14.5 mmol) of R-(+)-glycidol, 2.4 g (14.2 mmol) of 
2-amino-6-chloropurine and 0.33 g (2.4 mmol) of K2CO3 to 45 ml of DMF 
in a 100-ml round bottom flask. 
2. Attach a condenser to the flask and stir the reaction at 90°C for 14 hr. 
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3. Immediately remove the precipitates by vacuum filtration before the 
reaction mixture cools to r. t. Wash the residue with MeOH. 
4. Remove the solvent using a rotary evaporator equipped with a vacuum 
pump and a cooling trap. 
5. Resuspend the residue in MeOH and adsorb the mixture onto silica gel 
(sample/silica gel ratio 1:1.2, w/w). 
6. Separate the mixture from step 5 by column chromatography using a 
step-wise gradient of AcOEt/MeOH 10:1 to 20:3 (v/v). Collect the product 
fractions and evaporate to dryness. 
The resulting product, (S)-9-(2,3-dihydroxypropyl)-2-amino-6-chloro- 
purine (S.8) should be obtained in a 32% yield (1.16 g, 4.77 mmol) as a white 
solid. TLC (AcOEt/MeOH 20:3): Rf = 0.40. 1H NMR (500 MHz, DMSO-d6): 
δ=3.30 (m, 1H), 3.40 (m, 1H), 3.81(m, 1H), 3.90 (dd, J=8.8, 13.8 Hz, 1H), 
4.18 (dd, J=3.2, 13.8 Hz, 1H), 4.81 (t, J=5.5 Hz, 1H), 5.09 (d, J=5.5 Hz, 1H), 
6.88 (s br, 2H), 8.01 (s, 1H). 
Prepare S.9 
1. Dissolve 1.84 g (7.54 mmol) of S.8 in 66 ml of 1N HCl in a 250-ml round 
bottom flask. 
2. Stir the reaction at 85°C for 3 h and cool the mixture to r. t. 
3. Adjust the pH of the solution from step 2 using conc. NH4OH to pH=9.0. 
The white product precipitates out of the solution. 
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4. Collect the product with vacuum filtration and remove the solvent under 
high vacuum. 
The resulting product, (S)-9-(2,3-dihydroxypropyl)-guanine (S.9) should 
be obtained in a 70% yield (1.20 g, 5.28 mmol) as a white solid. TLC 
(AcOEt/MeOH 20:3): Rf = 0.04. 1H NMR (500 MHz, DMSO-d6): δ=3.28 (m, 
1H), 3.40 (m, 1H), 3.76 (m, 1H), 3.80 (dd, J=8.0, 13.5 Hz, 1H), 4.08 (dd, 
J=3.5, 13.5 Hz, 1H), 4.78 (t, J=5.5 Hz, 1H), 5.06 (d, J=5.0 Hz, 1H), 6.46 (s, 
2H), 7.59 (s, 1H), 10.54 (s, 1H). 
Prepare S.10 
1. Add 350 mg (1.55 mmol) of S.9 in 10 ml of anhydrous pyridine to a 50-ml 
round bottom flask in a water-ice bath at 0°C under an argon atmosphere. 
2. Add 1.5 ml (11.8 mmol) of TMS-Cl to the solution and stir the reaction at 
0°C for 30 min and thereafter at r. t. for another 2 hr. 
3. Cool the mixture in a water-ice bath to 0°C and add 1.3 ml (7.75 mmol) of 
i-PrOCl in a drop-wise fashion to the reaction mixture. 
4. Stir the reaction at 0°C for 30 min and thereafter at r. t. for another 4 hr. 
5. Cool the solution to 0°C in a water-ice bath and quench the reaction by 
adding 2 ml of water to the solution, and stir for an additional 15 min. 
6. Add 2 ml of conc. NH4OH and incubate for 50 min at 0°C. 
7. Evaporate the solvent to dryness using a rotary evaporator equipped with a 
vacuum pump and a cooling trap.  
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8. Resuspend the residue in MeOH, adsorb the mixture onto silica gel 
(sample/silica gel ratio 1:1.2, w/w). 
9. Purify the sample by column chromatography using a step-wise gradient of 
AcOEt/MeOH 20:3 to 40:9 (v/v). Collect the product fractions and 
evaporate to dryness. 
The resulting product, N2-Isobutyryl-(S)-9-(2,3-dihydroxypropyl)- 
guanine (S.10) should be obtained in a 68% yield (283 mg, 0.96 mmol) as a 
white solid. TLC (AcOEt/MeOH 20:3): Rf = 0.15. 1H NMR (300 MHz, 
DMSO-d6): δ=1.08 (d, J=7.2 Hz, 6H), 2.75 (sept, J=7.1 Hz, 1H), 3.32 (m, 1H), 
3.38 (m, 1H), 3.78 (m, 1H), 3.90 (dd, J=8.7, 13.8 Hz, 1H), 4.18 (dd, J=3.3, 
13.8 Hz, 1H), 4.80 (t, J=5.4 Hz, 1H), 5.07 (d, J=5.7 Hz, 1H), 7.86 (s, 1H), 
11.65 (s br, 1H), 12.02 (s br, 1H). 
Prepare S.11 
1. Dissolve 780 mg (2.65 mmol) of S.10 in 11.5 ml of anhydrous pyridine in 
a 50-ml round bottom flask. 
2. Add 1.1 g (3.24 mmol) of DMT-Cl to the solution from step 1. 
3. Stir the reaction at r. t. for 3 hr under an argon atmosphere. 
4. Remove the solvent using a rotary evaporator equipped with a vacuum 
pump and a cooling trap. 
5. Purify the residue from step 4 by column chromatography. Deactivate the 
column with hexanes/Et3N 97:3 and elute using gradient elution 
(hexanes/AcOEt/Et3N 1:2:0.01, then AcOEt/Et3N 100:1, and finally 
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AcOEt/MeOH/Et3N 25:1:0.01). Collect the product fractions and 
evaporate to dryness. 
The resulting product, 3’-O-(4,4’-dimethoxytriphenyl)methyl-N2-iso- 
butyryl-(S)-9-(2,3-dihydroxypropyl)-guanine (S.11) should be obtained in a 
80% yield (127 mg, 2.12 mmol) as a white solid. TLC (AcOEt/MeOH 50:1): 
Rf = 0.10. 1H NMR (500 MHz, CDCl3): δ=1.27 (t, J=7.0 Hz, 6H), 2.62 (sept, 
J=6.8 Hz, 1H), 3.18 (dd, J=5.8, 9.8 Hz, 1H), 3.27 (dd, J=5.0, 9.5 Hz, 1H), 3.80 
(s, 6H), 4.03 (dd, J=8.0, 14.0 Hz, 1H), 4.25 (dd, J=2.5, 14.0 Hz, 1H), 4.36 (m, 
1H), 4.81 (br, 1H), 6.83 (d, J=8.5 Hz, 4H), 7.22 (t, J=7.2 Hz, 1H), 7.26-7.34 
(m, 6H), 7.45 (d, J=7.0 Hz, 2H), 7.55 (s, 1H), 8.43 (br, 1H), 11.79 (br, 1H). 
Prepare S.12 
1. Dry 200 mg (0.33 mmol) of S.11 overnight under vacuum of 0.05 mmHg 
in a 25-ml round bottom flask. 
2. Dissolve S.11 from step 1 and 0.11 ml (0.6 mmol) of DIPEA in 3.5 ml of 
THF (freshly distilled over sodium) under an argon atmosphere. 
3. Add 0.1 ml (0.45 mmol) of chloro(2-cyanoethoxy)(diisopropyl- 
amino)phosphine to the reaction mixture in a drop-wise fashion in a 
water-ice bath at 0°C. 
4. Stir the reaction at r. t. After 2 hr, add another 0.01 ml (0.05 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine (1/10 the volume 
from step 3) to the reaction mixture. 
5. Allow the reaction to stir overnight at r. t under an argon atmosphere. 
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6. Evaporate the solvent and dissolve the residue in a minimal amount of 
DCM. Add the solution to 100 ml of vigorously stirring pentane. Collect 
the white precipitate by vacuum filtration.  
7. Purify the residue by column chromatography. Deactivate the column with 
hexanes/Et3N 97:3 and elute with a step-wise gradient of 
DCM/AcOEt/Et3N 45:45:1 to AcOEt/Et3N 100:1. Combine the product 
fractions and evaporate to dryness. 
The resulting product, 2’-O-(2-cyanoethoxy)(diisopropylamino)- 
phosphino-3’-O-(4,4’-dimethoxytriphenyl)methyl-N2-isobutyryl-(S)-9-(2,3-dih
ydroxypropyl)-guanine (S.11) should be obtained in a 60% yield (158 mg, 0.2 
mmol) as a white foam. TLC (AcOEt/MeOH 50:1): Rf = 0.32, 0.42. 1H NMR 
(500 MHz, CDCl3): δ=1.06 (t, J=7.0 Hz, 2H), 1.10-1.15 (m, 17H), 1.20-1.29 
(m, 17H), 2.47 (t, J=6.0 Hz, 1H), 2.52-2.65 (m, 4H), 3.02 (dd, J=4.0, 9.5 Hz, 
1H), 3.08 (dd, J=5.2, 9.8 Hz, 1H), 3.13-3.23 (m, 2H), 3.46-3.82 (m, 10H), 3.78 
(s, 6H), 3.79 (s, 6H), 4.26-4.38 (m, 5H), 4.53 (m, 1H), 6.80 (m, 8H), 7.18-7.33 
(m, 14H), 7.42-7.48 (m, 4H), 7.49 (s, 1H), 7.55 (s, 1H), 8.38 (br, 1H), 8.70 (br, 
1H). 31P NMR (202 MHz, CDCl3): δ=148.20, 148.28. 
2.8 Basic Protocol 5 
Synthesis of 2’-O-(2-cyanoethoxy)(diisopropylamino)phosphino-3’-O- 
(4,4’-dimethoxytriphenyl)methyl-(S)-1-(2,3-dihydroxypropyl)thymine 
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This protocol describes the synthesis of (S)-GNA thymidine nucleoside 
phosphoramidite monomer S.14 from S.2 (Figure 2.6). 
 
Figure 2.6. Preparation of S.14. Abbreviations: NaH, sodium hydride; DMF, 
dimethylformamide; DIPEA, diisopropylethylamine; DCM, dichloromethane. 
Reprinted with permission from Current Protocols in Nucleic Acid Chemistry. 
Copyright 2010 John Wiley & Sons, Inc. 
Materials 
DMT-O-(S)-glycidol (S.2) 
Thymine 
Sodium hydride (60% in mineral oil) (NaH) 
Dimethylformamide (DMF), anhydrous 
Dichloromethane (DCM) 
Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Hexanes 
Ethyl acetate (AcOEt) 
Triethylamine (Et3N) 
Methanol (MeOH) 
25- and 50-ml round bottom flasks 
Oil bath 
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Magnetic stir plate and stir bar 
Gas balloon 
Graham condenser 
Rotary evaporator equipped with a vacuum pump 
1.3 x 30-cm chromatography column 
6.4 x 45-cm chromatography column 
Silica gel (60 Å, 230-400 mesh) 
TLC plate, EMD silica gel 60 F254 
200-ml separatory funnel 
UV lamp, 254 nm 
Büchner funnel  
Filter paper 
Additional reagents and equipment for TLC and column chromatography  
Prepare S.13 
1. Add 0.95 g (7.54 mmol) of thymine and 64 mg (1.60 mmol) of NaH (60% 
in mineral oil) in 12 ml DMF to a 50-ml round bottom flask.  
2. Stir the mixture at r. t. for 2 hr under an argon atmosphere. 
3. Dissolve 2.68 g (7.13 mmol) of S.2 in 15 ml of DMF in a 50-ml round 
bottom flask. 
4. Add the solution from step 3 to the 50-ml round bottom flask from step 1, 
attach a condenser to the flask, and stir the mixture at 110°C for 20 hr 
under an argon atmosphere. 
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5. Cool the reaction mixture to r. t. and remove the precipitate by vacuum 
filtration. Wash the residue with AcOEt. 
6. Evaporate the organic solvent from step 5 to dryness using a rotary 
evaporator equipped with a vacuum pump and a cooling trap. 
7. Purify the residue by column chromatography on 60 g of silica gel in a 6.4 
x 45-cm column. Deactivate the column with DCM/Et3N 97:3 and elute 
using DCM/MeOH/Et3N 50:1:0.01. Collect the product fractions and 
evaporate to dryness. 
The resulting product, 3’-O-(4,4’-dimethoxytriphenyl)methyl (S)-1-(2,3- 
dihydroxypropyl)thymine (S.13), should be obtained in a 54% yield (1.95 g, 
3.88 mmol) as a colorless foam. TLC (DCM/MeOH 25:1): Rf = 0.14. 1H NMR 
(400 MHz, CDCl3): δ= 1.73 (s, 3H), 3.07 (d, J=5.6 Hz, 2H), 3.55 (dd, J=7.2, 
14.0 Hz, 1H), 3.68 (s, 6H), 3.89-3.96 (m, 2H), 6.73 (m, 4H), 6.94 (d, J=1.2 Hz, 
1H), 7.10-7.22 (m, 7H), 7.30 (m, 2H). 
Prepare S.14 
1. Dry 1.1 g (2.2 mmol) of S.13 under vacuum of 0.05 mmHg in a 100-ml 
round bottom flask overnight. 
2. Dissolve S.13 from step 1 and 2.2 ml (11.7 mmol) of DIPEA in 36 ml of 
DCM (freshly distilled over CaH2) under an argon atmosphere. 
3. Add 0.62 ml (2.8 mmol) of chloro(2-cyanoethoxy)(diisopropylamino)- 
phosphine to the reaction mixture in a drop-wise fashion. 
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4. After 2 hr, add another 0.06 ml (0.3 mmol) of chloro(2-cyanoethoxy)- 
(diisopropylamino)phosphine (1/10 of the amount from step 3) to the 
reaction mixture. 
5. Stir the mixture at r. t. under an argon atmosphere for a total 3 hr. 
Evaporate the solvent and purify the residue by column chromatography. 
Deactivate the column with hexanes/Et3N 97:3 and elute using 
hexanes/AcOEt/Et3N 1:2:0.01. Combine the product fractions and evaporate 
to dryness. 
The resulting product, 2’-O-(2-cyanoethoxy)(diisopropylamino)- 
phosphino-3’-O-(4,4’-dimethoxytriphenyl)methyl-(S)-1-(2,3-dihydroxy- 
propyl)thymine (S.14) should be obtained in a 78% yield (1.21 g, 1.72 mmol) 
as a colorless foam. TLC (hexanes/AcOEt/Et3N 1:2:0.01): Rf = 0.33, 0.42. 1H 
NMR (300 MHz, CDCl3): δ=1.12-1.18 (m, 24H), 1.84 (m, 6H), 2.41 (t, J=6.3 
Hz, 2H), 2.59 (t, J=6.3 Hz, 2H), 3.16-3.32 (m, 4H), 3.49-3.88 (m, 10H), 3.78 
(s, 6H), 3.79 (s, 6H), 4.03-4.23 (m, 4H), 6.83 (m, 8H), 7.05 (m, 2H), 7.18-7.36 
(m, 14H), 7.44-7.46 (m, 4H). 31P NMR (121 MHz, CDCl3): δ=148.76, 148.95. 
2.9 Basic Protocol 6 
Synthesis, Isolation, and Characterization of Glycerol Nucleic Acid (GNA) 
Oligonucleotides 
The glycerol nucleoside phosphoramidites are completely stable under 
standard oligonucleotide synthesis conditions on a DNA synthesizer. An 
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Applied Biosystems 3400 DNA synthesizer has been used successfully on 
both a 0.2- and 1.0-µmol scale synthesis. Optimal yields were achieved by 
extending the coupling time of the GNA phosphoramidite monomers to 300 s 
(5 min). Because the free hydroxyl termini of GNA nucleotides are subject to 
decomposition during the base-deprotection step (Tsai et al., 2007), we 
recommend capping the 5’- and 3’-ends of each GNA sequence with a single 
DNA residue, typically T (Yang et al., 2007). Several techniques have been 
reported for the isolation and purification of sequences containing GNA 
nucleotides, such as C18 reverse phase HPLC and denaturing polyacrylamide 
gel electrophoresis (PAGE). This protocol describes the synthesis of GNA 
oligonucleotides from GNA monomer phosphoramidite precursors. 
Materials 
GNA phosphoramidite monomers bearing nucleobases A, C, G, and T (S.5, S.7, 
S.12, and S.14, respecttively) 
Anhydrous acetonitrile (MeCN) (Applied Biosystems) 
Standard 5’-O-(4,4’-dimethoxytrityl)phosphoramidites (Glen Research) 
Argon gas (Ultra high purity) 
Ammonium hydroxide, concentrated (conc. NH4OH) 
n-Butanol 
Nanopure water 
25-ml round bottom flasks 
4Å molecular sieves (freshly activated by heating at 300°C for at least 3 hr) 
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0.45-µm disposable syringe filter 
Syringes and needles 
Screw-capped eppendorf tube (2 ml) 
Screw-capped falcon centrifuge tubes 
Additional reagents and equipments for automated solid-phase 
oligodeoxyribonucleotide synthesis, isolation and characterization of synthetic 
nucleic acids 
Synthesize GNA oligonucleotides (0.2 µmol scale synthesis) 
1. Dissolve each GNA phosphoramidte (pre-dried under high vacuum for 48 
hr) in anhydrous MeCN in a 25-ml round bottom flask to make an 
approximate 0.05 M solution (150 mg, 150 mg, 150 mg, and 130 mg in 3 
ml MeCN for S.5 (A), S.7 (C), S.12 (G), and S.14 (T), respectively). 
2. Dry the phosphoramidite solutions from step 1 over freshly activated 
molecular sieves overnight at r. t. 
3. Filter the amidites solution using 0.45-µm disposable syringe filters 
directly into clean, dry bottles and immediately place the bottles on the 
corresponding amidite ports of the DNA synthesizer. 
Steps 1 through 3 are carried out under argon atmosphere. All the 
glassware, syringes and needles are pre-dried in a drying oven and then cooled 
to r. t. in a desiccator for later use.Start the automated solid-phase 
oligonucleotide synthesis from CPG-column pre-charged with a 
deoxynucleotide monomer or the universal support. 
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4. After completing the synthesis, remove the column and dry it for 2 min 
using vacuum pipeline. 
5. Open the CPG-column container and transfer the CPG beads into a 2-ml 
screw-capped eppendorf tube. 
Deprotect and purify GNA oligonucleotides  
6. Add 1 ml of conc. NH4OH, seal the tube, and incubate at 55°C for 48 hr. 
7. Place the tube on ice and cool for at least 10 min prior to opening  
8. Transfer the supernatant to a Falcon tube and add 10 ml of n-butanol. 
9. Place the tube on ice for 5 min. 
10. Centrifuge for 5 min at 4000 rpm, discard the supernatant and collect the 
oligonucleotide (white precipitate) 
11. Re-suspend the oligonucleotide pellet in 500 µl of nanopure water. 
12. Purify the crude product by denaturing PAGE and desalt the 
oligonucleotide by ethanol precipitation. 
13. Quantify the oligonucleotide by UV absorbance using Beer’s law at 254 
nm. 
Check molecular weight 
14. Check the molecular weight of the desired GNA oligonucleotide by 
MALDI-TOF mass spectroscopy using aqueous saturated 
3-hydroxypicolinc acid solution as matrix. Prepare matrix just before 
spotting the sample onto a MALDI-TOF mass spectrometry gold plate. 
See Figure 2.7 for sample MALDI-TOF mass spectroscopy result. 
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Figure 2.7. MALDI-TOF mass spectrum of GNA oligonucleotide. Reprinted 
with permission from Current Protocols in Nucleic Acid Chemistry. Copyright 
2010 John Wiley & Sons, Inc. 
2.10 Commentary 
Background Information 
Synthesis 
The “spring-loaded” epoxide ring-opening procedure was first reported by 
Acevedo and Andrews to increase the structural diversity of acyclic libraries 
aimed at creating therapeutic agents to cellular and viral targets (Acevedo et 
al., 1996). This unit presents a modified version of this synthetic strategy. 
GNA nucleoside derivatives can also be synthesized using a nucleobase 
substitution approach with a tosylated isopropylidene-glycerol (Holý, 1975). 
However, this approach requires more synthetic steps and results in a lower 
overall yield. Another approach is to use modified base protecting groups 
(N-dimethylformamidine group for A and G, acetamide for C) (Schlegel et al., 
2009b). Both of these protecting groups are compatible with faster 
oligonucleotide deprotection conditions, which can be advantageous for 
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minimizing GNA decomposition during the final deprotection step in 
ammonium hydroxide. 
Properties of glycerol nucleic acid 
GNA has an acyclic backbone composed of a three-carbon sugar 
connected by phosphodiester linkages. The repeating backbone unit contains 
one stereocenter, which results in two enantiomers, namely (S)- and (R)-GNA. 
Both (S)- and (R)-GNA form antiparallel duplex structures with 
complementary GNA strands of the same stereoconfiguration, and GNA 
duplexes are generally more stable than natural DNA and RNA (Zhang et al., 
2005, 2006, Yang et al., 2007). For this reason, GNA represents the simplest 
solution to a stable nucleic acid structure based on phosphodiester bonds. 
Cross-pairing between complementary strands of GNA and RNA results in the 
formation of a dramatically weaker duplex than pure GNA or RNA alone. 
Cross-pairing between complementary sequences of GNA and DNA has not 
been observed, suggesting that the GNA helix is incompatible with the 
standard B-form helix of natural DNA (Zhang et al., 2005, Yang et al., 2007). 
This is also indicated by the fact that the incorporation of GNA residues into 
DNA strands strongly destabilizes duplex formation. Cross-pairing between 
(R)- and (S)-GNA is also highly destabilizing (Schlegel et al., 2007). 
The X-ray crystal structure of a self-complementary (S)-GNA double helix 
was recently solved to a resolution limit of 1.3 Å (Schlegel et al., 2008). The 
three-dimensional structure revealed that (S)-GNA adopts a right-handed helix 
 62 
that is significantly different from the standard A- and B-form helical 
structures observed for natural RNA and DNA, respectively. A striking feature 
of the GNA duplex is the large average slide (3.4 Å) between adjacent base 
pairs due to a large backbone-base inclination of the duplex (42-50º in GNA 
versus almost 0º in the B-form DNA). This structural change results in 
extensive interstrand base stacking and significantly less intrastrand base 
stacking common to standard A- and B-form helical structures. Another 
unusual feature is the formation of a loosely wrapped helical ribbon around the 
central helix axis, which replaces the major groove by a convex surface and 
leaves just one large minor groove (Schlegel et al., 2008, 2009a, and 2010). 
GNA application 
GNA, which is a structurally simplified artificial oligonucleotide, is 
capable of forming stable duplex structures by Watson-Crick base-pairing 
rules. This property indicates that GNA represents an interesting synthetic 
material for constructing programmable nucleic acid nanostructures. Toward 
this goal, we recently described the synthesis of a nanostructure composed 
entirely of GNA. The GNA nanostructure, a 4-helix junction (4HJ) (Zhang et 
al., 2008), mimics a fixed-sequence DNA Holliday junction described 
previously by Seeman and co-workers (Kallenbach et al., 1983). Because the 
GNA backbone contains only one stereocenter per repeating unit, it was 
possible to synthesize two mirror-image nanostructures using (S)- and 
(R)-GNA. A major finding was that the GNA 4HJ was significantly more 
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stable than the earlier 4HJ composed entirely of DNA (Tm 73°C for GNA 
versus 37°C for DNA). This feature coupled with the ability to construct left- 
and right-handed nanostructures provides new opportunities for building 
highly stable nanostructures with topologies that are not readily available to 
DNA.  
Critical Parameters 
For all reactions using anhydrous solvents, the glassware must be pre-dried 
in a drying oven (80°C). To obtain optimal separations and to reduce the 
purification time, we recommend using flash column chromatography for all 
purification steps. For phosphoramidite synthesis, the reaction progress is 
monitored by TLC and should be stopped as soon as the starting material is 
consumed. The phosphitylation reaction affords two diastereomeric 
phosphoramidite products, which are general visualized as two spots on the 
TLC plate. However, phosphoramidites bearing cytosine migrate on the TLC 
plate as a one spot, even though the products are actually two isomers. The 
GNA phosphoramidite building blocks must be dried under high vacuum in a 
desiccator for 24 hr to give a well-foamed solid before they can be used for 
solid-phase synthesis. 
Trouble shooting 
The phosphoramidites containing the nucleobase, guanine, will decompose 
when purified on a silical gel column (Zhang et al., 2006). In this protocol, a 
modified method is described for column chromatography purification that 
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affords the desired intact compound verified by 1H and 31P NMR 
characterization. 
Anticipated Results 
The protocols described in this unit are useful for preparing GNA 
oligonucleotides. The GNA phosphoramidite monomers can be synthesized on 
a multi-gram scale. The oligonucleotide synthesis is similar to the standard 
DNA phosphoramidite protocol with the noted exception of elongated 
coupling times. The average stepwise yield is >95%, which is sufficient to 
produce GNA oligonucleotides in high yield. 
Time Considerations 
Each step in the chemical synthesis can be accomplished in 1-2 working 
days (including purification). The time for oligonucleotide synthesis varies 
slightly from the standard phosphoramidite method by longer coupling times. 
The deprotection, isolation and the analysis of the final synthetic 
oligonucleotide are accomplished in 2-3 days. 
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Chapter 3 
SYNTHESIS OF THREOSE NUCLEIC ACID (TNA) PHOSPHORAMIDITE 
MONOMERS AND OLIGONUCLEOTIDE POLYMERS 
3.1 Contributions 
The following chapter describes a published protocol for the synthesis of 
TNA phosphoramidite monomers and oligonucleotide polymers. All 
experiments were performed by Su Zhang under the guidance of Professor 
John Chaput. Su Zhang and John Chaput wrote the manuscript. The results 
from this work were submitted to Current Protocols in Nucleic Acid 
Chemistry. 
3.2 Abstract 
This unit describes in detail the preparation of (3’→2’)-α-L-threo- 
furanosyl nucleic acid (TNA) phosphoramidite building blocks bearing 
adenine (A), cytosine (C), diaminopurine (D), guanine (G), and thymine (T) as 
the bases and the oligonucleotide thereof. Starting from commercially 
available L-ascorbic acid, protected threofuranosyl sugars are obtained (Basic 
Protocol 1) and subsequently converted to protected threonucleosides via 
Vorbrüggen-Hilbert-Johnson reactions. The nucleosides are then converted to 
their corresponding phosphoramidites (Basic Protocols 2 to 6), which can then 
be used for the solid-phase synthesis of TNA oligonucleotides (Basic Protocol 
7). 
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3.3 Introduction 
TNA is a structural alternative of DNA with only a four-carbon 
sugar-phosphate backbone repeating unit (Figure 3.1). Although containing 
one less bond per repeating unit than DNA, TNA is capable of adapt itself to 
Watson-Crick base-paring with DNA, RNA, and TNA complementary 
 
Figure 3.1. Chemical structures of DNA, RNA, and TNA. 
sequence, respectively (Schöning et al. 2000; 2002). TNA has been considered 
as an evolutionary progenitor of RNA due to the facts that TNA could transfer 
genetic information as well as its simpler structure (Orgel 2000). The sequence 
space of TNA has been recently explored to test the ability for TNA to possess 
chemical and biological functions such as the ability to bind a desired target 
with high affinity and specificity and the potential to catalyze reactions on a 
particular substrate (Chaput et al. 2003a, 2003b; Horhota et al. 2005; Ichida et 
al. 2005a, 2005b). These experiments might provide evidence to answer the 
question whether TNA is a viable progenitor candidate of RNA, and hopefully, 
shed light on the etiology and evolution of genetic system. This unit describes 
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the synthesis of TNA phosphoramidites monomers (Basic Protocol 2 through 6) 
and the solid-phase synthesis and purification of TNA oligonucleotides using 
these building blocks (Basic Protocol 7). 
3.4 Basic Protocol 1 
Synthesis of protected L-threofuranose, 1-O-Acetyl-2,3-di-O-benzoyl-L- 
threofuranose and 1,2,3-tri-O-benzoyl-L-threofuranose 
The synthesis of L-threose has been reported by several different groups, 
although most of the methods were not suitable for large-scale preparation. 
The present protocol is based on Eschenmoser’s procedure (Schöning et al. 
2000, 2002) and is illustrated in Figure 3.2. The synthesis is initiated from the 
oxidative degradation of L-ascorbic acid (1) to afford L-threonic acid. A one- 
pot lactonization and in-situ benzoylation affords the 2,3-di-O-benzoyl-L- 
threonolactone (3). The lactone is then treated with DIBAL-H to furnish the 
2,3-di-O-benzoylated lactol. 1-O-Acetyl-2,3-di-O-benzoyl-L-threofuranose (5) 
obtained by acetylation of the lactol is used to prepare the C, D, G, and T 
threose nucleoside phosphoramidites (see Basic Protocols 2-5, respectively). 
The benzoylated lactol 1,2,3-Tri-O-benzoyl-L-threofuranose (6) is used to 
make A threose nucleoside phosphoramidite (see Basic Protocol 6). 
Materials 
L-Ascorbic acid (1) 
p-Toluenesulfonic acid (TsOH) 
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Benzoyl chloride (BzCl) 
Diisobutylaluminium hydride (DIBAL-H) 
4-Dimethylaminopyridine (DMAP) 
Acetic anhydride (Ac2O) 
Acetonitrile, anhydrous (MeCN) 
Pyridine, anhydrous 
 
Figure 3.2. Preparation of protected L-threofuranoses S.5 and S.6. 
Abbreviations: TsOH, p-toluenesulfonic acid; MeCN, acetonitrile; BzCl, 
benzoyl chloride; DIBAL-H, diisobutylaluminium hydride; DCM, 
dichloromethane. 
Tetrahydrofuran, anhydrous (THF) 
Calcium carbonate (CaCO3) 
Hydrogen peroxide (H2O2) 
Ultra pure water (H2O) 
Dichloromethane (DCM) 
Ethyl acetate (EtOAc) 
Hexanes 
Methanol (MeOH) 
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Ethanol (EtOH) 
1M aqueous hydrochloric acid solution (1M HCl) 
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Saturated aqueous sodium potassium tartrate 
Activated charcoal 
Magnesium sulfate (MgSO4) 
Dowex 50WX4-50 resin 
Argon gas 
250-, 500-, 1000-, and 2000-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
250-, 500-, 1000-, and 2000-ml separatory funnel 
Büchner funnel  
Allihn condenser 
Filter paper 
UV lamp, 254 nm 
Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
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Prepare S.2 
1. Dissolve 88 g (0.5 mol) of L-ascorbic acid in 700 ml of H2O in a 2000-ml 
round bottom flask and slowly add 100 g (1 mol) of CaCO3 with stirring. 
2. Cool the mixture to 15 °C and add 200 ml of 30% aq. H2O2 over a period 
of 3 hr using a dropping funnel. 
3. Warm the reaction to r. t. and stir the reaction for 18 hr. 
4. Add 20 g of activated charcoal to the solution and increase the temperature 
to 70 °C until no more peroxide. 
5. Filter the hot reaction mixture and wash the filter cake with water. 
6. Concentrate the filtrate to ca. 500 ml under reduced pressure.  
7. Add 200 ml of MeOH dropwise using a dropping funnel over 5 hr at r. t. 
The product gradually precipitates out of the solution during this process.  
8. Stir the mixture for an additional 5 hr at r. t., and then add another 200 ml 
of MeOH to the solution. 
9. Isolate the precipitate by vacuum filtration and wash with cold MeOH. 
10. Collect the filtrate and repeat step 5-9 to obtain additional precipitate. 
Dry the product under reduced pressure to a constant weight. 
The resulting product, Calcium-L-threonate monohydrate (S.2), is obtained 
in a 76% yield (64g, 195 mmol) as a white powder. 1H-NMR (300 MHz, D2O): 
δ=3.63 (dd, J=11.6, 7.8, 1H), 3.70 (dd, J=11.4, 5.4, 1H), 3.98 (ddd, J=12.6, 5.4, 
2.1, 1H), 4.04 (d, J=2.1, 1H). 
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Prepare S.3 
1. Dissolve 30 g (91.3 mmol) of S.2 in 640 ml of water at 40 °C, and then 
add 190 ml of Dowex 50WX4-50 resin (acidic form) to the solution. 
2. Stir the reaction mixture at 70 °C for 30 min. Remove the resin by vacuum 
filtration and wash with water. 
3. Concentrate the filtrate to dryness under reduced pressure to a constant 
weight at 50 °C. 
4. Resuspend the residue in MeCN, co-evaporate it twice with MeCN, and 
resuspend the residue in 320 ml of anhydrous MeCN. 
5. Add 0.64 g (3.2 mmol) of TsOH to the suspension and reflux the reaction 
for 24 hr under an argon atmosphere. 
6. Allow the reaction to cool to r. t. Filter the solution and evaporate the 
solvent to dryness under reduced pressure. 
7. Dissolve the residue in 128 ml of pyridine and cool the solution to 0 °C in 
a water-ice bath. 
8. Add 26.4 ml (228 mmol) of BzCl dropwise to the solution from step 7. 
9. Remove the water-ice bath and stir the reaction at r. t. for 16 hr. 
10. Dilute the reaction mixture with 250 ml of DCM and wash the organic 
solvent with 160 ml of ice-cold 1M aq. HCl. Then wash the organic 
solvent sequentially with 200 ml of water, 200 ml of sat. aq. NaHCO3 and 
130 ml of brine. 
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11. Dry the organic phase over MgSO4 and evaporate the solvent to dryness 
under reduced pressure. 
12. Crystallize the residue from hexanes/EtOAc 6:1 (v/v). 
The resulting product, 2,3-Di-O-benzoyl-L-threonolactone (S.3), is 
obtained in a 60% yield (17.9 g, 54.8 mmol) as colorless needles. 1H-NMR 
(300 MHz, CDCl3): δ=4.38 (m, 1H), 5.02 (m, 1H), 5.81 (m, 2H), 7.45-8.12 (m, 
10H). 
Prepare S.4 
1. Dissolve 20 g (60 mmol) of S.3 in 250 ml of anhydrous THF at -78 °C 
under an argon atmosphere, and then add 75 ml (225 mmol) of 1.5 M 
DIBAL-H solution in Toluene dropwise using a dropping funnel. 
2. Stir the reaction at -78 °C until S.3 is completely consumed. 
3. Add 10 ml of MeOH over 3 min to the mixture from step 2 to quench the 
reaction. And then let the reaction mixture warm to r. t.  
4. Dilute the mixture from step 3 with 400 ml of EtOAc and 200 ml of sat. aq. 
sodium potassium tartrate. Then vigorously stir the mixture at r. t. for 3 hr. 
5. Separate the organic phase from step 4. Wash the organic solution with 
brine and dry it over MgSO4. 
6. Remove the solvent under reduced pressure to afford both diastereomers of 
the product without further purification. 
The resulting product, 2,3-Di-O-benzoyl-L-threofuranose (S.4), is obtained 
in a 60% yield as colorless oil. TLC (hexanes/EtOAc 2:1): Rf 0.37. 1H-NMR 
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(400 MHz, CDCl3): δ=3.97 (dd, J=8.1, 3.0, 1H), 4.26 (dd, J=10.2, 4.0), 4.60 
(m, 2H), 5.47 (t, J=4.0, 1H), 5.53 (m, 2H), 5.57 (s, 1H), 5.75 (m, 1H), 5.85 (d, 
J=4.0, 1H), 7.42-7.47 (m, 8H), 7.53-7.59 (m, 4H), 8.01-8.10 (m, 8H). 
Prepare S.5 
1. Dissolve the crude S.4 (19.7 g) in 200 ml of DCM/pyridine 1:1. Add 6.8 
ml (62 mmol) of Ac2O and 50 mg (0.4 mmol) of DMAP to the solution. 
2. Stir the reaction at r. t. for 18 hr. 
3. Pour the reaction mixture into a stirring solution of ice-cold sat. 
NaHCO3/DCM 1:1. Let the stirring continue at 0 °C for 1 hr. 
4. Separate and wash the organic phase with sat. NaHCO3, water, and brine. 
Dry the organic phase over MgSO4. 
5. Evaporate the organic solvent to dryness and purify the residue by column 
chromatography (SiO2, hexanes/EtOAc 2:1 (v/v)) to afford both 
diastereomers of the product. 
The resulting product, 1-O-Acetyl-2,3-Di-O-benzoyl-L-threofuranose (S.5), 
is obtained in an 89% yield (19.6 g, 53.4 mmol) as a colorless oil. TLC 
(hexanes/EtOAc 2:1): Rf 0.43. 1H-NMR (400 MHz, CDCl3): δ=2.04 (s, 3H), 
2.16 (s, 3H), 4.05 (dd, J=10.4, 3.6, 1H), 4.22 (dd, J=10.6, 3.8, 1H), 4.62 (dd, 
J=10.8, 6.4, 1H), 4.67 (dd, J=10.4, 6.0, 1H), 5.56 (m, 1H), 5.65 (s, 1H), 5.70 (t, 
J=4.6, 1H), 5.76 (m, 1H), 6.38 (s, 1H), 6.64 (d, J=4.4, 1H), 7.26-7.50 (m, 8H), 
7.58-7.64 (m, 4H), 8.05-8.10 (m, 8H). 
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Prepare S.6 
1. Dissolve 4.1 g (12.5 mmol) of S.4 in 42 ml of DCM/pyridine 1:1. Add 1.7 
ml (14 mmol) of BzCl to the solution at 0 °C in a water-ice bath. 
2. Remove the water-ice bath and stir the reaction at r. t. for 18 hr. 
3. Cool the reaction mixture to 0 °C and add 16 ml of 0.1 M aq. HCl. 
4. Separate and wash the organic phase with sat. NaHCO3, water, and brine. 
Dry the organic phase over MgSO4. 
5. Recrystallize the residue from EtOH to afford the β-isomer. 
6. Concentrate the ethanolic mother liquor and run the residue through SiO2 
using hexanes/EtOAc 2:1 (v/v) to yield the α-isomer. 
The resulting product, 1,2,3-Tri-O-benzoyl-L-threofuranose (S.6), is 
obtained in a combined 72% yield (3.9 g, 9 mmol). 1H-NMR α-isomer (300 
MHz, CDCl3): δ=4.15 (dd, J=11.6, 3.0, 1H), 4.70 (dd, J= 11.8, 6.0, 1H), 5.84 
(m, 2H), 6.86 (d, J=4.0, 1H), 7.38-7.55 (m, 9H), 7.95-7.20 (m, 6H). β-isomer 
(300 MHz, CDCl3): δ=4.32 (dd, J=10.5, 3.0, 1H); 4.74 (dd, J=10.7, 5.9, 1H), 
5.64 (dd, J=5.1, 3.0, 1H), 5.82 (s, 1H), 6.64 (s, 1H), 7.40-7.51 (m, 6H), 
7.56-7.65 (m, 3H), 8.06-8.14 (m, 6H). 
3.5 Basic Protocol 2 
Synthesis of 4-Benzoyl-1-{2’-O-[(2-cyanoethoxy)(diisopropylamino)- 
phosphino]-3’-O-[(4,4’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}- 
cytosine 
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This protocol describes the synthesis of N4-benzoylated TNA cytidine 
nucleoside phosphoramidite S.10 from S.5 (Figure 3.3). 
 
Figure 3.3. Preparation of S.10. Abbreviations: BSA, N,O-bis(trimethyl- 
silyl)acetamide; TMSOTf, trimethylsilyl trifluoromethanesulfonate; MeCN, 
acetonitrile; NaOH, sodium hydroxide; THF, tetrahydrofuran; MeOH, 
methanol; DMT-Cl, 4,4’-dimethoxytritylchloride; AgOTf, silver 
trifluoromethanesulfonate; DCM, dichloromethane; DMF, dimethylformamide; 
DIPEA, diisopropylethylamine. 
Materials  
N4-benzoylcytosine (CBz) 
Sodium hydroxide (NaOH) 
0.1 M aqueous hydrochloric acid solution (0.1 M HCl) 
2,6-lutidine 
N,O-bis(trimethylsilyl)acetamide (BSA) 
4,4'-Dimethoxytriphenylmethyl chloride (DMT-Cl) 
Trimethylsilyl trifluoromethanesulfonate (TMSOTf) 
Silver trifluoromethanesulfonate (AgOTf) 
Acetonitrile, anhydrous (MeCN) 
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Tetrahydrofuran (THF) 
Ultra pure water (H2O) 
Dichloromethane (DCM) 
Ethyl acetate (EtOAc) 
Hexanes 
Dichloromethane (DCM) 
N,N-dimethylformamide (DMF) 
Triethylamine (Et3N) 
Methanol (MeOH) 
N,N-Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Magnesium sulfate (MgSO4) 
Sodium sulfate (Na2SO4) 
Argon gas 
100- and 250-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
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250-ml separatory funnel 
Büchner funnel  
Allihn condenser 
Filter paper 
UV lamp, 254 nm 
Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
Prepare S.7 
1. Dissolve 2.4 g (6.5 mmol) of S.5 in 19 ml of anhydrous MeCN in a 100-ml 
round bottom flask. To this solution, add 4 ml (16.2 mmol) of BSA and 
1.45 g (6.8 mmol) of N4-benzoylcytosine. 
2. Attach a condenser to the flask and stir the mixture at 70 °C for 1 hr. 
3. Add 3.5 ml (19.4 mmol) of TMSOTf to the mixture from step 2 and stir 
the reaction at 70 °C for an addition ca. 1 hr until S.5 is completely 
consumed. 
4. Cool the reaction to 24 °C, dilute the mixture with 60 ml of AcOEt and 
pour it into 76 ml of sat. NaHCO3. 
5. Stir the mixture for 15 min, isolate the product by vacuum filtration and 
wash the product with cold EtOAc. 
6. Wash the organic phase of the filtrate with brine and dry it over MgSO4. 
Evaporate the organic solvent under reduced pressure. 
 79 
7. Purify the residue from step 6 by column chromatography. Elute the 
product from SiO2 using a step-wise gradient of hexanes/EtOAc 4:1 to 
DCM/EtOAc 3:1 (v/v). 
The resulting product, N4-benzoyl-1-(2’,3’-di-O-benzoyl-α-L-threo- 
furanosyl)cytosine (S.7), is obtained in a combined 71% yield (2.4 g, 4.6 
mmol) as a white solid. TLC (DCM/EtOAc 1:1): Rf 0.48. 1H-NMR (400 MHz, 
CDCl3): δ=4.57 (d, J=11.2, 1H), 4.61 (dd, J=11.2, 3.6, 1H), 5.61 (d, J=3.2, 1H), 
5.84 (s, 1H), 6.30 (s, 1H), 7.40-7.66 (m, 10H), 7.87 (m, 2H), 7.92 (d, J=7.6, 
1H), 8.03 (d, J=7.2, 1H), 8.09 (m, 2H), 8.75 (br, s, 1H). 
Prepare S.8 
1. Suspend 2.6 g (5.1 mmol) of S.7 in 83 ml of THF/MeOH/H2O 5:4:1 and 
cool the mixture to 0 °C in a water-ice bath. 
2. Add 8.3 ml of 2N NaOH and stir the reaction at 0 °C for 30 min. 
3. Neutralize the mixture from step 2 with 2N HCl and evaporate the solvent 
to dryness under reduced pressure. 
4. Re-suspend the residue in MeOH and co-evaporate it with toluene. 
5. Resuspend the residue in MeOH, adsorb the mixture onto silica gel 
(sample/silica gel ratio 1:1.2, w/w) 
6. Purify the residue by column chromatography. Elute the product using a 
step-wise gradient of DCM/MeOH 25:1 to 10:1 (v/v). 
The resulting product, N4-benzoyl-1-(α-L-threofuranosyl)cytosine (S.8), is 
obtained in a 92% yield (1.5 g, 4.7 mmol). TLC (DCM/MeOH 25:1): Rf 0.02. 
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1H-NMR (400 MHz, DMSO-d6): δ=4.03 (s, 1H), 4.08 (s, 1H), 4.19 (m, 2H), 
5.66 (s, 1H), 7.30 (d, J=7.2, 1H), 7.52 (m, 2H), 7.63 (m, 1H), 8.00 (m, 2H), 
8.11 (d, J=7.6, 1H). 
Prepare S.9 
1. Dissolve 1.5 g (4.7 mmol) of S.8 in 9 ml of anhydrous DCM and 30 ml of 
anhydrous DMF. 
2. To the solution from step 1, add 2.2 g (6.3 mmol) of DMT-Cl, 2.8 ml (24 
mmol) of 2,6-lutidine and 1.44 g (0.6 mmol) of AgOTf. 
3. After 5 hr of stirring at r. t., add another 0.15 g (0.45 mmol) of DMT-Cl 
and 0.14 g (0.6 mmol) of AgOTf and stir the reaction at r. t. overnight. 
4. Quench the reaction with 6 ml of MeOH. Then add 1.5 ml of water and 
dilute the mixture with 150 ml of DCM. 
5. Filter the mixture and wash the residue with DCM. 
6. Wash the combined filtrate sequentially with ice-cold 0.1M aq. HCl 
solution (2x), water (2x), sat. aq. NaHCO3 and brine. 
7. Dry the solution over Na2SO4, and remove the organic solvent under 
reduced pressure. 
8. Purify the residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the column using a step-wise gradient of 99:1 
(v/v) DCM/Et3N to DCM/MeOH/Et3N 98:1:1. 
 
 
 81 
The resulting product, N4-benzoyl-1-{3’-O-[(4”,4”’-dimethoxy- 
triphenyl)]-α-L-threofuranosyl}cytosine (S.9), is obtained in a 51.3% yield 
(1.5 g, 2.4 mmol). TLC (DCM/MeOH 16:1): Rf 0.26. 1H-NMR (400 MHz, 
CDCl3): δ=3.37 (d, J=9.6, 1H), 3.62 (dd, J=10.0, 3.2, 1H), 3.77 (2s, 6H), 3.95 
(br, s, 1H), 4.26 (m, 2H), 5.64 (s, 1H), 6.80-6.84 (m, 4H), 7.20-7.36 (m, 9H), 
7.53-7.66 (m, 4H), 7.91 (1H), 7.92 (d, J=7.6, 1H), 8.05 (d, J=7.6, 1H), 8.76 (br, 
s, 1H). 
Prepare S.10 
1. Dissolve 400 mg (0.68 mmol) of S.9 in 3.2 ml of anhydrous DCM and 
0.67 ml (3.8 mmol) of DIPEA in a 50 ml round bottom flask at r. t. under 
an argon atmosphere. 
2. To the solution from step 1, add 180 µl (0.68 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine in a dropwise manner. 
3. Stir the reaction at r. t. for 1 hr. Then add an extra 20 µl (0.07 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine to the reaction 
mixture. 
4. Stir the reaction at r. t. for 18 hr. 
5. Quench the reaction with 1 ml of MeOH. 
6. Remove the solvent to dryness under reduced pressure and purify the 
residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3, load the sample with benzene, and elute the product 
using hexanes/EtOAc/Et3N 59:39:2. 
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The resulting product, N4-benzoyl-1-{2’-O-[(2-cyanoethoxy)- 
(diisopropylamino)phosphino]-3’-O-[(4”,4”’-dimethoxytriphenyl)]-α-L-threo- 
furanosyl}cytosine (S.10), is obtained in an 87% yield (466 mg, 0.59 mmol) as 
a mixture of diastereomers. TLC (DCM/MeOH 50:1): Rf 0.11, 0.17. 1H-NMR 
(400 MHz, CDCl3): δ=1.06-1.22 (m, 24H), 2.33, 2.68 (2m, 4H), 3.13 (d, J=10, 
1H), 3.22 (d, J=9.6, 1H), 3.46-3.52 (m, 4H), 3.68, 3.69 (2s, 12H), 3.78-3.83 
(m, 4H), 3.98-4.06 (m, 4H), 4.17 (d, J=3.6, 1H), 4.47 (d, J=8.4, 1H), 4.65 (d, 
J=9.2, 1H), 5.79 (s, 1H), 5.81 (s, 1H), 6.72-6.76 (m, 8H), 7.09-7.19 (m, 14H), 
7.45-7.58 (m, 8H), 7.84-7.85 (m, 6H), 7.91 (d, J=7.6, 1H), 7.96 (d, J=7.2, 1H), 
8.58 (br, 2H). 31P-NMR (161 MHz, CDCl3): δ=150.60, 152.58. 
3.6 Basic Protocol 3 
Synthesis of N2,N6-Dibenzoyl-9-{2’-O-[(2-cyanoethoxy)(diisopropyl- 
amino)-phosphino]-3’-O-[(4,4’-dimethoxytriphenyl)methyl]-α-L-threo- 
furanosyl}-2,6-diaminopurine 
This protocol describes the synthesis of N2,N6-Dibenzoylated TNA 
diaminopurine nucleoside phosphoramidite S.14 from S.5 (Figure 3.4). 
Materials 
N2,N6-dibenzoyl-2,6-diaminopurine (D(Bz)2) 
Sodium hydroxide (NaOH) 
0.1 M aqueous hydrochloric acid solution (0.1 M HCl) 
Ammonium chloride (NH4Cl) 
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Figure 3.4. Preparation of S.14. Abbreviations: BSA, N,O-bis(trimethylsilyl)- 
acetamide; TMSOTf, trimethylsilyl trifluoromethanesulfonate; MeCN, 
acetonitrile; NaOH, sodium hydroxide; THF, tetrahydrofuran; MeOH, 
methanol; DMT-Cl, 4,4’-dimethoxytritylchloride; AgOTf, silver 
trifluoromethanesulfonate; DCM, dichloromethane; DMF, dimethylformamide; 
DIPEA, diisopropylethylamine. 
2,6-lutidine 
N,O-bis(trimethylsilyl)acetamide (BSA) 
4,4'-Dimethoxytriphenylmethyl chloride (DMT-Cl) 
Trimethylsilyl trifluoromethanesulfonate (TMSOTf) 
Silver trifluoromethanesulfonate (AgOTf) 
Acetonitrile, anhydrous (MeCN) 
Tetrahydrofuran (THF) 
Ultra pure water (H2O) 
Dichloromethane (DCM) 
Ethyl acetate (EtOAc) 
Hexanes 
Dichloromethane (DCM) 
N,N-dimethylformamide (DMF) 
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Triethylamine (Et3N) 
Methanol (MeOH) 
N,N-Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Benzene 
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Magnesium sulfate (MgSO4) 
Sodium sulfate (Na2SO4) 
Argon gas 
Activated molecular sieves 
100- and 250-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
250-ml separatory funnel 
Büchner funnel  
Allihn condenser 
Filter paper 
UV lamp, 254 nm 
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Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
Prepare S.11 
1. Suspend 3.2 g (8.9 mmol) of N2,N6-dibenzoyl-2,6-diaminopurine in 30 ml 
of anhydrous MeCN. Stir the mixture under an argon atmosphere at 65 °C. 
2. To the suspension from step 1, add 5.9 ml (23.8 mmol) of BSA. Stir the 
mixture at 65 °C for an additional 30 min until a clear solution is formed. 
3. Add 2.86 g (7.7 mmol) of S.5 in 25.5 ml of anhydrous MeCN to the clear 
solution from step 2. Then add 2 ml (10 mmol) of TMSOTf to the solution. 
4. Stir the reaction at 65 °C for 3 hr, and then cool it down to r. t. 
5. Dilute with 190 ml of EtOAc and wash the reaction mixture with 250 ml 
of sat. aq. NaHCO3. 
6. Separate and filter the organic phase, wash it with sat. aq. NaHCO3, then 
brine, and dry it over MgSO4. 
7. Remove the organic solvent under reduced pressure and purify the residue 
by column chromatography. Elute the column using a step-wise gradient of 
hexanes/EtOAc 3:2 to 1:3 (v/v). 
The resulting product, N2,N6-Dibenzoyl-9-(2’,3’-di-O-benzoyl-α-L-threo- 
furanosyl)-2,6-diaminopurine (S.11), is obtained in a 35% yield (1.8 g, 2.7 
mmol) as a white foam. TLC (hexanes/EtOAc 1:3): Rf 0.48. 1H-NMR (400 
MHz, DMSO-d6): δ=4.64 (dd, J=10.0, 6.4, 1H), 4.82 (dd, J=9.6, 4.8, 1H), 5.89 
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(m, 1H), 6.49 (m, 2H), 7.33-8.10 (m, 20H), 8.61 (s, 1H), 10.99 (s, 1H), 11.27 
(s, 1H). 
Prepare S.12 
1. Dissolve 1.9 g (2.8 mmol) of S.11 in 160 ml of ice-cold THF/MeOH/H2O 
5:4:1. To this solution slowly add 11 ml (22.1 mmol) of 2N aq. NaOH over 
10 min. 
2. Stir the reaction at 0 °C for an additional 5 min. 
3. Quench the reaction with 1.25 (23.5 mmol) of solid NH4Cl. Keep stirring 
the reaction at 0 °C for 30 min. 
4. Remove the solvent under reduced pressure and co-evaporate the residue 
twice with MeOH. 
5. Adsorb the residue from step 4 onto silica gel. Purify the product by 
column chromatography. Elute the column using a step-wise gradient of 
DCM/MeOH 100:1 to 40:1 (v/v). 
The resulting product, N2,N6-Dibenzoyl-9-(α-L-threofuranosyl)- 
2,6-diaminopurine (S.12), is obtained in an 84% yield (1.1 g, 2.4 mmol) as a 
white powder. TLC (DCM/MeOH 20:1): Rf 0.26. 1H-NMR (400 MHz, 
DMSO-d6): δ=4.07 (dd, J=9.2, 2.4, 1H), 4.14 (dd, J=9.2, 3.6, 1H), 4.18 (m, 
1H), 4.41 (m, 1H), 5.61 (br, s, 1H), 5.90 (d, J=4.0, 1H), 5.95 (br, s, 1H), 
7.46-7.59 (m, 6H), 7.98-8.05 (m, 4H), 8.05 (s, 1H), 11.00 (br, s, 2H). 
 
 
 87 
Prepare S.13 
1. Dissolve 3.44 g (7.5 mmol) of S.12 in 63 ml of DCM/DMF 1:1 in a 500 ml 
round bottom flask at r. t. under an argon atmosphere and a water bath. 
2. Add 3.46 g (10.2 mmol) of DMT-Cl to the solution from step 1 with 
stirring, then add 5.1 ml (44.2 mmol) of 2,6-lutidine. 
3. Add ca. 3.5 g of activated molecular sieves, and then add 2.94 g (11.4 
mmol) of AgOTf over a period of 10 min in 4 portions at r. t. 
4. After stirring the reaction for an additional 4 hr, add 457 mg (1.4 mmol) of 
DMT-Cl and 330 mg (1.3 mmol) of AgOTf to the mixture from step 3. 
5. Stir the reaction in the water bath at r. t. for an additional 20 hr. 
6. Quench the reaction by 2.5 ml of MeOH, dilute with 290 ml of DCM, and 
then filter the resulting mixture. 
7. Cool the filtrate to 0 °C and wash it with 290 ml of cold 0.1 M aq. HCl 
(2x), with sat. aq. NaHCO3, and brine.  
8. Dry the organic phase over Na2SO4, and then evaporate the solvent to 
dryness under reduced pressure. 
9. Purify the residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the column using a step-wise gradient of 
hexanes/benzene/DCM/EtOAc/Et3N/MeOH 10:10: 2.5:2.5:0.2:0.1 to 10:10: 
2.5:2.5:0.2:0.4 and finally DCM/ Et3N 35:1 plus 1% Et3N. 
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The resulting product, N2,N6-Dibenzoyl-9-{3’-O-[(4”,4”’-dimethoxy- 
triphenyl)methyl]-α-L-threofuranosyl}-2,6-diaminopurine (S.13), and its 
2’-O-regioisomer N2,N6-Dibenzoyl-9-{2’-O-[(4”,4”’-dimethoxytriphenyl)- 
methyl]-α-L-threofuranosyl}-2,6-diaminopurine (S.13a), are obtained in a 
33.7% (2.0 g, 2.5 mmol) and 16% (0.9 g, 1.2 mmol) yield, respectively. TLC 
(benzene/EtOAc/DCM/MeOH 8:1:1:0.2): Rf 0.40 (S.13), 0.35 (S.13a). 
1H-NMR S.13 (400 MHz, CDCl3): δ=3.05 (dd, J=9.4, 6.2, 1H), 3.36 (dd, J=9.2, 
6.2, 1H), 3.77 (2s, 6H), 4.44 (m, 1H), 4.76 (m, 1H), 5.79 (d, J=4.4, 1H), 
6.80-6.85 (m, 4H), 7.18-7.64 (m, 15H), 7.99-8.06 (m, 5H), 9.43 (br, s, 1H), 
9.64 (br, s, 1H). S.13a (500 MHz, DMSO-d6): δ=3.62 (2s, 6H), 3.76 (m, 1H), 
3.97 (d, J=7.6, 1H), 4.08 (dd, J=7.6, 2.4, 1H), 4.44 (s, 1H), 5.36 (d, J=2.8, 1H), 
5.92 (s, 1H), 6.70-6.77 (m, 4H), 7.14-7.65 (m, 16H), 7.98-8.20 (m, 4H), 11.01 
(s, 1H), 11.19 (s, 1H). 
Prepare S.14 
1. Dissolve 400 mg (0.52 mmol) of S.13 in 3.8 ml of anhydrous DCM and 
0.34 ml of DIPEA in a 50 ml round bottom flask at r. t. under an argon 
atmosphere. 
2. To the solution from step 1, add 840 µl (3.7 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine in a dropwise manner. 
3. Stir the reaction at r. t. for 1 hr. Then add an extra 84 µl (0.4 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine to the reaction 
mixture. 
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4. Stir the reaction at r. t. for an additional 1 hr. 
5. Remove the solvent to dryness under reduced pressure and purify the 
residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3, load the sample with benzene, and elute the product 
using benzene/DCM/EtOAc/Et3N/MeOH 10:1:1:0.2:0.2. 
The resulting product, N2,N6-Dibenzoyl-9-{2’-O-[(2-cyanoethoxy)- 
(diisopropylamino)phosphino]-3’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L-
threofuranosyl}-2,6-diaminopurine (S.14) is obtained in a 89% (450 mg, 0.46 
mmol) yield as a mixture of two diastereoisomers. TLC (DCM/MeOH 50:1): 
Rf 0.21. 1H-NMR (400 MHz, CDCl3): δ=1.08-1.30 (m, 24H), 2.39 (m, 2H), 
2.60 (m, 2H), 3.36-3.39 (m, 1H), 3.54-3.90 (m, 8H), 3.72 (2s, 12H), 4.27 (m, 
2H), 4.35 (m, 1H), 4.71 (d, J=8.0, 2H), 5.16 (d, J=9.6, 1H), 6.12 (s, 1H), 6.22 
(s, 2H),6.78 (m, 8H), 7.12-7.35 (m, 17H), 7.46-7.50 (m, 13H), 7.94-8.04 (m, 
8H), 8.26, 8.31 (2s, 2H), 8.90, 9.11, 9.23 (3br, 4H). 31P-NMR (161 MHz, 
CDCl3): δ=150.5, 151.9. MOLDI-TOF MS (pos. 4-hydroxybenzylidene- 
malononitrile): 985.63 (M+Na+). 
3.7 Basic Protocol 4 
Synthesis of N2-Acetyl-O6-diphenylcarbamoyl-9-{2’-O-[(2-cyanoethoxy)- 
(diisopropylamino)phosphino]-3’-O-[(4,4’-dimethoxytriphenyl)methyl]-α-L-th
reofuranosyl}guanine 
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This protocol describes the synthesis of base-protected TNA guanosine 
nucleoside phosphoramidite S.18 from S.5 (Figure 3.5). 
 
Figure 3.5. Preparation of S.18. Abbreviations: BSA, N,O-bis(trimethylsilyl)- 
acetamide; TMSOTf, trimethylsilyl trifluoromethanesulfonate; NaOH, sodium 
hydroxide; THF, tetrahydrofuran; MeOH, methanol; DMT-Cl, 
4,4’-dimethoxytritylchloride; AgOTf, silver trifluoromethanesulfonate; DCM, 
dichloromethane; DMF, dimethylformamide; DIPEA, diisopropylethylamine. 
Materials 
N2-acetyl-O6-diphenylcarbamoylguanine (GPAC) 
Sodium hydroxide (NaOH) 
Ammonium chloride (NH4Cl) 
2,6-lutidine 
N,O-bis(trimethylsilyl)acetamide (BSA) 
4,4'-Dimethoxytriphenylmethyl chloride (DMT-Cl) 
Trimethylsilyl trifluoromethanesulfonate (TMSOTf) 
Silver trifluoromethanesulfonate (AgOTf) 
Acetonitrile, anhydrous (MeCN) 
Tetrahydrofuran (THF) 
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Ultra pure water (H2O) 
Dichloromethane (DCM) 
1,2-Dichloroethane, anhydrous ((CH2Cl)2),  
Toluene, anhydrous 
Ethyl acetate (EtOAc) 
Hexanes 
Dichloromethane (DCM) 
N,N-dimethylformamide (DMF) 
Triethylamine (Et3N) 
Methanol (MeOH) 
N,N-Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Magnesium sulfate (MgSO4) 
Sodium sulfate (Na2SO4) 
Argon gas 
100- and 250-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
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Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
250-ml separatory funnel 
Büchner funnel  
Allihn condenser 
Filter paper 
UV lamp, 254 nm 
Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
Prepare S.15 
1. Suspend 3.2 g (8.3 mmol) of N2-acetyl-O6-diphenylcarbamoylguanine in 
77 ml of anhydrous 1,2-Dichloroethane. To this suspension add 4ml (16.8 
mmol) of BSA. Stir the mixture under an argon atmosphere at 70 °C for 
1hr. 
2. Evaporate the solvent to dryness and dissolve the residue in 35 ml of 
anhydrous toluene. To this solution, add 4 ml (16.8 mmol) of TMSOTf. 
3. Add 2.8 g (7.6 mmol) of S.5 in 35 ml of anhydrous toluene to the solution 
from step 2. 
4. Stir the reaction at 70 °C for an additional 2.5 hr, and then cool it down to 
r.t. 
5. Dilute with 70 ml of EtOAc and wash the reaction mixture with 100 ml of 
sat. aq. NaHCO3, then brine, and dry it over MgSO4. 
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6. Remove the organic solvent under reduced pressure and purify the residue 
by column chromatography. Elute the column using a step-wise gradient of 
DCM/EtOAc 18:1 plus 1% Et3N to DCM/EtOAc/MeOH 13:1:0.05 plus 
1% Et3N (v/v). 
The resulting product, N2-acetyl-O6-diphenylcarbamoyl-9-(2’,3’-di-O- 
benzoyl-α-L-threofuranosyl)guanine (S.15), is obtained in a 51% yield (2.74 g, 
4.2 mmol) as a colorless foam. TLC (hexanes/EtOAc 1:3): Rf 0.27. 1H-NMR 
(400 MHz, CDCl3): δ=2.48 (s, 3H), 4.57 (dd, J=11.0, 1.8, 1H), 4.66 (dd, 
J=11.0, 4.6, 1H), 5.74 (dd, J=2.8, 1.6, 1H), 6.21 (s, 1H), 6.32 (d, J=1.6, 1H), 
7.34-8.09 (m, 20H), 8.23 (s, 1H). 
Prepare S.16 
1. Dissolve 2.74 g (3.9 mmol) of S.15 in 230 ml of ice-cold THF/MeOH/H2O 
5:4:1. To this solution, slowly add 16 ml of 2N aq. NaOH over 5 min 
under an argon atmosphere. 
2. Stir the reaction at 0 °C for an additional 15 min. 
3. Quench the reaction with 1.8 (34 mmol) of solid NH4Cl. Keep stirring the 
reaction at 0 °C for 30 min. 
4. Remove the solvent under reduced pressure. 
5. Adsorb the residue from step 4 onto silica gel. Purify the product by 
column chromatography. Elute the column using DCM/MeOH 15:1 (v/v). 
 
 
 94 
The resulting product, N2-acetyl-O6-diphenylcarbamoyl-9-(α-L-threo- 
furanosyl)guanine (S.16), is obtained in a 70% yield (1.34 g, 2.7 mmol) as a 
white powder. TLC (DCM/MeOH 5:1): Rf 0.68. 1H-NMR (400 MHz, 
DMSO-d6): δ=4.08-4.16 (m, 3H), 4.42 (m, 1H), 5.53 (d, J=3.2, 1H), 5.88 (d, 
J=4.4, 1H), 5.92 (d, J=1.6, 1H), 7.29-7.48 (m, 10H), 8.52 (s, 1H), 10.73 (br, s, 
1H). 
Prepare S.17 
1. Dissolve 1.0 g (2.0 mmol) of S.16 in 30 ml of anhydrous DMF in a 100 ml 
round bottom flask at r. t. under an argon atmosphere. 
2. Add 0.94 ml (8.2 mmol) of 2,6-lutidine and 1.4 g (4.1 mmol) of DMT-Cl 
to the solution from step 1 with stirring.  
3. Stir the reaction at r. t. for 24 hr. 
4. Add an additional 350 mg (1.0 mmol) of DMT-Cl and stir the reaction at 
r.t. for an additional 6 hr. 
5. Quench the reaction by 8.5 ml of MeOH, dilute with 25 ml of DCM, and 
wash the organic solvent with sat. aq. NaHCO3 and brine. 
6. Dry the organic phase over MgSO4, and evaporate the solvent to dryness 
under reduced pressure. 
7. Purify the residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the column using a step-wise gradient of 
DCM/Et3N 99:1 to DCM/MeOH/Et3N 98:1:1 (v/v). 
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The resulting product, N2-acetyl-O6-diphenylcarbamoyl-9-{3’-O-[(4”,4”’- 
dimethoxytriphenyl)methyl]-α-L-threofuranosyl}guanine (S.17), and its 
2’-O-regioisomer N2-acetyl-O6-diphenylcarbamoyl-9-{3’-O-[(4”,4”’- 
dimethoxytriphenyl)methyl]-α-L-threofuranosyl}guanine (S.17a), are obtained 
in a 50% (0.79 g, 1 mmol) and 31% (0.5 g, 0.6 mmol), respectively. TLC 
(DCM/MeOH 25:1) Rf 0.36 (S.17), 0.52 (S.17a). 1H-NMR S.17 (500 MHz, 
DMSO-d6): δ=2.20 (s, 3H), 3.44 (dd, J=7.4, 4.4, 1H), 3.58 (dd, J=7.6, 2.8, 1H), 
3.68 (2s, 6H), 4.13 (m, 1H), 4.44 (m, 1H), 5.78 (m, 2H), 6.79-6.81 (m, 4H), 
7.10-7.48 (m, 19H), 8.49 (s, 1H), 10.68 (s, 1H). S.17a (500 MHz, DMSO-d6): 
δ=2.16 (s, 3H), 3.52 (s, 3H), 3.56 (s, 3H), 3.92 (dd, J=8.0, 2.8, 1H), 4.12 (m, 
2H), 4.53 (s, 1H), 5.42 (d, J=7.2, 1H), 5.62 (s, 1H), 6.61-6.70 (m, 4H), 
7.13-7.47 (m, 19H), 8.17 (s, 1H), 10.73 (s, 1H). 
Prepare S.18 
1. Dissolve 200 mg (0.25 mmol) of S.17 and 0.27 ml (2.5 mmol) of DIPEA 
in 6.2 ml of anhydrous DCM. 
2. To the solution from step 1, add 140 µl (0.62 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine in a dropwise manner. 
3. Stir the reaction at r. t. for 45 min. Then add an extra 15 µl (0.07 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine to the reaction 
mixture. 
4. Stir the reaction at r. t. for an additional 1hr. 
5. Quench the reaction with 1 ml of MeOH.  
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6. Remove the solvent to dryness under reduced pressure and purify the 
residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the product using DCM/Et3N 99:1 to give a 
syrup. 
7. Dissolve the syrup from step 6 in 2 ml of DCM and add this solution 
slowly into 90 ml of rapidly stirred pentane. Collect the white precipitate 
by filtration.  
The resulting product, N2-acetyl-O6-diphenylcarbamoyl-9-{2’-O- 
[(2-cyanoethoxy)(diisopropylamino)phosphino]-3’-O-[(4”,4”’-dimethoxytriph
enyl)methyl]-α-L-threofuranosyl}guanine (S.18) is obtained in a 60% (150mg, 
0.15 mmol) as a mixture of diastereomers. TLC (DCM/MeOH 50:1): Rf 0.24, 
0.33. 1H-NMR (400 MHz, CDCl3): δ=1.06-1.15 (m, 24H), 2.12-2.44 (m, 4H), 
2.51, 2.60 (2s, 6H), 3.51-3.68 (m, 10H), 3.69-3.72 (4s, 12H), 4.30, 4.42 (m, 
2H), 4.70 (d, J=8.4, 1H), 4.79 (d, J=8.0, 1H), 5.96, 6.03 (2s, 2H), 6.74-7.44 (m, 
46H), 7.90, 8.02 (2br, 2H), 8.24, 8.25 (2s, 2H). 31P-NMR (161 MHz, CDCl3): 
150.99, 151.34. 
3.8 Basic Protocol 5 
Synthesis of 1-{2’-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]- 
3’-O-[(4,4’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}thymine 
This protocol describes the synthesis of TNA thymidine nucleoside 
phosphoramidite S.22 from S.5 (Figure 3.6). 
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Figure 3.6. Preparation of S.22. Abbreviations: BSA, N,O-bis(trimethyl- 
silyl)acetamide; TMSOTf, trimethylsilyl trifluoromethanesulfonate; MeCN, 
acetonitrile; NaOH, sodium hydroxide; THF, tetrahydrofuran; MeOH, 
methanol; DMT-Cl, 4,4’-dimethoxytritylchloride; AgOTf, silver 
trifluoromethanesulfonate; DCM, dichloromethane; DMF, dimethylformamide; 
DIPEA, diisopropylethylamine. 
Materials 
Thymine (T) 
2 M NH3 in MeOH 
0.1 M aqueous HCl solution (0.1 M HCl) 
2,6-lutidine 
N,O-bis(trimethylsilyl)acetamide (BSA) 
4,4'-Dimethoxytriphenylmethyl chloride (DMT-Cl) 
Trimethylsilyl trifluoromethanesulfonate (TMSOTf) 
Silver trifluoromethanesulfonate (AgOTf) 
Acetonitrile, anhydrous (MeCN) 
Tetrahydrofuran (THF) 
Ultra pure water (H2O) 
Dichloromethane (DCM) 
 98 
Ethyl acetate (EtOAc) 
Hexanes 
Dichloromethane (DCM) 
N,N-dimethylformamide (DMF) 
Triethylamine (Et3N) 
Methanol (MeOH) 
N,N-Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Magnesium sulfate (MgSO4) 
Sodium sulfate (Na2SO4) 
Argon gas 
100- and 250-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
250-ml separatory funnel 
Büchner funnel  
Allihn condenser 
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Filter paper 
UV lamp, 254 nm 
Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
Prepare S.19 
1. Suspend 4.4 g (12 mmol) of S.5 and 1.5 g (12 mmol) of thymine in 35 ml 
of anhydrous MeCN in a 100-ml round bottom flask. 
2. Attach a condenser to the flask and heat the mixture to 60 °C. Treat the hot 
reaction mixture with 5.8 ml (24 mmol) of BSA. Stir the reaction at 60 °C 
for an additional 1 hr under an argon atmosphere.  
3. Add 6.4 ml (36 mmol) of TMSOTf to the mixture from step 2 and stir the 
reaction at 60 °C for an addition ca. 3 hr until S.5 is completely consumed. 
4. Cool the reaction to 24 °C, pour the reaction mixture into an ice-cold 
stirred mixture of 120 ml of sat. aq. NaHCO3 and 150 ml EtOAc. 
5. Separate and wash the organic phase with brine and dry it over MgSO4. 
Evaporate the organic solvent under reduced pressure. 
6. Purify the residue from step 5 by column chromatography. Elute the 
product from SiO2 using DCM/EtOAc 7:1 (v/v). 
The resulting product, 1-(2’,3’-di-O-benzoyl-α-L-threofuranosyl)thymine 
(S.19), is obtained in an 89% yield (2.4 g, 4.6 mmol) as a colorless foam. TLC 
(hexanes/EtOAc 1:1): Rf 0.41. 1H-NMR (400 MHz, CDCl3): δ=1.88 (s, 3H), 
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4.48 (m, 2H), 5.60 (t, 1H), 5.67 (s, 1H), 6.21 (m, 1H), 7.27-8.09 (m, 11H), 
8.25 (br, s, 1H). 
Prepare S.20 
1. Suspend 4.67 g (11.1 mmol) of S.19 in 220 ml of 2 M NH3 in MeOH and 
stir the reaction at r. t. for ca. 18 hr. 
2. Concentrate the solution under reduced pressure and co-evaporate the 
residue three times with water. 
3. Dissolve the residue in water and wash the solution with DCM. 
4. Remove the solvent under reduced pressure to give the product. 
The resulting product, 1-(α-L-threofuranosyl)thymine (S.20), is obtained 
in a 98% yield (2.5 g, 10.9 mmol). 1H-NMR (400 MHz, DMSO-d6): δ=1.74 (s, 
3H), 3.32 (br, s, 2H), 4.00 (m, 4H), 5.64 (m, 1H), 7.56 (m, 1H), 11.27 (br, s, 
1H). 
Prepare S.21 
1. Dissolve 2.5 g (11 mmol) of S.20 in 150 ml of anhydrous DCM/DMF 1:1 
in a 500 ml round bottom flask at r. t. under an argon atmosphere. 
2. Add 4.4 g (13 mmol) of DMT-Cl to the solution from step 1 with stirring, 
then add 6.4 ml (55 mmol) of 2,6-lutidine and 3.1 g (12 mmol) of AgOTf. 
3. Stir the reaction at r. t. overnight under an argon atmosphere. 
4. Quench the reaction by 15.2 ml of MeOH, dilute with 500 ml of DCM, 
and then filter the resulting mixture. 
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5. Wash the filtrate with ice-cold 0.1 M aq. HCl (2x), water (2x), sat. aq. 
NaHCO3 (2x), and brine.  
6. Dry the organic phase over Na2SO4, and then evaporate the solvent to 
dryness under reduced pressure. 
7. Purify the residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the column using a step-wise gradient of 
DCM/Et3N 100:1 to DCM/MeOH/Et3N 98:1:1. 
The resulting product, 1-{3’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L- 
threofuranosyl}thymine (S.21), and its 2’-O-regioisomer 1-{2’-O-[(4”,4”’- 
dimethoxytriphenyl)methyl]-α-L-threofuranosyl}thymine (S.21a), are obtained 
in a 44% (2.55 g, 4.8 mmol) and 31% (1.79 g, 3.4 mmol), respectively. TLC 
(DCM/MeOH 25:1): Rf 0.33 (S.21), 0.43 (S.21a). 1H-NMR S.21 (400 MHz, 
DMSO-d6): δ=1.68 (s, 3H), 3.56-3.57 (m, 3H), 3.60 (s, 3H), 3.73 (s, 3H), 3.99 
(d, J=1.6, 1H), 5.46 (d, J=1.6, 1H), 5.58 (d, J=4.4, 1H), 6.85-6.88 (m, 4H), 
7.20-7.50 (m, 10H), 11.28 (s, 1H). S.21a (400 MHz, DMSO-d6): δ=1.66 (s, 
3H), 3.32 (s, 3H), 3.34 (s, 3H), 3.71 (d, J=2.8, 1H), 3.82 (m, 2H), 3.92 (d, 
J=1.6, 1H), 5.10 (d, J=2.8, 1H), 5.91 (d, J=1.6, 1H), 6.80-7.20 (m, 4H), 
7.21-7.39 (m, 10H), 11.33 (s, 1H). 
Prepare S.22 
1. Dissolve 330 mg (0.63 mmol) of S.21 and 0.43 ml (2.5 mmol) of DIPEA 
in 4.0 ml of anhydrous DCM. 
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2. To the solution from step 1, add 150 µl (0.7 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine in a dropwise manner. 
3. Stir the reaction at r. t. for 1 hr. Then add an extra 15 µl (0.07 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine to the reaction 
mixture. 
4. Stir the reaction at r. t. overnight. 
5. Remove the solvent to dryness under reduced pressure and purify the 
residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the product using a step-wise gradient of 
hexanes/EtOAc/Et3N 80:18:2 to 50:48:2. 
The resulting product, 1-{2’-O-[(2-cyanoethoxy) (diisopropylamino)- 
phosphino]-3’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}- 
thymine (S.22), is obtained in a 77% (400 mg, 0.48 mmol) as a mixture of 
diastereomers. TLC (DCM/MeOH 25:2): Rf 0.26, 0.36. 1H-NMR (300 MHz, 
CDCl3): δ=1.03, 1.13 (m, 24H), 1.79 (s, 6H), 2.64 (m, 4H), 3.13 (m, 2H), 
3.55-3.80 (m, 18H), 4.25 (d, J=3.3, 1H), 4.47 (d, J=9.3, 1H), 5.77 (br, 2H), 
6.81-6.86 (m, 8H), 7.22-7.40 (m, 20H). 31P-NMR (202 MHz, CDCl3): 153.4, 
154.4. 
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3.9 Basic Protocol 6 
Synthesis of N6-Benzoyl-9-{2’-O-[(2-cyanoethoxy)(diisopropylamino)- 
phosphino]-3’-O-[(4,4’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}- 
adenine 
This protocol describes the synthesis of N6-benzoylated TNA adenosine 
nucleoside phosphoramidite S.26 from S.6 (Figure 3.7). 
 
Figure 3.7. Preparation of S.26. Abbreviations: BSA, N,O-bis(trimethylsilyl)- 
acetamide; SnCl4, tin(IV) chloride; MeCN, acetonitrile; NaOH, sodium 
hydroxide; THF, tetrahydrofuran; MeOH, methanol; DMT-Cl, 
4,4’-dimethoxytritylchloride; AgOTf, silver trifluoromethanesulfonate; DCM, 
dichloromethane; DMF, dimethylformamide; DIPEA, diisopropylethylamine. 
Dichloromethane (DCM) 
Materials 
N6-Benzoyladenine (ABz) 
Sodium hydroxide (NaOH) 
2N aqueous HCl solution (2N HCl) 
0.1 M aqueous HCl solution (0.1 M HCl) 
2,6-lutidine 
N,O-bis(trimethylsilyl)acetamide (BSA) 
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4,4'-Dimethoxytriphenylmethyl chloride (DMT-Cl) 
Tin (IV) Chloride (SnCl4) 
Silver trifluoromethanesulfonate (AgOTf) 
Acetonitrile, anhydrous (MeCN) 
Tetrahydrofuran (THF) 
Ultra pure water (H2O) 
Ethyl acetate (EtOAc) 
Hexanes 
Dichloromethane (DCM) 
N,N-dimethylformamide (DMF) 
Triethylamine (Et3N) 
Methanol (MeOH) 
N,N-Diisopropylethylamine (DIPEA) 
Chloro(2-cyanoethoxy)(diisopropylamino)phosphine 
Saturated aqueous sodium bicarbonate solution (sat. aq. NaHCO3) 
Brine (sat. aq. NaCl) 
Magnesium sulfate (MgSO4) 
Sodium sulfate (Na2SO4) 
Argon gas 
100- and 250-ml round-bottom flask 
Magnetic stir plate and stir bar 
Gas balloon 
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Rotary evaporator equipped with a vacuum pump 
Thin layer chromatography (TLC) plate, EMD silica gel 60 F254 
Silica gel (60 Å, 230-400 mesh) (Whatman Inc.) 
250-ml separatory funnel 
Büchner funnel  
Allihn condenser 
Filter paper 
UV lamp, 254 nm 
Additional reagents and equipment for thin layer chromatography (TLC) and 
column chromatography 
Prepare S.23 
1. Dissolve 1.33 g (3.1 mmol) of S.6 in 8 ml of anhydrous MeCN in a 50 ml 
round bottom flask equipped with a stirring bar. 
2. To the solution from step 1 add 830 mg (3.5 mmol) of N6-benzoyladenine 
and 1.5 ml (6.2 mmol) of BSA. 
3. Stir the reaction at 65 °C for ca. 30 min until a clear solution is formed. 
4. To the solution from step 3, add 1.1 ml (5 mmol) of SnCl4 in 3 portions 
over 2 min. 
5. Stir the reaction at 65 °C for an additional 1 hr under an argon atmosphere. 
6. Cool the reaction to r. t. and pour the reaction solution into an ice-cold 
mixture of EtOAc and sat. aq. NaHCO3 1:1. 
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7. Separate the organic phase, extract the aqueous phase with EtOAc, and 
combine the organic phase. 
8. Wash the combined organic phase with sat. aq. NaHCO3 and dry it over 
MgSO4. 
9. Evaporate the solvent to dryness under reduced pressure. 
10. Purify the residue by column chromatography. Elute the product using 
DCM/EtOAc 5:2. 
The resulting product, N6-benzoyl-9-(2’,3’-di-O-benzoyl-α-L-threo- 
furanosyl)adenine (S.23), is obtained in an 76% yield (1.29 g, 2.3 mmol) as a 
colorless foam. TLC (DCM/EtOAc 1:1): Rf 0.43. 1H-NMR (300 MHz, CDCl3): 
δ=4.58 (dd, J=11.1, 2.0, 1H), 4.68 (dd, J=11.1, 3.3, 1H), 5.77 (m, 1H), 6.30 
(dd, J=2.0, 0.5, 1H), 6.47 (d, J=1.8, 1H), 7.43-7.67 (m, 9H), 7.86-7.89 (m, 2H), 
8.03-8.12 (m, 4H),8.33 (s, 1H), 8.78 (s, 1H), 9.02 (br, 1H). 
Prepare S.24 
1. Dissolve 1.28 g (2.3 mmol) of S.22 in 45 ml of THF/MeOH/H2O 5:4:1 in a 
water-ice bath at 0 °C. 
2. To the solution from step 1 slowly add 3 ml of 2N aq. NaOH.  
3. Stir the reaction at 0 °C for 20 min. 
4. Neutralize the solution with 3 ml of 2N aq. HCl. 
5. Concentrate the mixture under reduced pressure until the desired product 
starts to precipitate. 
6. Cool the flask to 10 °C and isolate the product by filtration. 
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7. Concentrate the filtrate and isolate a second precipitate by filtration. 
8. Evaporate the filtrate from step 7 to dryness under reduced pressure and 
dissolve the residue in MeOH. 
9. Co-evaporate the solution from step 8 with toluene and purify the residue 
by column chromatography. Elute the sample using DCM/EtOH 7:3 to 
give more product. 
10. Recrystallize the combined products from EtOH.    
The resulting product, N6-benzoyl-9-(α-L-threofuranosyl)adenine (S.24), is 
obtained in a 76% yield (600 mg, 1.8 mmol) as a colorless crystal. TLC 
(DCM/AcOEt 1:1): Rf 0.03. 1H-NMR (300 MHz, DMSO-d6): δ=4.17 (m, 3H), 
4.44 (m, 1H), 5.60 (br, 1H), 5.94 (d, J=4.5, 1H), 6.06 (d, J=2.0, 1H), 7.56 (m, 
2H), 7.64 (m, 1H), 8.05 (m, 2H), 8.55 (s, 1H), 8.76 (s, 1H), 11.17 (br, 1H). 
Prepare S.25 
1. Dissolve 500 mg (1.45 mmol) of S.24 in 9 ml of anhydrous DCM/DMF 
1:1 in a 100 ml round bottom flask equipped with a stirring bar. 
2. Cool the solution from step 1 to 10-15 °C. 
3. Add 650 mg (1.9 mmol) of DMT-Cl, 0.9 ml (7.3 mmol) of 2,6-lutidine and 
440 mg (1.7 mmol) of AgOTf to the round bottom flask. 
4. Stir the reaction at 10 °C for 5 hr. 
5. Add 65 mg (0.2 mmol) of DMT-Cl and 44 mg (0.2 mmol) of AgOTf to the 
reaction. 
6. Stir the reaction at r. t. overnight. 
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7. Quench the reaction with 1.5 ml of MeOH/H2O 1:4. 
8. Dilute the mixture from step 7 with 75 ml of DCM. 
9. Filter the mixture and wash the residue with DCM. 
10. Wash the combined filtrate with ice-cold 0.1 M HCl (2x), water (2x), sat. 
aq. NaHCO3 and brine. 
11. Dry the organic solvent over Na2SO4. 
12. Evaporate the solvent to dryness under reduced pressure. 
13. Purify the residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the product using a step-wise gradient of 
DCM//Et3N 99:1 to DCM/MeOH/Et3N 98:1:1. 
The resulting product, N6-benzoyl-9-{3’-O-[(4”,4”’-dimethoxytriphenyl)- 
methyl]-α-L-threofuranosyl}adenine (S.25), and its 2’-O-regioisomer 
N6-benzoyl-9-{2’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}
adenine (S.25a), are obtained in a 72% (679 mg, 1.05 mmol) and 2% (25 mg, 
0.04 mmol), respectively. TLC (DCM/MeOH 16:1): Rf 0.24 (S.25), 0.51 
(S.25a). 1H-NMR S.25 (300 MHz, CDCl3): δ=3.76 (s, 3H), 3.77 (s, 3H), 3.80 
(m, 2H), 4.26 (m, 1H), 4.33 (m, 1H), 5.90 (d, J=2.1, 1H), 6.80 (m, 4H), 
7.28-7.61 (m, 12H), 8.02 (d, J=7.2, 2H), 8.30 (s, 1H), 8.78 (s, 1H), 9.02 (br, 
1H). S.25a (300 MHz, CDCl3): δ=3.77 (s, 3H), 3.78 (s, 3H), 4.07 (dd, J=10.2, 
1.2, 1H), 4.25 (dd, J=10.3, 4.2, 1H), 4.40 (m, 1H), 4.72 (m, 1H), 5.51 (d, J=1.5, 
1H), 6.78 (m, 4H), 7.25-7.45 (m, 10H), 7.52-7.67 (m, 3H), 8.05 (m, 2H), 8.76 
(s, 1H), 9.05 (br, 1H). 
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Prepare S.26 
1. Dissolve 200 mg (0.31 mmol) of S.25 and 0.3 ml of DIPEA in 2.0 ml of 
anhydrous DCM. 
2. To the solution from step 1, add 80 µl (0.4 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine in a dropwise manner. 
3. Stir the reaction at r. t. for 1 hr. Then add an extra 10 µl (0.04 mmol) of 
chloro(2-cyanoethoxy)(diisopropylamino)phosphine to the reaction 
mixture. 
4. Stir the reaction at r. t. overnight. 
5. Quench the reaction with 2 drops of MeOH. 
6. Remove the solvent to dryness under reduced pressure and purify the 
residue by column chromatography. Deactivate the column with 
DCM/Et3N 97:3 and elute the product using hexanes/DCM/Et3N 19:80:1. 
The resulting product, N6-benzoyl-9-{2’-O-[(2-cyanoethoxy) (diisopropyl 
amino)phosphino]-3’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L-threofurano
syl}adenine (S.26), is obtained in an 84% (220 mg, 0.26 mmol) as a mixture 
of diastereomers. TLC (DCM/MeOH 50:1): Rf 0.20, 0.25. 1H-NMR (300 MHz, 
CDCl3): δ=1.10-1.26 (m, 24H), 2.35-2.44 (m, 2H), 2.53-2.60 (m, 2H), 3.44 (m, 
2H), 3.55-3.89 (m, 32H), 4.26 (m, 1H), 4.36 (m, 1H), 4.50 (m, 1H), 4.98 (m, 
1H), 6.16 (s, 1H), 6.23 (s, 1H), 6.77-6.81 (m, 8H), 7.08-7.28 (m, 18H), 
7.52-7.62 (m, 6H), 8.02-8.05 (m, 4H), 8.34 (s, 1H), 8.39 (s, 1H), 8.80 (s, 1H), 
8.81 (s, 1H), 9.00 (br, 2H). 
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3.10 Basic Protocol 7 
Synthesis, Isolation, and Characterization of Threose Nucleic Acid (TNA) 
Oligonucleotides 
The threofuranosyl nucleoside phosphoramidites are completely stable 
under standard oligonucleotide synthesis conditions on a DNA synthesizer. An 
Applied Biosystems 3400 DNA synthesizer has been used successfully on a 
1.0-µmol scale synthesis (Yang et al. 2007). Alternative reagents in certain 
steps are used in order to increase the reactivity of the phosphoramidites. 
These include 1) the use of 0.1 M solution of threofuranosyl nucleoside 
phosphoramidites in MeCN, 2) the use of a 6% Cl2CHCO2H solution in 
(ClCH2)2 for detritylation, 3) the use of a 0.35 M solution of 
(ethylthio)-1H-tetrazole for the coupling step. Meanwhile the modifications to 
the synthesis cycle are employed to optimize the chemistry of the automated 
synthesis (Figure 3.8). Several techniques have been reported for the isolation 
and purification of sequences containing TNA nucleotides, such as C18 
reverse phase HPLC and denaturing polyacrylamide gel electrophoresis 
(PAGE). This protocol describes the synthesis of TNA oligonucleotides from 
TNA monomer phosphoramidite precursors. 
Materials 
TNA phosphoramidite monomers bearing nucleobases A and T (S22 and S.26, 
respectively) 
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Figure 3.8. Synthesis cycle of automated solid phase TNA synthesis 
Abbreviations: DCA, dichloroacetic acid; MeCN, acetonitrile; Ac2O, acetic 
anhydride; THF, tetrahydrofuran; Py, pyridine. 
Anhydrous acetonitrile (MeCN) (Applied Biosystems) 
6% Cl2CHCO2H solution in (ClCH2)2 
0.35 M solution of (ethylthio)-1H-tetrazole 
Universal support II (Glen Research) 
Argon gas (Ultra high purity) 
Ammonium hydroxide, concentrated (conc. NH4OH) 
n-Butanol 
Nanopure water 
25-ml round bottom flasks 
4Å molecular sieves (freshly activated by heating at 300°C for at least 3 hr) 
0.45-µm disposable syringe filter 
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Syringes and needles 
Screw-capped eppendorf tube (2 ml) 
Screw-capped falcon centrifuge tubes 
Additional reagents and equipments for automated solid-phase 
oligodeoxyribonucleotide synthesis, isolation and characterization of synthetic 
nucleic acids 
Synthesize TNA oligonucleotides (0.2 µmol scale synthesis) 
1. Dissolve each TNA phosphoramidte (pre-dried under high vacuum for 48 
hr) in anhydrous MeCN in a 25-ml round bottom flask to make an 
approximate 0.1 M solution (310 mg in 3.7 ml MeCN for S.26 (A), 300 
mg in 4.1 ml for S.22 (T), respectively). 
2. Dry the phosphoramidite solutions from step 1 over freshly activated 
molecular sieves overnight at r. t. 
3. Filter the amidites solution using 0.45-µm disposable syringe filters 
directly into clean, dry bottles and immediately place the bottles on the 
corresponding amidite ports of the DNA synthesizer. 
Steps 1 through 3 are carried out under argon atmosphere. All the 
glassware, syringes and needles are pre-dried in a drying oven and then cooled 
to r. t. in a desiccator for later use. 
4. Start the automated solid-phase oligonucleotide synthesis from 
CPG-column pre-charged with a universal support using the modified 
cycle. 
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5. After completing the synthesis, remove the column and dry it for 2 min 
using vacuum pipeline. 
6. Open the CPG-column container and transfer the CPG beads into a 2-ml 
screw-capped eppendorf tube. 
Deprotect and purify TNA oligonucleotides  
7. Add 1 ml of conc. NH4OH, seal the tube, and incubate at 55°C for 12 hr. 
8. Place the tube on ice and cool for at least 10 min prior to opening  
9. Transfer the supernatant to a Falcon tube and add 10 ml of n-butanol. 
10. Place the tube on ice for 5 min. 
11. Centrifuge for 5 min at 4000 rpm, discard the supernatant and collect the 
oligonucleotide (white precipitate). 
12. Re-suspend the oligonucleotide pellet in 500 µl of nanopure water. 
13. Purify the crude product by denaturing PAGE and desalt the 
oligonucleotide by ethanol precipitation. 
14. Quantify the oligonucleotide by UV absorbance using Beer’s law at  
254 nm. 
Check molecular weight 
15. Check the molecular weight of the desired TNA oligonucleotide by 
MALDI-TOF mass spectroscopy using aqueous saturated 
3-hydroxypicolinc acid solution as matrix. Prepare matrix just before 
spotting the sample onto a MALDI-TOF mass spectrometry gold plate. 
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3.11 Commentray 
Background Information 
Synthesis 
The preparation of TNA building block monomers described in this unit is 
adopted from the method developed by Eschenmoser (Schöning et al. 2000, 
2002). The α/β anomeric mixtures of the protected threofuranose undergo 
Vorbrüggen-Hilbert-Johnson reactions (Vorbrggen and Bennua 1981) with 
suitably protected nucleobases in the presence of a proper Lewis acid to afford 
the corresponding L-threofuranosyl nucleosides in exclusive α-configuration. 
The tritylation steps of these nucleosides show low regioselectivity and require 
careful chromatographic separations of the 3’-tritylated isomers from their 2’ 
analogues. 
Properties of threose nucleic acid system 
TNA is discovered as an evolutionary progenitor of RNA as a result of 
systematic exploration of structural neighborhood of natural nucleic acids 
(Eschenmoser 1999; Schöning et al. 2000, 2002). Although the backbone 
displays a constitutional periodicity of five atoms with a phosphodiester 
connection between the 3’- and 2’-positions of the threose sugar, TNA is 
capable of intra- and intersystem base-pairing with itself and natural nucleic 
acids (RNA and DNA), respectively, to form stable duplexes in an antiparallel 
orientation (Schöning et al. 2000, 2002). Structural studies show that the 
intrasystem duplex of TNA forms a curved right-handed double helix in the 
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Watson-Crick pairing mode. Both the NMR and X-ray experiments implicate 
that TNA remarkably resemble the structure of A-form RNA/DNA (Ebert et al. 
2008; Pallan et al. 2003; Wilds et al. 2002). These findings corroborate the 
experimental observations that TNA base pairs stronger with RNA than with 
DNA and that RNA serves as a better template for ligating TNA fragments 
than DNA (Wu et al. 2002). 
Critical Parameters 
For all reactions using anhydrous solvents, the glassware must be pre-dried 
in a drying oven (80°C). To obtain optimal separations and to reduce the 
purification time, we recommend using flash column chromatography for all 
purification steps. For phosphoramidite synthesis, the reaction progress is 
monitored by TLC and should be stopped as soon as the starting material is 
consumed. The phosphitylation reaction affords two diastereomeric 
phosphoramidite products, which are general visualized as two spots on the 
TLC plate. The TNA phosphoramidite building blocks must be dried under 
high vacuum in a desiccator for 24 hr to give a well-foamed solid before they 
can be used for solid-phase synthesis. 
Trouble shooting 
The constitutional assignment of the 2’- and 3’-O-DMT isomers are based 
on homo decoupling and/or H1,H1-COSY-NMR spectroscopy by correlating 
the H-C(2’) or H-C(3’) to the OH atom. The TNA guanosine phosphoramidite 
appears as a syrup after column purification. Thus, a pentane precipitation is 
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further performed to convert the syrup into a solid form, which would be 
conveniently used in the solid phase synthesis. 
Anticipated Results 
The protocols described in this unit are useful for preparing TNA 
oligonucleotides. The TNA phosphoramidite monomers can be synthesized on 
a multi-gram scale. The oligonucleotide synthesis is similar to the standard 
DNA phosphoramidite protocol with the noted exception of elongated 
coupling times. The average stepwise yield is >95%, which is sufficient to 
produce TNA oligonucleotides in high yield. 
Time Considerations 
Each step in the chemical synthesis can be accomplished in 1-2 working 
days (including purification). The time for oligonucleotide synthesis varies 
slightly from the standard phosphoramidite method by longer coupling times 
and multiple times of reagent delivery and wash. The deprotection, isolation 
and the analysis of the final synthetic oligonucleotide are accomplished in 2-3 
days. 
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Chapter 4 
EXPERIMENTAL EVIDENCE THAT GNA AND TNA WERE NOT 
SEQUENTIAL POLYMERS IN THE PREBIOTIC EVOLUTION OF RNA 
4.1 Contributions 
The following chapter describes an experimental investigation into the 
molecular recognition properties of GNA and TNA. The reported experiments 
were performed by Ying-Wei Yang, Su Zhang and Elizabeth McCullum under 
the guidance of Professor John Chaput. Ying-Wei Yang, Su Zhang and 
Elizabeth McCullum synthesized the GNA and TNA phosphoramidites and 
oligonucleotides. Ying-Wei Yang and Su Zhang measured the thermodynamic 
properties of complementary GNA and TNA helices. John Chaput wrote the 
manuscript with communications from Su Zhang. The results from this work 
were published in Journal of Molecular Evolution. 
4.2 Abstract 
Systematic investigation into the chemical etiology of ribose has led to the 
discovery of glycerol nucleic acid (GNA) and threose nucleic acid (TNA) as 
possible progenitor candidates of RNA in the origins of life. Coupled with 
their chemical simplicity, polymers for both systems are capable of forming 
stable Watson-Crick antiparallel duplex structures with themselves and RNA, 
thereby providing a mechanism for the transfer of genetic information between 
successive genetic systems. Investigation into whether both polymers arose 
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independently or descended from a common evolutionary pathway would 
provide additional constraints on models that describe the emergence of a 
hypothetical RNA world. Here we show by thermal denaturation that 
complementary GNA and TNA mixed sequence polymers are unable, even 
after prolonged incubation times, to adopt stable helical structures by 
intersystem cross-pairing. This experimental observation suggests that GNA 
and TNA, whose structures derive from one another, were not consecutive 
polymers in the same evolutionary pathway to RNA. 
4.3 Introduction 
The belief that life on Earth arose during an ancestral period in which 
RNA stored genetic information and catalyzed reactions is commonly referred 
to as the RNA world hypothesis (Gilbert 1986; Joyce 1989). Although 
RNA-based organisms have yet to be discovered, presumably because any 
such organism would have predated all known geological record, evidence of 
their existence can be found in contemporary living systems (Joyce 2002). 
Principal among these are catalytic RNA, first discovered in RNA molecules 
derived from group I intervening sequences (Kruger et al. 1982), and the x-ray 
crystal structure of the ribosome, which shows that RNA is responsible for 
protein synthesis (Ban et al. 2000; Wimberly et al. 2000; Yusupov et al. 2001). 
Whether RNA was the first genetic material or an evolutionary intermediate 
that eventually gave rise to biotic life based on DNA and proteins remains less 
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clear. Limitations over the prebiotic synthesis of ribose and the problem of 
enantiomeric cross-inhibition during nonenzymatic replication have led some 
to speculate that RNA was preceded by a simpler genetic system that was 
more prebiotically accessible and capable of synthesizing chiral polymers 
from racemic mixtures of activated mononucleotides (Chaput and Switzer 
2000; Joyce et al. 1987; Schneider and Benner 1990). 
Determining the structures and conditions that may have given rise to an 
RNA world is fundamental to understanding the origin and evolution of life. 
The approach taken thus far has been to construct by chemical methods a 
series of potentially natural nucleic acid systems whose structures derive from 
a sugar-phosphate backbone, and to compare the capacity for each system to 
transfer genetic information, in the form of Watson-Crick base pairing, 
between itself and RNA (Eschenmoser 1999). Since each structure derives 
from a natural sugar and nucleic acid-base pairing is a chemical property 
considered fundamental to biology, nucleic acid systems capable of adopting 
stable helical structures with themselves and RNA are considered potentially 
natural progenitor candidates of RNA. Initial investigation into the chemical 
etiology of ribofuranosyl nucleic acids by systematic exploration of the 
structures related to RNA led to the observation that Watson-Crick base 
pairing among the hexo- and pentopyranosyl analogues of RNA (in systems 
where it occurs) is orthogonal to that of natural nucleic acids (Eschenmoser 
1999). While the hexose and pentose systems were reportedly chosen for their 
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ability to maintain the same six-atom backbone repeat unit found in natural 
nucleic acids, modeling studies combined with NMR data later revealed that 
these systems did not adopt a standard RNA helix (Schlonvogt et al. 1996). 
Further examination of other members of the aldose family of sugars, however, 
led to the unexpected discovery that the tetrapyranosyl analogue, 
(3′,2′)-α-L-threose nucleic acid (TNA), which has a five-atom backbone repeat 
unit (one atom shorter than natural RNA), was able to form stable double 
helical structures with itself and natural RNA and DNA (Schöning et al. 2000). 
More recently, glycerol nucleic acid (GNA), an acyclic analogue of TNA 
composed of a three-carbon propylene glycol backbone with a five-atom 
repeat unit, was also found to base pair with itself and complementary RNA 
(Zhang et al. 2005). Together, GNA and TNA (Figure 4.1) represent the only  
known candidate progenitors of RNA that derive from a sugar-phosphate 
backbone and exchange information with themselves and RNA. 
4.4 Materials and Methods 
4.4.1 Oligonucleotide Synthesis 
GNA and TNA phosphoramidites were synthesized as previously described 
(Acevedo and Andrews 1996; Holý 1975; Schöning et al. 2002). 
Oligonucleotides were synthesized on an Applied Biosystems 3400 DNA 
synthesizer using standard β-cyanoethyl phosphoramidite chemistry. GNA and 
TNA oligonucleotides were synthesized on a Universal Support II CPG 
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Figure 4.1. Possible candidate progenitors of RNA. Glycerol-derived nucleic 
acid (GNA) is composed of a three-carbon sugar with a five-atom backbone 
repeat unit. Threose nucleic acid (TNA) derives from a four-carbon sugar with 
a five-atom backbone repeat unit. Natural ribose nucleic acid (RNA) is a 
five-carbon sugar with a six-atom backbone repeat unit. GNA and TNA are 
both capable of forming stable duplexes with themselves and RNA, thereby 
providing a mechanism for the transfer of information between successive 
genetic systems. Reprinted with permission from Journal of Molecular 
Evolution. Copyright 2007 Springer. 
column (1 µM scale; Glen Research). GNA oligonucleotides required a 
synthesis protocol with extended (5 min) coupling times. TNA 
oligonucleotides were synthesized under modified conditions as previously 
described (Schöning et al. 2000). Stepwise coupling yields were greater than 
95% for all GNA and TNA oligonucleotides. Cleavage from the solid support 
and deprotection of the oligonucleotides was achieved in NH4OH (33%) for 
12–16 h at 55°C. RNA oligonucleotides were purchased from Dharmacon 
RNA technologies and deprotected using the manufacturer’s recommended 
protocol. Oligonucleotides were purified by preparative denaturing 
polyacrylamide gel electrophoresis, isolated, ethanol precipitated, and desalted 
on a Sephadex G-25 ion-exchange resin. Pure salt-free oligonucleotides were 
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validated by MALDI-TOF mass spectroscopy and stored in H2O at −20°C. 
4.4.2 Thermal Melting Measurements 
UV absorbance-versus-temperature profiles were measured on a Varian 
Cary 300 Bio UV-visible spectrophotometer in a temperature-controlled cell 
holder. All melts were performed under standard conditions with 1.0 M NaCl, 
10 mM NaH2PO4, 0.1 mM NaEDTA, pH 7.0, and 1:1 oligonucleotide 
stoichiometry (c = 2.5 µM + 2.5 µM). Melting curves were obtained in the 
reverse and forward melting directions with a temperature gradient of 0 to 
90°C and a ramping speed of 1°C per minute by monitoring the change in UV 
absorbance at 260 nm at each temperature. T m values were determined as the 
first-order derivative using the Cary software package, and represent the 
average of three independent trials. Thermodynamic values for ∆G, ∆H, and 
∆S were determined from plots of T m −1 versus lnc (Marky and Breslauer 
1987). 
4.5 Results and Discussion 
In the present study, we sought to investigate the evolutionary relationship 
between GNA and TNA as possible progenitor candidates of RNA. This 
investigation can be viewed as a functional selection for informational systems 
compatible with RNA. The observation that GNA pairs with RNA, but not 
DNA, while TNA pairs efficiently opposite both DNA and RNA led us to 
wonder whether TNA might be closer in evolutionary history to RNA than 
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GNA. This question stems from the belief that a nucleic acid polymer closer in 
evolutionary history to RNA would be expected to have greater affinity for 
DNA than a system closer to the primordial origin. Consistent with this notion 
is the general trend in structural complexity, which follows the order GNA << 
TNA < RNA due to intrinsic differences between the constitutional and the 
configuration isomers of the individual sugars. The same trend also applies to 
the observed base-pairing efficiency of GNA and TNA with RNA. 
4.5.1 Chemical Synthesis of GNA and TNA Oligonucleotides 
We began with the chemical synthesis of GNA and TNA oligonucleotides 
using previously established methodologies (Acevedo and Andrews 1996; 
Holý 1975; Schöning et al. 2002). GNA phosphoramidite monomers were 
synthesized from commercially available R-(+)-glycidol, 1 (Figure 4.2), by  
treating the protected chiral epoxide 2 with thymine or adenine in the presence 
of NaH to afford the acyclic glycol nucleosides 3 and 5, respectively. The 
thymidine derivative 3 was directly converted to the phosphoramidite product 
4, while the adenosine derivative 5 required benzoyl protection of the 
exocyclic amine prior to phosphitylation of 5 to 7. Synthesis of TNA 
phosphoramidite monomers (Figure 4.3) initiated with a multistep synthesis of  
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Figure 4.2. Chemical synthesis of (S)-glycol nucleic acid building blocks for 
automated solid phase oligonucleotide synthesis: (a) DMT-Cl, TEA, DCM 
(88%). (b) thymine, NaH, DMF (55%). (c) chloro(2-cyanoethoxy)- 
(diisopropylamino)phosphine, (i-Pr)2NEt, DCM (78%). (d) adenine, NaH, 
DMF (51%). (e) TMSCl, Pyridine, BzCl, then concentrated ammonia (80%). 
(f) chloro(2-cyanoethoxy)-(diisopropylamino)phosphine, (i-Pr)2NEt, DCM 
(70%). Reprinted with permission from Journal of Molecular Evolution. 
Copyright 2007 Springer. 
triacylated L-threofuranose derivatives 9a and 9b, from L-ascorbic acid, 8. 
Vorbrüggen-Hilbert-Johnson glycosylation of the α/β-anomer mixtures of 9a 
and 9b with thymine and benzoyl protected adenosine gave nucleosides 10a 
and 10b, respectively, in high yield. Hydrolysis and tritylation afforded both 
the 2′ and the 3′ regioisomers for 12a and 12b that were separated by silica gel 
chromatography. The low tritylation yield (c.a. 25%) of the thymidine 
nucleoside 12a was considered acceptable since the alternative strategy, which 
proceeds through an anhydrothymidine derivative, involves several additional 
steps, with an overall yield of c.a. 30%. Thymidine and adenosine nucleosides  
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Figure 4.3. Chemical synthesis of (L)-α-threofuranosyl nucleic acid building 
blocks for automated solid phase oligonucleotide synthesis: (a) for 10a: 
thymine, BSA, TMS-Tf, MeCN (89%); for 10b: benzoyl adenine, BSA, 
TMS-Tf, MeCN (76%). (b) for 11a: NH3 in MeOH (99%); for 11b: aq. NaOH, 
THF, MeOH, H2O (85%). (c) DMT-Cl, 2,6-lutidine, Ag-Tf, DMF, DCM, 
followed by chromatographic separation (25% for 12a and 25% for 12b). (d) 
chloro(2-cyanoethoxy)-(diisopropylamino)phosphine, (i-Pr)2NEt, DCM (70% 
for 13a and 84% for 13b). Reprinted with permission from Journal of 
Molecular Evolution. Copyright 2007 Springer. 
12a and 12b were then converted to phosphoramidite monomers 13a and 13b 
by standard phosphitylation chemistry. Thymidine and adenosine phosphor- 
amidite monomers of GNA (4, 7) and TNA (13a, 13b) were used as building 
blocks for automated solid phase oligonucleotide synthesis. 
4.5.2 Comparison of GNA, TNA, RNA, and DNA Self-Pairing Modes 
We examined the base-pairing properties of GNA and TNA mixed 
sequence polymers by temperature-dependent ultraviolet (UV) spectroscopy. 
Melting temperature (T m ) values and thermodynamic parameters for all 
self-pairing and cross-pairing duplex structures are summarized in Tables 4.1 
and 4.2. Self-pairing among the four genetic systems (Table 4.1, Figure 4.4a) 
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reveals that TNA base pairing occurs with similar thermal stability, but 
markedly lower thermodynamic stability (∆∆G ∼ 4 kcal/mol), than duplexes 
formed by RNA and DNA. By contrast, GNA base pairing gives rise to 
duplexes with greater thermal stability (58°C versus 45–47°C, respectively) 
but lower thermodynamic stability (∆∆G ∼ 2 kcal/mol) than RNA and DNA. 
This observation is consistent with the earlier finding that the thermal and 
thermodynamic stabilities of TNA self-pairing modes are not entirely 
Table 4.1. Temperature-dependent UV melting data for all GNA, TNA, RNA, 
and DNA self-pairing and cross-pairing modes. Reprinted with permission 
from Journal of Molecular Evolution. Copyright 2007 Springer. 
Entry Oligonucleotide pairing system Tm  
(°C) a 
∆G  
(kcal/mol) 
∆H  
(kcal/mol)
T∆S  
(kcal/mol) 
1 d(A4T3AT3AT2A2)+d(T4A3TA3TA2T2) 47 -14.6 -93.1 -78.5 
2 r(A4U3AU3AU2A2)+r(U4A3UA3UA2U2) 45 -14.0 -94.4 -80.4 
3 d(A4T3AT3AT2A2)+r(U4A3UA3UA2U2) 36 -8.6 -31.3 -22.7 
4 r(A4U3AU3AU2A2)+ d(T4A3TA3TA2T2) 30 -7.9 -31.1 -23.2 
5 g(A4T3AT3AT2A2)+g(T4A3TA3TA2T2) 58 -12.3 -42.4 -30.1 
6 g(A4T3AT3AT2A2)+r(T4A3TA3TA2T2) 36 -8.2 -16.9 -8.7 
7 r(A4T3AT3AT2A2)+g(T4A3TA3TA2T2) 39 -8.6 -20.4 -11.8 
8 t(A4T3AT3AT2A2)+t(T4A3TA3TA2T2) 42 -10.6 -47.1 -36.5 
9 t(A4T3AT3AT2A2)+d(T4A3TA3TA2T2) 29 -8.7 -53.2 -44.5 
10 d(A4T3AT3AT2A2)+t(T4A3TA3TA2T2) 45 -12.1 -65.4 -53.3 
11 t(A4T3AT3AT2A2)+r(T4A3TA3TA2T2) 33 -9.7 -61.6 -51.9 
12 r(A4T3AT3AT2A2)+t(T4A3TA3TA2T2) 42 -12.1 -74.9 -62.8 
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Table 4.2. Tm values for intra- and intersystem base pairing between GNA, 
TNA, RNA, and DNA. Reprinted with permission from Journal of Molecular 
Evolution. Copyright 2007 Springer. 
 A4T3AT3AT2A2 
 GNA TNA RNA DNA 
GNA 58 na 39 na 
TNA na 42 42 45 
RNA 36 33 45 36 
 
T 2
A 2
TA
3T
A 3
T 4
 
DNA na 29 31 47 
comparable with natural systems (Schöning et al. 2000), possibly due to subtle 
differences in the helical structure of TNA relative to RNA and DNA. A 
similar comparison of GNA was not possible since the thermodynamic 
properties of GNA were not previously reported. 
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Figure 4.4. Temperature-dependent UV melting curves for all self-pairing and 
RNA cross-pairing modes. (A) Melting curves for GNA-GNA, TNA-TNA, 
RNA-RNA, and DNA-DNA self-pairing modes. (B-C) Melting curves for 
GNA and TNA cross-pairing modes opposite complementary RNA. Sigmoidal 
curves obtained for each melting plot show cooperative duplex formation. 
Reprinted with permission from Journal of Molecular Evolution. Copyright 
2007 Springer. 
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4.5.3 Comparison of GNA and TNA Cross-Pairing with RNA 
Cross-pairing of GNA and TNA oligonucleotides with natural RNA and 
DNA confirms that both GNA and TNA base pair opposite complementary 
RNA, while only TNA base pairs opposite complementary DNA. Among the 
cross-pairing data some differences occur in the melting behavior of the 
duplexes. Interstrand pairing between TNA and RNA was found to be more  
sequence dependent than interstrand pairing between GNA and RNA. 
GNA-RNA base pairing gives rise to two 16-mer duplexes (Table 4.1, 
Figure 4.4b) with comparable thermal and thermodynamic stabilities (∆T m ∼ 
3°C, ∆∆G ∼ 0.4 kcal/mol), while TNA-RNA base pairing leads to the 
formation of two duplexes (Figure 4.4c) with different thermal (∆T m ∼ 9°C) 
and thermodynamic (∆∆G ∼ 2.4 kcal/mol) properties. Comparison of these 
differences to the differences found in duplexes formed by interstrand pairing 
between DNA and RNA, where the ∆T m is 6°C and the ∆∆G value is 0.7 
kcal/mol, suggest that TNA and DNA are more sequence dependent than GNA. 
This unusual property could be a consequence of the intrinsic flexibility of the 
acyclic backbone of GNA relative to the rigid backbones of all other nucleic 
acid systems that derive from natural sugars.  
4.5.4 Comparison of GNA Cross-Pairing with TNA 
We assessed the possibility of whether complementary strands of GNA 
and TNA would associate to form stable duplex structures by collecting 
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temperature-dependent UV absorbance profiles for both sets of  
complementary strands. In sharp contrast to GNA and TNA self-pairing, 
where thermal melting curves give sigmoidal plots with a single cooperative 
transition between the native and the denatured states, melting curves obtained 
for complementary GNA and TNA sequences (Figure 4.5) result in  
Figure 
4.5. Temperature-dependent UV melting curves for GNA-TNA cross-pairing. 
(A) Melting curves for GNA duplex pairing relative to the individual GNA 
strands. (B) Melting curves for TNA duplex pairing relative to the individual 
TNA strands.  (C-D) Melting curves for GNA-TNA heteroduplexes relative 
to their individual strands. The absence of a clear melting transition for 
GNA-TNA and TNA-GNA duplexes demonstrates that GNA and TNA are not 
capable of interstrand base pairing. Reprinted with permission from Journal of 
Molecular Evolution. Copyright 2007 Springer. 
hyperchromicity changes that are indistinguishable from the single strands. 
Attempts to overcome this problem by slowing the rate of temperature change 
and sampling various salt and annealing conditions failed to induce duplex 
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formation. One possible reason for this could be that TNA adopts a backbone 
geometry that more closely resembles the B-form helix of DNA, a helical 
geometry that is incompatible with GNA base pairing (Zhang et al. 2005). 
Indirect evidence to support a B-form helix can be found in the high-resolution 
crystal structure of a self-complementary DNA duplex containing a single 
(L)-α-threofuranosyl thymidine residue in each strand (Wilds et al. 2002) and 
DNA polymerase experiments which show that threose nucleoside 
triphophates (tNTPs) are significantly more efficient substrates for 
template-directed polymerization by DNA polymerases than glycerol 
nucleotide triphosphates (gNTPs) (Horhota et al. 2005, 2006). 
4.6 Conclusions 
In summary, we find that GNA and TNA, two potentially primordial 
ancestors of RNA, are not capable of adopting stable helical structures by 
interstrand cross-pairing and thus were not consecutive polymers in the same 
evolutionary pathway to RNA. Given the potential for both systems to serve as 
functional progenitors of RNA and the need for a pre-RNA world to overcome 
inherent limitations in the synthesis and replication of RNA, we suggest three 
possible roles for GNA and TNA in the origin and evolution of RNA. One 
possibility is that an unknown adapter polymer may have emerged that 
bridged the two systems, thereby allowing RNA to evolve by a single 
evolutionary pathway from more prebiotically available materials. The second 
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possibility is that both systems independently converged on RNA through two 
separate evolutionary lineages. A significant implication of the second 
scenario is that RNA might possess unique chemical and physical properties 
not present in any of the ancestral systems that eventually led to the evolution 
of biotic life based on DNA and proteins. Although it is also possible that 
GNA and TNA were simply not progenitors of RNA, their unusual ability to 
transfer genetic information with RNA, chemical simplicity, and abundance 
on carbonaceous meteorites suggests that both molecules may have played an 
important role on the early Earth (Cooper et al. 2001). Discerning which 
evolutionary scenario most likely occurred will require comparing the fitness 
of each candidate system with respect to a given functional property. Such 
experiments are expected to challenge our ability to generate unnatural nucleic 
acid aptamers and catalysts by in vitro selection and directed evolution (Ichida 
et al. 2005).  
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Chapter 5 
SYNTHESIS OF TWO MIRROR IMAGE 4-HELIX JUNCTIONS  
DERIVED FROM GLYCEROL NUCLEIC ACID 
5.1 Contributions 
The following chapter describes the use of glycerol nucleic acid (GNA) for 
assembling nucleic acid nanostructures. The reported experiments were 
performed by Su Zhang and Elizabeth McCullum under the guidance of 
Professor John Chaput. Su Zhang synthesized GNA phosphoramidites and 
oligonucleotides. Su Zhang and Elizabeth McCullum characterized the 
assembly of the GNA 4-helix junctions. John Chaput wrote the manuscript 
with comments from Su Zhang and Elizabeth McCullum. The results from this 
work were published in Journal of the American Chemical Society. 
5.2 Abstract 
Structural DNA nanotechnology relies on Watson−Crick base pairing rules 
to assemble DNA motifs into diverse arrangements of geometric shapes and 
patterns. While substantial effort has been devoted to expanding the 
programmability of natural DNA, considerably less attention has been given to 
the development of nucleic acid structures based on non-natural DNA 
polymers. Here we describe the use of glycerol nucleic acid (GNA), a simple 
polymer based on an acyclic repeating unit, as an alternative genetic material 
for assembling nucleic acid nanostructures independent of RNA or DNA 
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recognition. We synthesized two 4-helix junctions based entirely on GNA 
self-pairing and showed that GNA provides easy access to highly stable 
nanostructures with left- and right-handed helical configurations. 
5.3 Introduction 
Structural DNA nanotechnology uses sequence minimization rules to 
construct micrometer scale objects with nanometer scale features (Seeman 
1982). This is a “bottom-up” approach to nanotechnology that relies on 
Watson−Crick base pairing to assemble DNA motifs into different geometric 
shapes and patterns (For reviews, see Lin et al. 2006; Niemeyer 2000; Seeman 
1998, 2005). While substantial effort has been devoted to expanding the 
programmability of standard B-form DNA (Feldkamp and Niemeyer 2006; 
Seeman 2003), considerably less attention has been given to the development 
of unnatural DNA nanostructures (Ng and Bergstrom 2005). By expanding 
DNA nanotechnology to include alternative polymers, it should be possible to 
create nanostructures with chemical and physical properties not found in 
natural DNA (For example, see Chaput and Switzer, 1999; Liu et al. 2003). 
Toward this goal, it would be useful to have a genetic system that was capable 
of forming nanostructures independent of DNA or RNA hybridization. Of the 
known orthogonal genetic systems (Eschenmoser 1999; Schöning et al. 2000), 
only glycerol nucleic acid (GNA) provides easy access to both left- and 
right-handed helical geometries (Yang et al. 2007; Zhang et al. 2005). This 
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unusual feature suggests that GNA could be used to construct nanostructures 
with unique topologies. Here, we wish to report the first synthesis of a 
nanostructure (Figure 5.1) based entirely on GNA self-pairing—two 4-helix 
junctions (4HJ) with mirror image symmetry. 
 
Figure 5.1. An immobile 4-helix junction composed of glycerol nucleic acid. 
(A) Chemical structure of (R)- and (S)-GNA. (B) Cartoon image of left and 
right-handed 4-helix junctions. Reprinted with permission from Journal of the 
American Chemical Society. Copyright 2008 American Chemical Society. 
5.4 Results 
Using established methodology (Acevedo and Andrews 1996; Holý 1975; 
Schlegel et al. 2007; Zhang et al. 2005, 2006; Yang et al. 2007), we 
synthesized all four phosphoramidite monomers of (R)- and (S)-GNA. The 
monomers were used as building blocks to construct mixed sequence 
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olignonucleotides of (R)- and (S)-GNA. To prevent unwanted base-catalyzed 
decomposition during the deprotection step, we capped each GNA strand at 
both ends with a single deoxyribonucleotide (Tsai et al. 2007). The sequence 
for each strand (Figure 5.2A) was chosen based on a previous design by  
Seeman and co-workers, where DNA was used to assemble a synthetic 4HJ 
(Kallenbach et al. 1983). In contrast to natural 4HJs, which undergo branch  
migration due to regions of symmetry within their sequence, synthetic 4HJs 
are designed to be immobile structures (Holliday 1964). Using our GNA 
oligonucleotides, we aimed to determine how well the sequence optimization 
strategies used for DNA nanotechnology would apply to GNA, and whether 
GNA could be used as a molecular scaffold for assembling nanostructures 
with left- and right-handed helical geometries. 
We began using nondenaturing gel electrophoresis to study the propensity for 
GNA to self-assemble into an immobile 4HJ. In this assay, DNA complexes 
are separated based on size and charge, with higher molecular weight 
complexes having a slower electrophoretic mobility than smaller complexes. 
On the basis of the design (Figure 5.2A), the desired 4HJ should result when 
GNA strands 1−4 are present in equimolar ratios in solution. To identify the 
intermediate forms of the 4HJ, we separately annealed strand 1 with strands 2, 
2 + 3, and 2 + 3 + 4 and analyzed the samples by nondenaturing gel 
electrophoresis. Our initial attempt at visualizing the gel by ethidium bromide 
or SYBR-Gold staining methods failed to detect the presence of any GNA. 
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Figure 5.2. Characterization of two GNA 4-helix junctions. (A) The design 
used to assemble the GNA 4HJ (left). Nondenaturing gel electrophoresis 
mobility shift assays showing the monomer, dimer, trimer, and tetramer forms 
of the 4HJ (right). Drawn above each lane is a schematic view of the resulting 
complex. (B) CD analysis of the 4HJs derived from (R)- and (S)-GNA. (C and 
D) Thermal denaturing curves obtained from temperaturedependent CD and 
UV absorbance indicate that GNA forms a closed 4HJ that is thermally 
superior to the analogous DNA nanostructure. Reprinted with permission from 
Journal of the American Chemical Society. Copyright 2008 American 
Chemical Society. 
Since this limitation could be due to structural differences between GNA and 
natural DNA and RNA, we decided to enzymatically radiolabel the DNA 
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residue at the 3′-end of each GNA strand with P32-ATP. To our surprise, the 
chimeric GNA strands proved to be remarkably good substrates for T4 
polynucleotide kinase. Using P32-labeled GNA, we then repeated the 
strand-mixing assay and imaged the gel by phosphorimaging. The resulting 
image (Figure 5.2A) shows that when adjacent strands are added to the 
mixture higher order complexes emerge that exhibit mobility shifts consistent 
with the formation of the dimer and trimer intermediates and final tetramer 
product of the 4HJ. The same result was observed using (R)- and (S)-GNA 
and natural DNA (Figure 5.3). We verified that all four strands associate in the 
 
Figure 5.3. The DNA 4-Helix Junction. A) The sequence and design used to 
assemble the DNA 4HJ. B) Non-denaturing gel electrophoresis image showing 
complete assembly of the DNA 4HJ. C) Circular dichroism spectra showing 
the thermal transition of the DNA 4HJ to single-stranded DNA. Reprinted 
with permission from Journal of the American Chemical Society. Copyright 
2008 American Chemical Society. 
4HJ by comparing the gel mobility of each monomer, dimer, and trimer strand 
combination (Figure 5.4) (Kallebach et al. 1983). Complete formation of the 
tetramer structure demonstrates that GNA is capable of forming simple nucleic 
acid nanostructures. 
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Next, we used circular dichroism (CD) spectroscopy to examine the 
structural properties of our GNA nanostructures. The CD spectra of both 4HJs 
are given in Figure 5.2B. The two nanostructures exhibit mirror image 
symmetry with strong CD signals at 224 and 280 nm. This result is consistent 
with previous CD data collected on double-stranded GNA duplexes (Zhang et 
al. 2005) and supports the formation of short helices in each arm of the 4HJ.  
 
Figure 5.4. Non-denaturing polyacrylamide gel electrophoresis of GNA 
strands and strand mixtures. Lanes 1-4 contain GNA strands 1-4, respectively; 
Lanes 5-8 contain strand dimer combinations 1-2, 2-3, 3-4, and 1-4, 
respectively; Lanes 9-12 contain strand trimer combinations 1-2-3, 4-1-2, 
2-3-4, and 3-4-1, respectively; Lane 13 contains strands 1-2-3-4 that form the 
complete 4-HJ; and Lanes 14 and 15 contain the non-hybridizing dimers 1-3 
and 2-4. Reprinted with permission from Journal of the American Chemical 
Society. Copyright 2008 American Chemical Society. 
The CD spectra for both GNA nanostructures differ considerably from natural 
DNA and RNA, indicating that GNA likely adopts a unique helical structure. 
This hypothesis is supported by the observation that GNA cross-pairs weakly 
with RNA but not all with DNA (Yang et al. 2007; Zhang et al. 2005). 
Analysis of the CD spectra at different temperatures revealed a Cotton effect  
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that decreases with increasing temperature, as expected for a self-assembled 
complex with a melting transition. 
Last, we examined the thermal stability of the GNA 4HJ using 
temperature-dependent spectroscopy. Quantitative values for the thermal 
stability of the 4HJs were obtained by monitoring the change in the CD signal 
at 280 nm as a function of increasing temperature. As illustrated in Figure 
5.2C, 4HJs constructed from (R)- and (S)-GNA gave nearly identical curves 
with a single transition between the folded and denatured states. The data from 
both melting experiments were fit to a standard sigmoidal curve, which gave a 
Tm of 76 °C for the two GNA structures. Comparison of the hyperchromicity 
(Figure 5.2D) obtained for UV melts on strands 1, 1 + 2, 1 + 2 + 3, and 1 + 2 + 
3 + 4 reveals a stepwise increase in absorbance consistent with a closed 4HJ 
(Kallenbach et al. 1983) 
To compare the thermal stability of a 4HJ constructed of GNA to one 
constructed of DNA, we repeated the thermal denaturation experiment using 
DNA oligonucleotides of identical sequence. As expected, the DNA version of 
the 4HJ (Figure 5.2C) gave a melting transition of 37 °C, which is consistent 
with the denaturing plot given in the original description of the 4HJ by 
Seeman (Kallenbach et al. 1983). On the basis of these data, it appears that the 
GNA 4HJ is significantly more stable than the DNA 4HJ. This is a remarkable 
achievement given that the GNA backbone is acyclic and one atom shorter 
than the backbone found in DNA and RNA. In the absence of detailed 
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structural information, it is difficult to rationalize the extreme thermal stability 
of GNA. One possibility is that the flexible nature of the acyclic backbone 
allows GNA to access base pairing and base stacking interactions that are 
optimal for two complementary strands. DNA and RNA, though optimal in 
many other ways, would then have pairing interactions that are weaker due to 
structural constraints imposed by the furanose ring. 
5.5 Conclusion 
In summary, we describe the use of glycerol nucleic acid as a simple 
building block for assembling nucleic acid nanostructures with left- and 
right-handed helical geometries. We suggest that GNA could be used as a 
general method for constructing chiral nanostructures with unique topologies 
and extreme thermal stabilities. Once the helical dimensions of GNA are 
known, we predict that the sequence optimization methods used to program 
DNA will also apply to GNA since both polymers self-assemble using the 
same Watson−Crick base pairing rules. The current study therefore represents 
a first step toward the development of unnatural nucleic acid nanostructures. 
5.6 Experimental Design 
Materials and Methods 
GNA Synthesis. (R)- and (S)-GNA phosphoramidite monomers were 
synthesized for all eight nucleotides using standard literature methods 
(Acevedo and Andrews 1996; Holý 1975; Schlegel et al. 2007; Zhang et al. 
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2005, 2006; Yang et al. 2007). GNA oligonucleotides were constructed using 
an Applied Biosystems 3400 DNA Synthesizer. GNA synthesis was 
performed in the trityl-off mode on 0.2 µmol scale with the coupling times 
extended to 300 sec. The GNA oligonucleotides were deprotected in 
concentrated NH4OH at 55ºC for 72 h and purified by denaturing 
polyacrylamide gel electrophoresis. The concentration of each strand was 
determined by optical density using extinction coefficients taken from natural 
DNA nucleotides. The identity of each GNA strand was confirmed by a 
MALDI-TOF mass spectrometry (Table 5.1). 
Table 5.1. MALDI-TOF MS Analysis of GNA Oligonucleotides. Reprinted 
with permission from Journal of the American Chemical Society. Copyright 
2008 American Chemical Society.  
Entry 1 Sequence* Calculated  Observed 
(R)- 4787.48 Strand 1 3’-TCGCAATCCTGAGCACGT-2’ 4787.80 
(S)- 4787.88 
(R)- 4797.06 Strand 2 3’-ACGTGCTCACCGAATGCA-2’ 4796.81 
(S)- 4797.39 
(R)- 4834.86 Strand 3 3’-TGCATTCGGACTATGGCT-2’ 4833.82 
(S)- 4834.33 
(R)- 4892.80 Strand 4 3’-AGCCATAGTGGATTGCGA-2’ 4891.86 
(S)- 4892.44 
Circular Dichroism. CD spectra were collected between 320 to 200 nm using a 
JASCO J-815 CD spectrophotometer. Each solution contained all four single- 
stranded GNA oligonucleotides in a 1:1:1:1 ratio (2.5 µM each) in a buffer 
containing 1 M NaCl, 0.5 M Na2HPO4, and 10 mM EDTA (pH 7.0). The 
strands were annealed prior to each run by heated the solution to 90ºC for 5 
min and slowly cooled to 4ºC. Thermally induced transitions of each mixture 
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were monitored at 280 nm for (R)-GNA and (S)-GNA 4HJs in the forward and 
reverse directions. Thermal denaturation studies involving the DNA 4HJ were 
performed by monitored the CD signal at 250 nm. The sample temperature 
was increased at a rate of 0.5ºC per minute, and the data was collected for 1 
sec at 1 nm intervals in a quartz crystal cuvette with 1 cm path-length. 
UV Absorbance. UV absorbance versus temperature profiles were measured 
on a Varian Cary 300 Bio UV-visible spectrophotometer in a temperature- 
controlled cell holder. All melts were performed under standard conditions 
with 1.0 M NaCl, 10 mM NaH2PO4, 0.1 mM NaEDTA, pH 7.0 and 1:1 strand 
stoichiometry (2.5 µM per strand). Melting curves were obtained in the 
reverse and forward melting directions with temperature gradient of 20º to 
90ºC and a ramping speed of 1°C per min by monitoring the change in UV 
absorbance at 260 nm at each temperature. Tm values were determined as the 
first-order derivative using the Cary software package, and represent the 
average of three independent trials. 
Non-denaturing Polyacrylamide Gel Electrophoresis. Formation of the 4HJ 
was analyzed by non-denaturing polyacrylamide gel electrophoresis. The 
GNA Strands were P32-radiolabeled by incubating γ-32P-ATP with T4 
polynucleotide kinase at 37ºC for 1 h. Individual complexes composed of 
strand 1 alone, strands 1+2, 1+2+3 and 1+2+3+4 were prepared in equimolar 
ratios and incubated in 20 µL of TAE-Mg buffer (20 mM Tris, pH 7.6, 2 mM 
EDTA, 12.5 mM MgCl2). The final concentrations for each strand was 5.0 µM. 
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Each complex was annealed, mixed with 2 µL of 50% glycerol, and analyzed 
by non-denaturing gel electrophoresis and imaged by phosphorimaging. 
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Chapter 6 
IN VITRO EVOLUTION PROVIDES EVIDENCE FOR TNA AS A 
FUNCTIONAL PROGENITOR OF RNA 
6.1 Contributions 
The following chapter describes an artificial genetic system based on 
threose nucleic acid (TNA) capable of Darwinian evolution. The reported 
experiments were performed by Su Zhang and Hanyang Yu under the guidance 
of Professor John Chaput. Su Zhang synthesized TNA triphosphates. Hanyang 
Yu and Su Zhang constructed the TNA library and designed the selection 
strategy. Hanyang Yu completed the TNA aptamer selection. Hanyang Yu and 
Su Zhang characterized the aptamers. John Chaput finished the manuscript 
with comments from Su Zhang and Hanyang Yu. The results from this work 
were submitted to Nature Chemistry. 
6.2 Abstract 
The RNA world hypothesis postulates that contemporary life evolved from 
a simpler form of life that was based entirely on RNA, but it is not known 
whether other genetic systems could perform this function. Presumably 
whatever prebiotic chemistry gave rise to RNA would have produced other 
RNA analogues, some of which may have preceded or competed directly with 
RNA. Threose nucleic acid (TNA), an unnatural derivative of RNA, has 
received considerable interest as a possible RNA progenitor due to its 
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chemical simplicity and ability to exchange genetic information with itself and 
RNA. Here, we demonstrate that TNA can fold into stable three-dimensional 
shapes that elicit a complex function. We applied the principles of Darwinian 
evolution to evolve a TNA receptor that binds to an arbitrary target with high 
affinity and specificity. This observation confirms that TNA could have 
functioned as an ancestral genetic system during an early stage of life. 
6.3 Introduction 
Systematic analysis of nucleic acid structure with regard to the chemical 
etiology of RNA reveals that several potentially natural RNA alternatives are 
capable of Watson-Crick base pairing (Eschenmose 1999). While this property 
demonstrates a capacity to store genetic information, primordial genetic 
systems would have needed to fold into stable tertiary structures with 
sophisticated functions like ligand binding and catalysis in order to establish a 
primitive metabolism (Benner et al. 1989). Determining which, if any, RNA 
analogues can fold into shapes that elicit a specific pre-defined function would 
constrain models that describe the origin and early evolution of life on Earth. 
Of those genetic systems studied thus far, (3’,2’)-α-L-threose nucleic acid 
(TNA, Figure 6.1) has generated considerable interest as a primordial genetic  
system because of the chemical simplicity of threose relative to ribose and the 
ability of TNA to form stable helical structures with complementary strands of 
itself and RNA (Ebert et al. 2008; Orgel 2000; Schöning et al. 2000). This 
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latter feature provides a plausible mechanism for the transfer of information 
between successive genetic systems and suggests an evolutionary path where 
life could have entered the RNA world. 
 
Figure 6.1. Structure of threose nucleic acid. a, Constitutional (left) and 
configurational (right) structures for the linearized backbone of an 
α-L-threofuranosyl-(3’→2’)-oligonucleotide. TNA contains one less atom per 
backbone repeat unit than natural RNA and DNA. b, Solution NMR structure 
for the duplex formed from the self-pairing complementary sequence 
3’-CGAATTCG-2’ (Ebert et al. 2008). Duplex structures were rendered in 
PyMol with models showing ball and stick (left) and surface (right) images. 
TNA adopts a right-handed structure with helical parameters similar to A-form 
RNA. 
Molecular evolution provides a powerful approach to investigate the 
functional properties of nucleic acids (Joyce 2007; Wilson and Szostak 1999). 
This method has traditionally been limited to DNA and RNA because these are 
the only polymers with enzymes that are available to transcribe, reverse- 
transcribe and amplify genetic information. Extending this approach to 
artificial genetic systems like TNA requires (i) polymerases that can transcribe 
a library of random DNA sequences into TNA; (ii) a method of selection that 
allows functional members to be separated from the non-functional pool; and 
(iii) a strategy to recover and amplify functional molecules that maintains the 
integrity of the selected sequence.  
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Creating an artificial genetic system capable of Darwinian evolution is one 
of the grand challenges in synthetic biology, and an important step in the 
chemical path to synthetic life (Benner and Sismour 2005). Inspired by the 
potential to explore the functional properties of an alternative genetic system, 
studies were undertaken by our lab and others to identify DNA polymerases 
that could recognize TNA either as a template or as a nucleoside triphosphate 
(Chaput et al. 2003a, 2003b; Kempeneers et al. 2003). This work showed that 
several DNA polymerases can synthesize short segments of DNA on a TNA 
template (Chaput et al. 2003a), and other polymerases can synthesize limited 
stretches of TNA on a DNA template (Chaput et al. 2003b; Kempeneers et al. 
2003). While the enzymes identified in these studies had activity that was too 
low to support in vitro selection; further screening of additional polymerases 
eventually led to the discovery of therminator DNA polymerase (Horhota et al. 
2005; Ichida et al. 2005b). Therminator is an engineered variant of the 9°N 
DNA polymerase that functions as a remarkably efficient DNA-dependent 
TNA polymerase. Under optimal conditions, therminator can transcribe an 
80-nt DNA template into TNA with high efficiency and fidelity (Ichida et al. 
2005a). Since natural polymers of this length can fold into shapes with defined 
ligand binding sites, it was postulated that therminator could be used to 
generate pools of TNA molecules for in vitro selection (Ichida et al. 2005b). 
However, subsequent studies revealed that existing conditions did not support 
the synthesis of full-length TNA libraries (Ichida et al. 2005a). 
 154 
6.4 Results 
To identify conditions that were better suited for TNA synthesis, we 
developed a program of research to overcome the limitations of 
therminator-mediated TNA synthesis. Using chemical methods, we 
synthesized all four TNA triphosphates (Figure 6.2a) and used these molecules 
as substrates in primer-extension assays. A synthetic DNA primer was  
 
Figure 6.2 Synthesis of TNA libraries by enzyme-mediated primer extension. a, 
Chemical structure of TNA triphosphates: tDTP 1; tTTP 2; tGTP 3; and tCTP 
4. b, Schematic diagram of the primer extension assay used to evaluate DNA 
libraries L1-L3. Each library contains a central random region of 50-nts 
flanked on either side by a 20-nt constant region. Library compositions: L1 
equal distribution of A, C, G, and T; L2 equal distribution of A, C, and T; and 
L3 one-half equivalent of G relative to A, C, and T. c, Therminator-mediated 
TNA transcription assays analyzed by denaturing polyacrylamide gel 
electrophoresis. Primer extension of L1 with tNTPs 1-4 yields only trace 
amounts of full-length product (left panel). Primer extension of L1 using 
defined combinations of dNTPs (black) and tNTPs (red) leads to full-length 
product when tCTP is replaced with dCTP (center panel). Primer extension 
across libraries L2 and L3 leads to full-length product in ~60% and ~30% 
yield, respectively (right panel). M denotes DNA marker. 
annealed to a synthetic DNA library (L1) that contained a central random 
region of 50-nts followed by a second primer-binding site that could be used 
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for reverse transcription or PCR. Theminator DNA polymerase was challenged 
to copy the DNA library into TNA by extending the DNA primer with 70 
sequential TNA residues (Figure 6.2b). The diaminopurine analogue of 
adenine was used in place of adenosine 3’-triphosphate, because this 
substitution is known to increase the thermo- dynamic stability of the 
TNA-DNA heteroduplex (Chaput et al. 2003a; Wu et al. 2002). As with earlier 
trials, attempts to copy the unbiased random- sequence DNA library into TNA 
failed under all conditions tested (Figure 6.2c, Ichida et al. 2005a). Varying the 
incubation time, temperature, and salt proved ineffective, suggesting that 
unbiased random-sequence DNA libraries likely contain sequence motifs such 
as repeating nucleotides or secondary structures that impede primer-extension 
activity. 
To determine which sequence elements in the DNA library inhibit TNA 
synthesis, a set of primer extension assays was performed using defined 
mixtures of tNTP and dNTP substrates. This assay allowed TNA residues with 
elongation problems to be identified since substitution of the TNA substrate 
for the natural residue should favored strand elongation. The result from our 
screen of nearly all possible nucleotide combinations is shown in Figure 6.2c. 
Full-length primer extension was observed in all cases, except when tCTP was 
used in place of dCTP (Figure 6.2c). This finding suggests that repeating G 
nucleotides in the DNA library cause therminator to pause during TNA 
transcription. Since unbiased DNA libraries like L1 would by chance alone 
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have an abundance of short G-repeats, only a small fraction of DNA templates 
would promote full-length TNA synthesis. Indeed, analysis of representative 
clones from our starting library showed an abundance of G3 and G4 repeats.  
To design DNA libraries that were better suited for TNA transcription, we 
synthesized DNA libraries L2 and L3 that minimized the occurrence of 
G-residues in the random region. L2 contained equal amounts of A, C, and T, 
while L3 limited the frequency of G nucleotides to 50% the occurrence of A, 
C, and T. Consistent with the design strategy, primer extension assays 
performed on the L2 and L3 libraries (Figure 6.2c) yield substantial amounts 
of the fully extended DNA primer (~60% and ~30%, respectively). In both 
cases, therminator DNA polymerase extended the DNA primer with 70 TNA 
nucleotides, demonstrating for the first time that combinatorial TNA libraries 
could be generated by enzyme-mediated extension of a DNA primer.  
To evaluate the fitness of TNA as a primordial biopolymer, we employed 
an in vitro selection strategy to enrich for TNA molecules with receptor 
activity. The approach taken is analogous to other display technologies like 
mRNA display and DNA display that provide a covalent link between 
genotype (DNA) and phenotype (TNA) (Roberts and Szostak 1997; 
Rosenbaum and Liu 2003). The following strategy was devised by Ichida and 
Szostak but never implemented due to the inefficiency of TNA synthesis 
(Ichida et al. 2005b). In this scheme, a single-stranded DNA library is 
constructed with a stable stem-loop structure that serves as a DNA primer for 
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the extension of TNA across the random region (Figure 6.3a). Extension of the 
primer leads to the formation of a chimeric TNA-DNA hairpin duplex. The 
TNA portion of the duplex is displaced by extending a separate DNA primer 
annealed to the stem-loop region of the hairpin with DNA. The product of the 
strand displacement is a TNA molecule that is physically linked to its own 
double-stranded DNA message. To enrich for TNA molecules with specific 
ligand binding activity, the pool of TNA-DNA fusions is incubated with a  
 
Figure 6.3. Evolution of TNA receptors in vitro. a, In vitro selection strategy 
designed to isolate TNA aptamers with affinity to human thrombin. The DNA 
library encodes a random region of 50-nt positions flanked on the 3’ end with 
a stem-loop structure that serves as a DNA primer and a fixed-sequence 
primer-binding site located at the 5’ end. The DNA primer is extended with 
tNTPs to produce a chimeric TNA-DNA hairpin. A separate DNA primer 
modified with 6-carboxy-fluorescein (star) is annealed to the stem-loop region 
and extended with DNA to displace the TNA strand. The resulting pool of 
TNA-DNA fusion molecules is incubated with the protein target. Bound 
molecules are separated from the unbound pool by capillary electrophoresis 
and amplified by PCR. The dsDNA is made single-stranded and the coding 
strand is annealed to generate a new pool of DNA templates for the next 
selection cycle. b, Equilibrium binding affinity measurement of the core 
binding domain of TNA aptamer 3.12. The aptamer 
(3’-TGTTDTDGDDDDDDTDDTGGTGGGGGGTTTDGDTDDDGGGG-2’) 
binds to human thrombin with a Kd of 200 nM and shows no detectable 
affinity for bovine serum albumin (BSA) or streptavidin. Error bars represent 
the standard deviation of each data point (n = 3). 
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desired target and bound sequences are recovered and amplified by PCR. The 
DNA is then denatured into single-stranded form that folds into a stable 
stem-loop structure to facilitate another selection cycle.  
Successive rounds of in vitro selection and amplification were performed 
using the L2 library, which gave the highest yield of full-length TNA product 
in our primer extension assay. Although the L2 library generates TNA 
polymers that lack cytidine, we reasoned that this was not a significant 
concern since cytidine was presumably not present in the first genetic material 
due to its tendency to undergo spontaneous deamination (t1/2 = 340 yr at pH 7 
and 25 °C) (Levy and Miller 1998). Furthermore, it has been shown that 
ribozymes missing cytidine can be generated by in vitro evolution, 
demonstrating that a three letter genetic alphabet retains the ability to fold and 
function (Rogers and Joyce 1999). Using the strategy described above, we 
selected for TNA molecules that could bind to human thrombin and therefore 
exhibit an arbitrary specific function. We chose capillary electrophoresis as 
our separation technique because it leads to a higher partitioning efficiency 
than is commonly observed for traditional gravity filtration methods (Lin et al. 
2007; Williams et al. 2009). TNA-DNA fusion molecules carried the 
fluorescent label 6-carboxy-fluorescein to facilitate detection by laser-induced 
fluorescence. For each selection cycle, five 70 nL portions of library (~1011 
TNA-DNA fusion molecules) were injected onto a neutral coated capillary. 
Functional sequences were recovered by allowing the unbound pool to pass 
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into a waste vial and applying pressure to the column to isolate the bound 
molecules in a separate vial. After three rounds, a slower migrating peak 
corresponding to TNA-DNA fusions bound to thrombin was visible (Figure 
6.4), indicating that the pool had become enriched in TNA aptamers with 
affinity to thrombin. 
 
Figure 6.4. Enrichment of functional TNA molecules by in vitro selection. A 
peak corresponding to the bound thrombin-TNA aptamers became visible in 
capillary electrophoresis electropherogram after iterative rounds of in vitro 
selection and amplification. 
We cloned and sequenced the DNA to determine the diversity of molecules 
that remained in the pool. Several clones contained isolated G residues, 
indicating that a low level of random mutagenesis had occurred during the 
selection. It is difficult to determine whether these mutations arose during 
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PCR or strand displacement, but their presence indicates a further level of 
diversification. Ten representative sequences were chosen for individual 
analysis. The TNA molecules were synthesized by extending a DNA primer 
annealed to a synthetic DNA template with TNA and purifying the 
DNA-tagged TNA molecules by denaturing gel electrophoresis. We noticed 
that the representative sequences transcribed with much greater efficiency than 
the starting pool (1 versus 10 hours), indicating that the selection favored the 
enrichment of DNA templates that transcribe with high efficiency. The 
resulting TNA aptamers have equilibrium dissociation constants (Kd) for 
thrombin that fall within the range of 200 to 900 nM (Table 6.1), which is 
Table 6.1. Sequence and Binding Affinity for TNA Aptamers. 
Clone Sequence (3’—2’) Kd (nM) 
3.12 TGTTDTDGDDDDDDTDDTGGTGGGGGGTTTDGDTDDDGGGGTDTGDGDG 190 
3.14 GGGGDGTGTGTCGGDDGTTGTGGGTTDGDTTDTTDGTGDDGTGDTGDDGG 250 
3.9 DDGDDTTGGGGGDTTGGTDGGGDGDGDDGDGGTTDDDGTDDGGTDTDTD 320 
3.11 TTGTTDDGTDTGDTGGTTTDTGTDDGGTGGDTDTTTTGDGTTGDGTGGGG 420 
3.1 TTTTTGDTGTGGDGTCTGTTGGDTTGGDDGTTGTTTTTGTGDDGGGG 510 
3.2 DGTGGDGTGTTDGTDDTGGTTTTDDGTGGGGTGDGDTGGGDDTTTGDTTT 590 
3.10 GDTTGDGTGGDGDTGDTTTDDTTTGDGGTGTGTTGGDTTGTTGGG 590 
3.5 DTGGTGDTTTGTTTDTGTGDDCDTGDTGTDTGDGDTTTTGGGGTGTTTTG 750 
3.13 TGDGTDGDTTGGGDDTGTGTGDTTTGGGDTGTGTGGGGGTDDDTTDG 830 
3.6 TGGGTDTDTGTTDGGDTDTDTGTTDDTTTDTDGGTTTGTGDGTGGTTTDG 880 
similar to previously evolved DNA and RNA aptamers that bind to thrombin 
(Bock et al. 1992; Kubik et al. 1994). We determined the minimum binding 
region for the highest affinity aptamer (clone 3.12, Kd ~200 nM at 25 °C) by 
deletion analysis. TNA variants were generated by primer extension using 
DNA templates that contain incremental deletions from both ends of the 
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coding region. We compared the Kd for each deletion construct to the parent 
sequence, which defined a core boundary of 41 nucleotides that retained high 
affinity binding (Figure 6.3b, 6.5). The affinity of the aptamer does not change 
when the DNA primer is exchanged for a different sequence and a randomly 
generated TNA sequence has no affinity to thrombin (data not shown). To  
 
Figure 6.5. Truncation analysis of TNA aptamer 3.12. Comparing the affinity 
of six deletion constructs with the parent sequence defined a core region of 41 
nucleotides (3.12-2t8) that retained high affinity binding to human thrombin. 
demonstrate that clone 3.12 folds into a structure with a ligand binding site 
that is complementary to the surface of human thrombin, we measured the 
solution binding affinity of clone 3.12 to two common proteins, bovine serum 
albumin (BSA) and streptavidin. In both cases, the TNA molecule shows no 
detectable affinity for the off-target protein (Figure 6.3b), indicating that the 
evolved aptamer binds to thrombin with high specificity.  
The idea that life on Earth arose during an ancestral period in which RNA 
stored genetic information and catalyzed metabolically relevant chemical 
reactions was discussed extensively over 40 years ago (Crick 1968; Orgel 
1968; Woese 1967), and later termed the RNA world hypothesis (Gilbert 
1986). While the chemical plausibility of the RNA world remains strong (Cech 
2011), it is not clear that RNA was the first genetic material (Joyce 2002). 
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Problems associated with the prebiotic synthesis of ribose and non-enzymatic 
replication of RNA have fueled interest in the possibility that RNA was 
preceded in the evolution of life by a genetic system that was more accessible 
on the primitive Earth (Joyce et al. 1987; Joyce 1991). Determining which 
genetic systems are both simpler than RNA and capable of Darwinian 
evolution is a daunting challenge. Chemical synthesis is required to build 
substrates that are not otherwise available and enzymes must be discovered 
that can make unnatural polymers with high efficiency and fidelity. In the case 
of TNA, for example, a decade-long effort was required to establish the 
methodology necessary to evolve TNA molecules in vitro. While new 
advances in protein engineering are making it easier to create polymerases that 
recognize unnatural substrates (Loakes and Holliger 2009), future examination 
of structurally diverse genetic systems by in vitro evolution will require 
similar advances in nucleic acid chemistry.  
6.5 Conclusion 
In summary, we have applied the principles of Darwinian evolution to 
evolve TNA molecules that fold into shapes that bind to an arbitrary protein 
target and therefore exhibit a complex function.  This observation coupled 
with the chemical simplicity of threose relative to ribose indicates that TNA 
could have functioned as an ancestral genetic system during a stage of life that 
preceded RNA. The best TNA aptamer identified in our selection binds to 
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human thrombin with activity similar to previously evolved RNA aptamers 
(Bock et al. 1992; Kubik et al. 1994), indicating that the chemical property of 
ligand binding is not unique to the DNA and RNA polymers. This fact was not 
clear at the beginning of our study and indeed one could imagine that purely 
chemical constraints, such as the shorter repeating backbone unit found in 
TNA, might preclude the ability of certain nucleic acid polymers to adopt 
folded structures that function in a desired pre-defined way. The fact that TNA 
is not limited in this regard suggests that it may be possible to isolate novel 
TNA enzymes from pools of random sequences using in vitro evolution. Such 
selections provide a rich opportunity to examine the fitness for TNA as an 
RNA progenitor in a hypothetical TNA world. 
6.6 Methods 
Genereal information 
Solvents (ACS reagent) for extraction and column chromatography were 
purchased from EMD chemicals. Solvents and reagents for reactions were 
purchased from Fluka and Sigma-Aldrich. All anhydrous solvents were dried 
and distilled freshly and stored over activated molecular sieves under Ar. 
Reactions were monitored by TLC on Silica G w/UV 254 aluminum plates 
(Sorbent Tech) visualized by UV absorption or by dipping into a solution of 
anisaldehyde/H2SO4/AcOH/EtOH 5:5:1:18 followed by heating. Solvents for 
NMR were purchased from Cambridge Isotope Laboratories. TMS was used 
 164 
as internal standard in 1H-NMR and 85% H3PO4 was used as external standard 
in 31P-NMR. MALDI-TOF MS was performed on a Voyager-Elite mass 
spectrometry (Applied Biosystems) with THAP or DHB as the matrix. Ion 
exchange chromatography was performed using a customized DEAE 
Sephadex column (EssentialLife solutions) on a GE Pharmacia AKTA FPLC 
system with UV detection eluting with 0-1 M TEAB pH 8.0. Reverse HPLC 
purification was performed using a ZORBAX C-18 reversed-phase HPLC 
column (Agilent Technologies) on an Agilent 1100 HPLC system with UV 
detection eluting with 95% 100 mM TEAA pH 7.0 and a linear gradient from 
5% methanol to 30% methanol. 
N4-Benzoyl-1-(2’-O-acetyl-α-L-threofuranosyl)cytosine 
2.0 g (3 mmol) of N4-Benzoyl-1-{2’-O-acetyl-3’-O-[(4”,4”’-Dimethoxy- 
triphenyl)methyl]-α-L-threofuranosyl}cytosine was treated with 100ml of 3% 
TCA in CH2Cl2 for 3min. MeOH was added dropwise to quench DMT cation 
until the orange color disappeared. The acid was neutralized by ca. 40 ml of 
Et3N, and the mixture was evaporated under reduced pressure immediately. 
The residue was adsorbed onto silica gel and purified by column 
chromatography (CH2Cl2/MeOH 50:1) to give the product (1g, 2.8 mmol) as a 
white powder in 93% yield. TLC (CH2Cl2/MeOH 25:1): Rf 0.23. 1H-NMR 
(400 MHz, DMSO-d6): δ=2.10 (s, 3H), 4.16 (m, 2H), 4.25 (d, J=9.2, 1H), 5.10 
(s, 1H), 5.70 (d, J=2.4, 1H), 5.79 (s, 1H), 7.36 (d, J=7.2, 1H), 7.50 (m, 2H), 
7.62 (m, 1H), 7.99 (m, 2H), 8.13 (d, J=8.0, 1H), 11.24 (s, 1H). 
 165 
9-{2’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}guanine 
1.5g (1.9 mmol) of N2-Acetyl-O6-diphenylcarbamoyl-9-{2’-O-[(4”,4”’- 
dimethoxytriphenyl)methyl]-α-L-threofuranosyl}guanine was dissolved in 8M 
methylamine in ethanol: 12M methylamine in water (1:1) for 3 h at 50℃ 
followed by solvent removal. The residue was purified by column 
chromatography (column deactivation with CH2Cl2/Et3N 100:1, gradient: 
CH2Cl2/Et3N 100:1 to CH2Cl2/MeOH/Et3N 100:4:1) to give the product (1g, 
1.8 mmol) as a white powder in 95% yield. 1H-NMR (500 MHz, CDCl3): 
δ=3.71 (2s, 6H), 4.05 (d, J=9.5, 1H), 4.14 (m, 2H), 4.64 (s, 1H), 5.34 (s, 1H), 
6.59 (br, 2H), 6.71-6.76 (m, 4H), 7.10 (br, s, 1H), 7.17-7.41 (m, 10H). 
9-{2’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L-threofuranosyl}-2,6- 
diaminopurine 
1.5g (1.9 mmol) of N2,N6-Dibenzoyl-9-{2’-O-[(4”,4”’-dimethoxy- 
triphenyl)methyl]-α-L-threofuranosyl}-2,6-diaminopurine was dissolved in 8M 
methylamine in ethanol: 12M methylamine in water (1:1) for 3 h at 50℃ 
followed by solvent removal. The residue was purified by column 
chromatography (column deactivation with CH2Cl2/Et3N 100:1, gradient: 
CH2Cl2/Et3N 100:1 to CH2Cl2/MeOH/Et3N 100:4:1) to give the product (1g, 
1.8 mmol) as a white powder in 95% yield. 1H-NMR (400 MHz, CDCl3): 
δ=3.77 (2s, 6H), 4.05 (d, J=9.6, 1H), 4.17 (dd, J=9.6, 3.6, 1H), 4.27 (m, 1H), 
4.67 (d, J=5.6, 1H), 5.21 (d, J=1.2, 1H), 5.42 (br, s, 2H), 6.72 (br, 2H), 
6.72-6.79 (m, 4H), 7.22-7.41 (m, 9H), 7.58 (s, 1H). 
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(α-L-threofuranosyl)thymine-3’-triphosphate 
50mg (95 µmol) of 1-{2’-O-[(4”,4”’-Dimethoxytriphenyl)methyl]-α-L- 
threofuranosyl}thymine was co-evaporated twice with anhydrous pyridine and 
stored under high vacuum over P2O5 for 1 h. The dry starting material 
obtained was dissolved in 100 µl of anhydrous pyridine and 300 µl of 
anhydrous dioxane and react with 95 µl of 2-chlor-4H-1,3,2-benzodioza- 
phosphorin-4-one in anhydrous dioxane (1M stock). After 10 min a 
well-vortexed mixture of 300 µl of tributylammonium pyrophosphate in 
anhydrous DMF (0.5M stock, 1.5 mol eq.) and 100µl of tributylamine were 
added and the reaction was allowed to stir for 15 min. 2.4 ml of I2 solution in 
pyridine/water 98:2 (1% stock, 1 mol eq.) was added to the reaction mixture. 
The excess iodine was quenched after 10 min by adding 0.8 ml of 5% aq. 
Na2SO3 solution followed by solvent removal. The residue was dissolved in 
50% acetic acid for 20 min at 0℃. The solvent was removed and the residue 
was then dissolved in water and washed twice with ethyl ether. The mixture 
was lyophilized to dryness and purified by ion exchange chromatography and 
reverse phase HPLC. The triethylammonium salt of the resulting triphosphate 
was then converted to the sodium salt as a 5 mM solution for stock in 15% 
yield. 31P NMR (161.8 MHz, D2O): δ=-10.3 (d, J=20.0), -12.4 (d, J=20.0), 
-22.8 (t, J=19.7). MALDI-TOF MS (neg.) 466.77 (calc. 467.14). 
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(α-L-threofuranosyl)cytosine-3’-triphosphate 
50mg (139 µmol) of N4-Benzoyl-1-(2’-O-acetyl-α-L-threofuranosyl)- 
cytosine was co-evaporated twice with anhydrous pyridine and stored under 
high vacuum over P2O5 for 1 h. The dry starting material obtained was 
dissolved in 150 µl of anhydrous pyridine and 450 µl of anhydrous dioxane 
and react with 139 µl of 2-chlor-4H-1,3,2-benzodiozaphosphorin-4-one in 
anhydrous dioxane (1M stock). After 10 min a well-vortexed mixture of 420 
µl of tributylammonium pyrophosphate in anhydrous DMF (0.5M stock) and 
140µl of tributylamine were added and the reaction was allowed to stir for 15 
min. 1.8 ml of I2 solution in pyridine/water 98:2 (1% stock) was added to the 
reaction mixture. The excess iodine was quenched after 10 min by adding 0.6 
ml of 5% aq. Na2SO3 solution followed by solvent removal. The residue was 
dissolved in 28% aq. NH4OH solution at r. t. for 3 h. The solvent was removed 
and the residue was then dissolved in water and washed twice with CH2Cl2. 
The mixture was lyophilized to dryness and purified by ion exchange 
chromatography and reverse phase HPLC. The triethylammonium salt of the 
resulting triphosphate was then converted to the sodium salt as a 5 mM 
solution for stock in 12% yield. 31P NMR (161.8 MHz, D2O): δ=-10.4 (d, 
J=19.6), -12.6 (d, J=20.0), -22.9 (t, J=19.6). MALDI-TOF MS (neg.) 451.71 
(calc. 452.13).  
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(α-L-threofuranosyl)guanine-3’-triphosphate 
65mg (117 µmol) of 9-{2’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L- 
threofuranosyl}guanine was co-evaporated twice with anhydrous pyridine and 
stored under high vacuum over P2O5 for 1 h. The dry compound obtained was 
dissolved in 195 µl of anhydrous pyridine and 780 µl of anhydrous DMF and 
react with 129 µl of 2-chlor-4H-1,3,2-benzodiozaphosphorin-4-one in 
anhydrous dioxane (1M stock). After 10 min a well-vortexed mixture of 351 
µl of tributylammonium pyrophosphate in anhydrous DMF (0.5M stock) and 
117 µl of tributylamine were added and the reaction was allowed to stir for 15 
min. 3.0 ml of I2 solution in pyridine/water 98:2 (1% stock) was added to the 
reaction mixture. The excess iodine was quenched after 10 min by adding 1.0 
ml of 5% aq. Na2SO3 solution followed by solvent removal. The residue was 
dissolved in 50% acetic acid for 20 min at 0℃. The solvent was removed and 
the residue was then dissolved in water and washed twice with ethyl ether. The 
mixture was lyophilized to dryness and purified by ion exchange 
chromatography and reverse phase HPLC. The triethylammonium salt of the 
resulting triphosphate was then converted to the sodium salt as a 5 mM 
solution for stock in 8% yield. 31P NMR (161.8 MHz, D2O): δ=-8.57 (d, 
J=20.0), -12.2 (d, J=20.1), -22.6 (t, J=20.0). MALDI-TOF MS (neg.) 491.76 
(calc. 491.97). 
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(α-L-threofuranosyl)-2,6-diaminopurine-3’-triphosphate 
53mg (95 µmol) of 9-{2’-O-[(4”,4”’-dimethoxytriphenyl)methyl]-α-L- 
threofuranosyl}-2,6-diaminopurine was co-evaporated twice with anhydrous 
pyridine and stored under high vacuum over P2O5 for 1 h. The dry starting 
material obtained was dissolved in 160 µl of anhydrous pyridine and 640 µl of 
anhydrous DMF and react with 104 µl of 2-chlor-4H-1,3,2- 
benzodiozaphosphorin-4-one in anhydrous dioxane (1M stock). After 10 min a 
well-vortexed mixture of 285 µl of tributylammonium pyrophosphate in 
anhydrous DMF (0.5M stock) and 95 µl of tributylamine were added and the 
reaction was allowed to stir for 15 min. 2.4 ml of I2 solution in pyridine/water 
98:2 (1% stock) was added to the reaction mixture. The excess iodine was 
quenched after 10 min by adding 0.8 ml of 5% aq. Na2SO3 solution followed 
by solvent removal. The residue was dissolved in 50% acetic acid for 20 min 
at 0℃. The solvent was removed and the residue was then dissolved in water 
and washed twice with ethyl ether. The mixture was lyophilized to dryness and 
purified by ion exchange chromatography and reverse phase HPLC. The 
triethylammonium salt of the resulting triphosphate was then converted to the 
sodium salt as a 5 mM solution for stock in 8% yield. 31P NMR (161.8 MHz, 
D2O): δ=-9.12 (d, J=20.0), -12.1 (d, J=20.0), -22.6 (t, J=18.4). MALDI-TOF 
MS (neg.) 490.76 (calc. 490.99). 
Oligonucleotides and TNA triphosphates. DNA primers and templates 
were purchased from Integrated DNA Technologies. DNA library L1 was 
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purchased from the Keck Facilities at Yale University. DNA libraries L2 and 
L3 were synthesized on an automated ABI 3400 DNA synthesizer, deprotected 
in concentrated NH4OH for 18 hours at 55 °C, butanol precipitated, and 
purified by denaturing polyacrylamide gel electrophoresis. TNA triphosphates 
were synthesized as previously described (Zou et al. 2005). 
Primer extension assay. DNA primers were 5’-end labeled by incubating in 
the presence of [γ-32P] ATP with T4 polynucleotide kinase for 1 hour at 37 °C. 
32P-labeled primer was annealed to the DNA template in 1x ThermoPol buffer 
[20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% 
Triton X-100, pH 8.8] by heating at 95 °C for 5 minutes and cooling on ice. 
Primer extension reactions contained 100 mM tNTPs (or a combination of 
defined tNTPs and dNTPs mixtures), 500 nM primer-template complex, 1 mM 
DTT, 100 mg/ml BSA, 1.25 mM MnCl2 and 0.1 U/ml Therminator DNA 
polymerase. Primer extension reactions were performed by adding the tNTP 
substrates to a solution containing all other reagents, and heating the mixture 
for 10 hours at 55 °C. Primer extension products were analyzed by 20% 
denaturing polyacrylamide gel electrophoresis. 
In vitro selection. For each round of selection, the self-priming DNA 
library L2 was extended with tNTPs to generate a pool of chimeric TNA-DNA 
hairpin structures. The extension product was phenol/chloroform extracted, 
desalted, and subjected to a strand invasion step. A DNA primer 
(5’-/FAM/AAGGCTACTGCATACGAGTGTCACTACGTACCGTGGTACG
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GCCGAGGTTG-3’) annealed to the stem-loop region of the chimeric 
TNA-DNA hairpin was extended with Therminator DNA polymerase using 
2.5 mM dNTPs in 1x ThermoPol buffer for 30 minutes at 55 °C, followed by 
an additional heating step of 90 minutes at 65 °C. The resulting pool of 
double-stranded DNA-TNA fusion molecules was incubated with human 
a-thrombin (Haematologic Technologies Inc.) at 25 °C for 1 hour. The ratio of 
human thrombin to the TNA library decreased over the course of the selection 
to favor the enrichment of high affinity aptamers. In round 1, the ratio was 
10:1; in round 2 the ratio was 1:1; and in round 3, the ratio was 1:10. Bound 
molecules were separated from the unbound pool using capillary 
electrophoresis. Capillary electrophoresis was performed on Beckman 
ProteomeLab PA 800 Protein Characterization System. Prior to use, the glass 
capillary (inner diameter = 0.1 mm, total length = 60 cm) was rinsed with 
water and equilibrated with selection buffer [50 mM Tris-HCl, 100 mM NaCl, 
1 mM MgCl2, pH 7.4]. A small portion (70 nL) of the library/thrombin mixture 
was injected onto the capillary using pressure injection (0.5 psi for 5 seconds) 
and electrophoresis was performed under a constant voltage of 10 kV at 20 °C 
for 30 minutes. Laser-induced fluorescence (LIF) was used to monitor the 
separation of 6-FAM labeled DNA-TNA fusion molecules (excitation = 488 
nm; emission = 520 nm). Five injections were performed for each round of in 
vitro selection. The thrombin bound TNA was collected and it encoding DNA 
template was amplified by polymerase chain reaction (PCR), which was then 
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used to generate a new self-priming library as input for the next round of 
selection. After three rounds, the library was cloned and sequenced to examine 
the diversity of molecules that remained in the pool. 
Filter binding assay. Representative TNA molecules were synthesized by 
primer extension and purified by denaturing polyacrylamide gel 
electrophoresis as described above with the exception that extension time was 
reduced to 1 hour. The DNA portion of the TNA molecule was labeled with 32P, 
desalted, and annealed by heating for 5 minutes at 95 °C and cooling on ice. 
Folded structures were incubated with human thrombin poised at 
concentrations spanning the expected Kd (typically 1 nM - 1 mM) at 25 °C. 
After 1 hour, the protein bound TNA molecules were partitioned away from 
the unbound fractions using vacuum to pass the solution through a layer of 
nitrocellulose and nylon membranes. Both membranes were quantified by 
phosphorimaging, and dissociation constants were calculated using nonlinear 
least-squares regression analysis performed with DeltaGraph program (Lin et 
al. 2007; Rogers and Joyce 1999). 
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Chapter 7 
CONCLUDING REMARKS 
The work presented in the preceding chapters explores the application of 
unnatural nucleic acids in DNA nanotechnology and molecular evolution. As 
molecules structurally different from natural DNA/RNA, these unnatural 
nucleic acids have to be chemically synthesized. Chapter 2 and 3 described the 
synthetic procedures of phosphoramidites and oligonucleotides for GNA and 
TNA, respectively. In Chapter 5, a simple nanostructure exclusively composed 
of GNA was demonstrated. This structure had extraordinary thermalstability 
comparing with the same structure made up of DNA. The results indicated that 
GNA could be potentially useful in nanoarchitecture construction as an 
orthogonal building material. In Chapter 6, TNA triphosphates were 
synthesized and subjected to polymerase-mediated primer extension. The 
results had lead to an effective way of TNA random library construction. It has 
been of great interest to investigate the sequence space of TNA as a potential 
RNA progenitor candidate. The results in Chapter 6 made it possible to evolve 
functional molecules using a large pool of random TNA sequences. The very 
first TNA aptamer evolved from this pool indicated that ligand binding is not 
limited to natural biopolymers. In Chapter 4, the cross-pairing between 
complementary GNA and TNA were examined in order to find out whether 
there could be a consecutive relationship between these two polymer systems 
in an evolutionary perspective since both polymer systems are structurally 
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simpler and more accessible to prebiotic conditions than RNA. However, the 
observation that there is no hybridization between the two polymer systems 
suggested that GNA and TNA might not be sequential polymers in prebiotic 
evolution of RNA. 
Future Directions 
In Chapter 5, the successful construction of 4-helix junction using GNA as 
building block has shown promising application of GNA in structural DNA 
nanotechnology. It is intriguing and necessary to bring this work further to 
build more complex nanostructures. In order to achieve this goal, it is 
imperative to understand the structure of GNA in more detail, which will 
provide useful information such as helical pitch and flexibility of the GNA 
strands to direct the design of GNA nanostructures with higher complexity. 
The conformation study of GNA is another interesting direction. This study 
might shed light on general understanding of the duplex formation and 
stability. 
In Chapter 6, TNA aptamers binding thrombin has been successfully 
isolated. Evolution of TNA catalysts will further enrich the functionality of 
TNA molecules. The next step of the research will be to understand the 
structural basis of these evolved TNA molecules. The binding site structures 
and catalytic mechanisms need to be elucidated and compared with that of 
RNA molecules. This will help address the question about the fitness 
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landscape of TNA comparing to RNA. This line of research may eventually 
lead to the evolution of artificial genetic systems. 
In summary, unnatural nucleic acids enrich the diversity of genetic 
alphabet, provide us with useful tools for both basic research and applications 
as well as expand the understanding to nucleic acid and evolution of life. A 
major goal of synthetic biology is to recapitulate emergent properties of life, in 
which genetic material plays an indispensable role. Unnatural nucleic acids 
might have found their niche as novel materials, metabolite regulators, and 
diagnostics and therapeutics. The evolution of unnatural nucleic acid 
molecules may ultimatelt lead to the creation of an artifical genetic system 
capable of Darwinian evolution. 
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